Regulation on state aid in sickness, nursing and birth cases (Federal Aid Regulation-BBhV)

Unofficial table of contents

BBhV

Date of completion: 13.02.2009

Full quote:

" Federal aid regulation of 13 February 2009 (BGBl. 326), as defined by Article 1 of the Regulation of 27 May 2015 (BGBl I). I p. 842).

Status:	Last amended by Art. 2 Abs. 28 G v. 1.4.2015 I 434
Note:	Amendment by Art. 1 V v. 27.5.2015 I 842 (No 21) in a textual proof, not yet concludedly processed in a documentary form

For more details, please refer to the menu under Notes

Footnote

(+ + + Text proof: 14.2.2009 + + +) 

  

Unofficial table of contents

Input formula

On the basis of § 80 (4) of the Federal Civil Service Act of 5 February 2009 (BGBl. 160), the Federal Ministry of the Interior, in agreement with the Federal Foreign Office, the Federal Ministry of Finance, the Federal Ministry of Defence, and the Federal Ministry of Health, is responsible for: Unofficial table of contents

Content Summary

Chapter 1
General provisions

§ 1	Regulatory purpose
§ 2	Persons entitled to aid
§ 3	Civil servants abroad
§ 4	Persons eligible for consideration
§ 5	Competitions
§ 6	Aid for expenditure
§ 7	References to the Social Code
§ 8	Exclusion of aid eligibility
§ 9	Settlement of refunds and benefits in kind
§ 10	Entitlement to aid
§ 11	Expenses abroad

Chapter 2
Expenditure incurred in cases of illness
Section 1
Outpatient services

§ 12	Medical services
§ 13	Benefits of health practitioners and practitioners
§ 14	Dental services
§ 15	Implantological, orthodontic, function-analytic and function-therapeutic services
§ 16	Outlays, material and laboratory costs
§ 17	Dental services for civil servants on revocation
§ 18	Psychotherapy, basic psychosomatic care
Section 18a	Common rules for the treatment of psychoanalytically based procedures and behavioural therapy
§ 19	Psychoanalytically substantiated procedures
§ 20	Behavioral therapy
Section 21	Psychosomatic Basic Care

Section 2
Other expenses

Section 22	Medicine and bandage
Section 23	Remedies
§ 24	Complex therapy and integrated care
Section 25	Aids, devices for self-treatment and self-control, body replacement parts
Section 26	Hospital services
§ 27	Home nursing
§ 28	Family and budgetary support
§ 29	Family and household assistance abroad
§ 30	Sociotherapy
§ 30a	Neuropsychological therapy
Section 31	Travel expenses
Section 32	Accommodation costs
§ 33	Life-threatening or regularly fatal diseases

Section 3
Rehabilitation

Section 34	Connection parts and addictive treatments
§ 35	Rehabilitative
§ 36	Requirements for rehabilitation measures

Chapter 3
Expenses in nursing care cases

Section 37	Care counseling, entitlement to care allowance for care services
§ 38	Home care, day care and night care
§ 39	Full-time care
§ 40	Palliative care

Chapter 4
Expenditure in other cases

Section 41	Early detection and preventive measures
§ 42	Pregnancy and Birth
Section 43	Artificial insemination, sterilization, contraception and abortion
Section 44	Transfer Cost
§ 45	First aid, decontamination, communication aid, organ donation and clinical cancer registry

Chapter 5
Amount of aid

Section 46	Measurement of aid
§ 47	Deviating design rate
§ 48	Limitation of aid
§ 49	Own contents
§ 50	Load limits

Chapter 6
Procedures and jurisdiction

Section 51	Authorisation procedure
Section 52	Allocation of expenses
Section 53	(dropped)
§ 54	Application deadline
§ 55	Secrecy
§ 56	Commit Points
Section 57	Administrative provisions

Chapter 7
Transitional and final provisions

Section 58	Transitional provisions
§ 59	entry into force

Appendix 1 (to § 6 (2))	Excluded and partially excluded examinations and treatments
Appendix 2 (to § 6 (3)) Sentence 4)	Maximum amounts for the appropriateness of expenditure on medical practitioners ' benefits
Appendix 3 (to § § 18 to 21)	Ambulant psycho-therapeutic treatments and psychosomatic basic care measures
Appendix 4 (to § 22 (1))	Medical devices eligible for aid
Appendix 5 (to § 22 (2)) Point 1)	Medicines that mainly serve to increase the quality of life
Appendix 6 (to § 22 (2)) Point 3 point (c)	Aid for non-prescription medicines
Appendix 7 (to § 22 (3))	Summary of group of medicinal products for which a fixed amount is applicable
Appendix 8 (to § 22 (4))	Medicinal products excluded or limited by the aid
Appendix 9 (to § 23 (1))	Maximum amounts eligible for aid for medicinal products
Appendix 10 (to § 23 (1)) and Article 24 (1)	Approved service providers for medicinal products
Appendix 11 (to § 25 (1) and (4))	Eligible expenditure for aids, self-treatment and self-control equipment, body replacement parts
Appendix 12 (on 25 (1), 2 and 4)	Non-aid tools, self-treatment and self-control equipment
Appendix 13 (to § 41 (1) sentence 3)	In accordance with § 41 (1) sentence 3, early detection examinations, preventive measures and protective vaccinations
Appendix 14 (to § 41 (3))	Early detection programme for hereditary persons with increased familial breast or ovarian cancer risk

Chapter 1
General provisions

Unofficial table of contents

§ 1 Regulatory purpose

This Regulation lays down rules on the granting of aid in the cases provided for by law. The aid supplements the health care, which is usually to be paid out of the current references. Unofficial table of contents

§ 2 persons entitled to the aid

(1) Unless otherwise specified in paragraphs 2 to 5, it shall be eligible for the assistance of who at the time of the performance of the service

1.

Official or official,

2.

Beneficiary or recipient of the supply, or

3.

Former official or former official

(2) The eligibility of the aid shall also be conditional on the person entitled to benefit from the allowance, the remuneration, the salary, the pension, the transitional allowance, the widows, the widows, the orphan's money, the maintenance contributions referred to in Section II, or the section V, in accordance with Section 22 (1) or in accordance with Article 26 (1) of the Civil Service Act or transitional allowance under Section VI of the Civil Service Act. The eligibility of the aid shall also apply if payments are not paid on the grounds of parental leave or the application of frenzied, accrual or reduction provisions. The right to the aid shall not be affected on leave under the omission of remuneration under the special leave regulation if it does not last longer than one month. (3) Not eligible for assistance

1.

Honorary officers and honorary officers,

2.

Civil servants whose service is limited to less than one year, unless they are employed for a total of at least one year in the public service in the sense of Section 40 (6) of the Federal Law on Remuneration, and

3.

Civil servants and recipients of care who are entitled to benefits under Section 11 of the European Members ' Act, Section 27 of the Act on Members of the European Parliament or corresponding priority national regulations.

(4) Non-eligible persons under this Regulation are those civil servants of the Federal Railways Property, which at the time of the merger of the Deutsche Bundesbahn and the Deutsche Reichsbahn are officials of the Germans. (5) Non-eligible persons under this Regulation are those who are A-members of the Postbeamtenkrankenkasse, in so far as the Statutes for the eligible expenditure of these members provide for benefits in kind and these are not limited by a maximum amount. Unofficial table of contents

§ 3 Officials and Officials abroad

According to Article 2 (1) (1) of the EC Treaty, those officials who have their place of residence abroad or who are secondarily secondhand are also entitled to state aid. Unofficial table of contents

§ 4 Ineligible persons

(1) Spouses, spouses, life partners and life partners of eligible persons are eligible if the total amount of their income (§ 2 (3) in conjunction with paragraph 5a of the Income Tax Act) or comparable foreign income in the second calendar year before application for the aid does not exceed EUR 17 000. If this total amount of income is not reached in the current calendar year, spouses, spouses, life partners and partners are eligible to take into account already in the current year under the reservation of withdrawal. The income earned abroad by the spouses, spouses, life partners and partners of the persons entitled to the assistance in accordance with § 3 abroad remains unaccounted for. The total amount of income is to be proved by submitting a tax certificate. If the tax notice does not completely cover the total amount of the income, other evidence can be requested. (2) Children are eligible if they are entitled to the family allowance of the person entitled to the benefit under the Bundesbesoldungsgesetz (Bundesbesoldungsgesetz) be eligible for consideration. This shall apply to persons entitled to the assistance in accordance with § 3, if:

1.

The right to a foreign surcharge pursuant to § 53 (4) (2) and (2a) of the Federal Law on Gesetz (Bundesbesoldungsgesetz)

2.

a surcharge in accordance with § 53 (4) (2) and (2a) of the Bundesbesoldungsgesetz (Bundesbesoldungsgesetz) is not paid because there is a household in Germany of a parent who is or has been entitled to care for the child.

(3) Members of the orphan who are eligible for assistance shall not be eligible for consideration. Unofficial table of contents

§ 5 Competitions

(1) The eligibility of the aid shall be excluded from a service

1.

an entitlement to the aid on the basis of a supply claim and

2.

the ability to take into account according to § 4

(2) The eligibility of the aid on the basis of a supply cover excludes the eligibility of the aid on the basis of previous pension rights and as a person eligible for consideration. Sentence 1 shall not apply if the former pension entitlement is based on its own service. (3) The entitlement to the aid on the basis of private-law legal relations under schemes which are essentially comparable to this Regulation shall be

1.

the entitlement to the aid on the basis of a supply claim and

2.

the ability to take into account according to § 4

before. There is no essentially comparable arrangement for the entitlement to the quota for employees who are part-time employees. (4) A child shall be taken into account in the person entitled to the allowance who receives the family allowance for the child. Eligible for aid within the meaning of the first sentence are also persons who are entitled to aid which is substantially comparable in its scope to the claim under this Regulation, irrespective of the basis for which the aid is based. Family surcharge for the child within the meaning of sentence 1 are the benefits in accordance with § § 39, 40 and 53 of the Bundesbesoldungsgesetz (Bundesbesoldungsgesetz) or comparable benefits granted with regard to the child. Sentences 1 and 2 shall not apply to persons who are entitled to health care or to troop medical care. Unofficial table of contents

§ 6 State aid eligibility of expenses

(1) State aid is in principle only necessary and economically reasonable expenditure. Other expenses are exceptionally eligible for aid in so far as this Regulation provides for the eligibility of the aid. (2) The need for expenditure on investigations and treatments requires, in principle, that they should be based on a scientific basis. be done. As a rule, examinations and treatments are deemed not to be necessary in so far as they are excluded in Appendix 1. (3) In principle, expenses for medical, dental and psychotherapeutic services are reasonable if: they comply with the fee schedule of the fees regulations for doctors, dentists as well as for psychological psychotherapists and children's and adolescents 'and adolescents' psychotherapists. Expenses due to an agreement pursuant to § 2 (2) of the Rules of Fees for Doctors, in accordance with § 2 (3) of the Fees Regulations for Dentists or according to sentences 2 to 4 of the General Provisions of the Section G of the system of fees for dentists. Also economically appropriate are services which are based on the agreements of statutory health insurance companies according to the Fifth Book of Social Code or on the basis of contracts of companies of private health insurance with service providers or service providers, if this saves costs. Expenses for services of medical practitioners are economically appropriate if they do not exceed the maximum amounts pursuant to Appendix 2. (4) For persons who are entitled under § 3 or with a person according to § 3 Eligible persons shall be considered to be economically appropriate, taking into account the special circumstances of the country. The Federal Ministry of the Interior may, in individual cases, apply the maximum amounts according to Appendix 11, in appropriate application of § 55 of the Federal Law of Remuneration, to the applicable sales force for the place of work. with the Federal Ministry of Finance declare the one-time participation of the federal government as state aid in general, non-individualisable measures. The Federal Ministry of the Interior may distribute payments and reimbursements to the institutions or bodies of the Federal Government which grant aid under this Regulation. At the request of the Federal Ministry of the Interior, the institutions or bodies shall make appropriate deductises and payments. The shares are calculated according to the ratio of actual state aid expenditure in 2009; annual expenditure of less than EUR 1 000 is not considered. At the request of at least five supreme federal authorities or authorities of the indirect federal administration, the Federal Ministry of the Interior shall set the shares in accordance with the ratio of actual state aid expenditure in the previous year for future measures (6) If, on a case-by-case basis, the refusal of the aid would constitute a particular hardship, the supreme service authority, with the agreement of the Federal Ministry of the Interior, may grant aid in order to mitigate the hardship. The decision shall be particularly justified and documented. Unofficial table of contents

§ 7 referrals to the Social Code

In so far as the content and design of benefits to which aid is granted are based on the provisions of the Fifth Book of Social Code, the eligibility of the expenditure shall require that the benefits, including those of the Medicinal products according to the generally accepted state of medical knowledge of diagnostic or therapeutic benefits, medical necessity and cost-effectiveness, and in particular a medicinal product is appropriate. and no other, more economical treatment option with comparable diagnostic or therapeutic benefit is available. Reference is made in this Regulation to the provisions of the Fifth Book of the Social Code, which in turn are based on the guidelines of the Joint Federal Committee pursuant to Article 91 of the Fifth Book of the Social Code, decisions or agreements of the In accordance with § 78 of the German Federal Civil Service Act (Bundesbeamtengesetz), the application of the law to the top associations of statutory health insurance companies or statutory health insurance companies refer to or refer to them in accordance with § 78 of the German Federal Civil Service Act (Bundesbeamtengesetz). to comply with these standards or decisions. This applies in particular to § § 22 and 27 (1) sentence 2, § § 30 and 40 (1), § 41 (1), § 43 (1) and § 50 (1) sentence 4. Moreover, the provisions of the Social Code, to which this Regulation refers, shall apply in so far as the basic differences between aid and social security law do not exclude this. Unofficial table of contents

Section 8 Exclusion of aid eligibility

(1) Non-eligible expenditure

1.

as far as persons who are eligible for assistance or are eligible for eligible persons have a right to health care pursuant to Section 70 (2) of the Bundesbesoldungsgesetz (Bundesbesoldungsgesetz) or equivalent national legal provisions,

2.

for opinions which have not been initiated by the authorities, but at the request of the person entitled to the assistance or the person to be taken into account,

3.

for medical and dental certificates for persons eligible for consideration, with the exception of medically necessary certificates,

4.

for the visit of pre-school or school facilities or workshops for the disabled,

5.

for professional, preparatory, vocational and curative pedagogical measures,

6.

for examinations and treatments as a result of medically non-indexed measures, in particular aesthetic operations, tattoos or piercings, and

7.

for examinations and treatment by the spouse, the spouse, the life partner, the life partner, the parents or the children of the person or treatment; in such cases, only the actual costs actually incurred shall be eligible for assistance.

(2) Furthermore, expenses are not eligible for assistance in so far as there is a substitute claim against a third party who does not transfer to the Dienstherrn or his representative. (3) Non-eligible payments and shares are not eligible for assistance. Self-contents according to § 53 of the Fifth Book of Social Code as well as expenses for medical care excluded from the health care, aids and remedies as well as discounts for administrative costs and lost pharmacist and manufacturer rebates at the Reimbursement of costs pursuant to § 13 para. 2 of the Fifth Book of Social Code. (4) Not Eligible property and services are provided in accordance with § 2 para. 2 of the Fifth Book of the Social Code. In accordance with § 2 (2) of the Fifth Book of the Social Code, the reimbursement of expenses in the case of orthodontic treatment and in the case of compulsory insured persons in accordance with § 5 of the Fifth Book of the Social Code, including the family-insured persons according to § 10 of the Fifth Book of the Social Code also the reimbursement according to § 13 of the Fifth Book of Social Code. In the case of persons who are granted a grant or an employer's share of the sickness insurance contribution or who are entitled to a non-contributory health insurance, they are also considered to be services and services.

1.

the amounts in excess of the fixed amounts for medical, association and aid under the fifth Book of Social Code and

2.

Expenditure which is based on the fact that insured persons have not used the material and service they are entitled to; this also applies when the service providers in other Member States of the European Union are in Claims are taken, except for expenses for election services in the hospital.

Sentence 3 shall not apply to:

1.

persons who receive benefits pursuant to § 10 (2), (4) or (6) of the Federal Supply Act or to the provisions of this Act,

2.

voluntary members of statutory health insurance, and

3.

Eligible children who are covered by compulsory insurance in the statutory health or pension insurance of another person.

(5) Paragraphs 3 and 4 shall not apply to benefits under the Twelfth Book of Social Code, where claims have been transferred to the social assistance carrier. Unofficial table of contents

Section 9 Invoice of refunds and benefits in kind

(1) Insofar as expenses are borne or reimbursed by third parties on the basis of legislation or contractual agreements, they shall be deducted from the eligible expenses before the aid is calculated. This shall not apply to refunds and benefits in kind

1.

persons entitled to the common health care system of the European Community, or

2.

of statutory health insurance from a voluntary insurance relationship.

Pension rights of persons entitled to the assistance shall not be deemed to be claims for reimbursement of expenses. (2) The maximum possible amount of the statutory health insurance shall be the expenses for dentures, dental crowns and supraconstructions. (3) In the case of aid, they must nevertheless be taken into account in the case of a grant or a kind of entitlement to benefits in respect of a third party or a third party. In this case, expenses for medical and bandage means are to be set at full height. Other expenses, the fictitious performance part of which cannot be proved or can be determined, shall be set at 50 per cent of the expenses incurred as an amount of benefits or benefits in kind. The rates 1 to 3 shall not apply to:

1.

Refunds and benefits in kind pursuant to Section 10 (2), (4) and (6) of the Federal Law on the Supply of Services or in accordance with provisions which refer to this

2.

eligible children who are covered by compulsory insurance in the statutory health or pension insurance scheme of another person, and

3.

Reimbursements and benefits in kind provided by statutory health insurance from a voluntary insurance relationship.

(4) In the case of persons who are eligible under § 3 or are eligible for a person entitled under § 3, the offsetting of a benefit in accordance with the first sentence of the third sentence of paragraph 3 may be waiver if the benefits to which the person is entitled to could not be used because of danger to life and life, or because of the special conditions in foreign countries could not actually be obtained. Unofficial table of contents

Section 10 Aid claim

(1) A legal claim shall be granted to aid. The claim cannot be resigned and, in principle, not pledged or paved. The pledge for a claim on the basis of a performance of the creditor's creditor or of the creditor is admissible in so far as the aid is not yet disbursed. (2) After the death of the person entitled to the aid, it may be possible to: the aid shall be paid in the following accounts with a liberating effect:

1.

the payment account of the deceased or the deceased,

2.

a different account specified by the deceased person in the application or in the power of atonation, or

3.

an account of one or more heirs or heirs designated by a certificate of inheritance or by another public or publicly certified certificate.

Unofficial table of contents

§ 11 expenses abroad

(1) expenditure on services in a Member State of the European Union should be treated as expenses incurred in the country. § 6 (3) shall not apply in such cases. Expenditure on services outside the European Union is eligible for aid up to the amount in which it was created and eligible for assistance. (2) expenses incurred outside the European Union in accordance with paragraph 1 shall be without limitation the costs that would have been incurred domestiously, if:

1.

they came into being on a mission and the treatment could not have been postponed until the return to the country,

2.

they do not exceed EUR 1 000 per disease case for medical and dental services,

3.

to seek the nearest hospital in the vicinity of the German border, or persons who are eligible for assistance, or who have been taken into account, in the case of acute treatment needs,

4.

to seek emergency care for the nearest hospital or to be able to take into account emergency care, or

5.

the eligibility of aid has been recognised before the journey is taken.

An acknowledgement as provided for in the first sentence of paragraph 5 shall be taken into account, exceptionally, where a medical opinion commissioned by the authorities proves that treatment outside the European Union is absolutely necessary, as this means that the treatment should be In duly justified exceptional cases, recognition may be retrospected. (3) In the case of persons who are entitled to receive assistance pursuant to § 3 of the German law of a person entitled to be eligible under § 3, are Expenses incurred during a non-service stay outside the host country and outside the European Union abroad, only to the extent that they were incurred in the host country or in the country, up to the level of the amount eligible for aid; would be eligible. This shall not apply in the cases of § 31 (5).

Chapter 2
Expenditure incurred in cases of illness

Section 1
Outpatient services

Unofficial table of contents

§ 12 Medical benefits

Expenses for out-patient medical examinations and treatments are, in principle, eligible for aid in accordance with § 6 in cases of illness. The provisions of Chapter 4 shall remain unaffected. Expenditure on work incapacity certificates for the person entitled to the benefit of the person entitled to the assistance shall be borne by the place of detention. Unofficial table of contents

§ 13 Benefits of medical practitioners and medical practitioners

Expenses for services of medical practitioners are eligible under the conditions of § 6 (3) sentence 4 and § 22 (6). Unofficial table of contents

§ 14 Dental benefits

Expenses for outpatient dental and orthodontic examinations and treatments are in principle eligible for assistance in accordance with § 6. For dentures and implantological services, a plan of salvation and cost can be submitted to the site of the arrest before the treatment is received. The costs of the salvation and cost plan are part of the eligible expenses. Expenditure on work incapacity certificates for the person entitled to the benefit of the person entitled to the assistance shall be borne by the place of detention. Unofficial table of contents

§ 15 Implantological, orthodontic, function-analytic and function-therapeutic services

(1) expenses for implantological services in accordance with Section K of the Appendix to the fees regulations for dentists are eligible for assistance with:

1.

greater jaw or facial defects, which have their cause in

a)

tumor operations,

b)

Inflammation of the jaw,

c)

Operations resulting from large cysts, such as large folicular cysts or keratocysts,

d)

operations resulting from osteopathies, provided that there is no contraindication for implant care,

e)

Congenital malformations of the jaw, cleft lip, jaw, palate, ectodermal Dyplasia, or

f)

accidents,

2.

permanently existing extreme xerostomy, in particular in the case of tumor treatment,

3.

Generalised genetic non-installation of teeth,

4.

non-willfully influenceable muscular dysfunctions in the mouth and face area (for example spastics) or

5.

Implant-based tooth replacement in the toothless upper or lower jaw.

In the case of the first sentence of point 5, the expenditure shall be eligible for a maximum of four implants per jaw, including existing implants for which aid or comparable benefits have been granted from public funds. If none of the cases referred to in the first sentence of the first sentence of 1 to 5 is present, the costs shall be for a maximum of two implants per jaw, including existing implants, for which aid or comparable benefits have been granted from public funds, be eligible for assistance. The expenses, including the material and laboratory costs in accordance with § § 4 and 9 of the fees regulations for dentists, shall be reduced in accordance with the ratio of the number of non-eligible persons to the total number of implants. Expenses for superstructures are always eligible for assistance. (2) expenses for orthodontic services are eligible for assistance if:

1.

at the beginning of treatment, 18. Year of age is not yet completed; or

2.

in case of severe jaw anomalies, a combined orthodontic and orthodontic treatment is performed

and the fixing body agreed to the expenses before the beginning of the treatment on the basis of a plan of salvation and cost. Expenses for retention of benefits are eligible for aid up to two years after the completion of the orthodontic treatment approved by the site on the basis of the salvation and cost plan. The costs of the salvation and cost plan in accordance with the first sentence shall be eligible for assistance. In the case of an abatement of an orthodontic treatment or a change of the orthodontist or the orthodontist to be represented by the person entitled to the assistance or the person taking into account, only the expenses shall remain (3) expenses for orthodontic services before the start of the second phase of the exchange of teeth are only eligible for assistance in the case of the

1.

Elimination of habits in the case of a habitually distalite at the distal sagittal stage with a frontline level of more than 9 millimetres,

2.

Elimination of habit at a vertical level of more than 4 millimetres in the case of a habitually open or lateral bite,

3.

keeping gaps due to premature milk tooth loss;

4.

Early treatment

a)

a distal sagittal step with a front tooth level of more than 9 millimetres,

b)

a lateral cross-or coercive bite in the case of a transverse deviation with one-sided or double-sided crossbite, which is not to be corrected by preventive measures,

c)

a buccal occlusion, a non-occlusion or a lingualocclusion of permanent teeth in the event of a transverse deviation,

d)

of a progenic coercive bisses or frontal crossbite at mesial sagittal level,

e)

in the case of a lack of space for the creation of tooth gaps of more than 3 and not more than 4 millimetres, or to increase tooth gaps by more than 3 and not more than 4 millimetres,

5.

early treatment

a)

a lip-jaw-palate-column or other craniofacial anomalies,

b)

a skeletal open bite at a vertical level of more than 4 millimetres,

c)

of a progeny at mesial sagittal level,

d)

injury-related jaw misalignments.

The early treatment referred to in the first sentence of paragraph 4 shall be completed within six calendar quarters and shall not be commenced before the fourth year of life; regular orthodontic treatment may be followed if the second stage of the treatment is completed. Tooth change is present. Expenses for the use of individually manufactured treatment equipment are separately eligible for treatment in addition to the expenses for a treatment according to the first sentence of 1. 4 and 5. (4) expenditure on functional and functional therapy services are only eligible for the presence of one of the following indications:

1.

jaw joint and muscular disorders,

2.

Dental carcases in the context of systematic periodontal treatment,

3.

Treatment with bite-on surfaces with adjusted surfaces according to numbers 7010 and 7020 of the fee schedule for dentists,

4.

extensive orthodontic measures including orthodontic orthodontic surgeries or

5.

Extensive pastries.

A denture is extensive if at least eight side teeth have to be supplied with dentures or inlays in a jaw, with missing teeth being equated in need of remediation, and the correct final bite position no longer being applied to the patient. can be manufactured in a different manner The person entitled to the assistance shall submit a copy of the dental documentation referred to in point 8000 of the Annex to the Fees Regulations for Dentists to the Enforcement Body. Unofficial table of contents

§ 16 expenses, material and laboratory costs

(1) separately calculable expenses for expenses, material and laboratory costs in accordance with § 4 (3) and § 9 of the fees regulations for dentists who are subject to a dental treatment according to the numbers 2130 to 2320, 5000 to 5340, 7080 to 7100 and 9000 up to 9170 of the charge order system for dentists have been created, 40% are eligible for aid. This shall not apply in the case of indications in accordance with Article 15 (1), first sentence, points 1 to 4. (2) If the proportion falling on the expenses referred to in paragraph 1 is not proven, 40 per cent of the total amount of accounts must be set. Unofficial table of contents

§ 17 Dental services for civil servants on revocation

(1) Expenditure on dental services for civil servants on revocation and persons who are eligible for them shall be eligible for aid, unless they are excluded in paragraph 2. (2) excluding expenses for

1.

Prosthetical services,

2.

inlays and dental crowns,

3.

functional analytical and function-therapeutic services, and

4.

Implantological services.

Expenditure under the first sentence shall exceptionally be eligible for aid if it is based on an accident during the preparatory service or if the person entitled to the assistance has previously been employed uninterrupted in the public service for at least three years is. Unofficial table of contents

§ 18 Psychotherapy, Psychosomatic Basic Care

(1) expenses for psychotherapy services in the forms of psychoanalytic-founded procedures and behavioural therapy as well as for services of psychosomatic basic care shall be provided in accordance with paragraphs 2 and 3 as well as § § 18a bis 21 eligible. (2) Before treatment by psychological psychotherapists or by children and adolescents psychotherapists, a somatic clarification must be made no later than after the probatoric meetings or prior to the initiation of the evaluation procedure. The eligibility of aid requires that the somatic clarification be confirmed by a doctor or a doctor in a written account. (3) Non-eligible expenses are not eligible for assistance.

1.

Simultaneous treatments according to § § 19 to 21,

2.

Services referred to in Section 1 of Annex 3.

Unofficial table of contents

Section 18a Common rules for the treatment of psychoanalytically based methods and behavioural therapy

(1) expenses for services of psychotherapy are eligible for assistance with

1.

affective disorders: depressive episodes, recurrent depressive disorders and dysthymia,

2.

Anxiety disorders and obsessive compulsive disorder,

3.

somatoform disorders and dissociative disorders,

4.

Adjustment disorders and reactions to heavy loads,

5.

Eating disorders,

6.

non-organ sleeping disorders,

7.

sexual dysfunction,

8.

Personality and behavioural disorders.

(2) In addition to or following a somatic medical treatment of diseases or their effects, expenses for services of psychotherapy are eligible for assistance in the case of

1.

mental disorders and behavioural disorders

a)

by psychotropic substances; in the event of dependence only where the freedom of the addiction or abstinence is reached or is likely to be achieved within ten sessions,

b)

by opioids and at the same time stable substitution-based treatment in the state of the freedom of the side-of-use,

2.

Mental diseases due to early childhood emotional states of deficiency or profound developmental disorders, in exceptional cases also in the case of mental illnesses associated with early childhood physical lesions or malformations are standing,

3.

Mental diseases as a result of severe chronic disease progression,

4.

schizophrenic and affective psychotic disorders.

The eligibility of aid shall require that the benefits be provided by a doctor, a doctor, a therapist or a therapist, in accordance with sections 2 to 4 of Annex 3. A session of psychotherapy comprises a treatment duration of at least 50 minutes in a single treatment and of at least 100 minutes in a group treatment. (3) expenses for services of psychotherapy, which are to the scientific in accordance with the conditions laid down in sections B and G of the Annex to the Rules relating to Fees for Doctors, shall be eligible for aid if:

1.

serve the purpose of detecting, curing or alleviating disorders referred to in paragraph 1 in which psychotherapy is indicated,

2.

After a biographical analysis or a behavioural analysis and after a maximum of five, a treatment success is to be expected after a maximum of eight probatoric sessions in the case of analytical psychotherapy, and

3.

the fixing body, prior to the start of the treatment, has recognised the eligibility of the expenditure on the basis of an opinion on the necessity, type and extent of the treatment.

Expenditure on the measures referred to in point 2 of the first sentence shall also be eligible if psychotherapeutic treatment has subsequently proved to be unnecessary. (4) The opinion referred to in paragraph 3, first sentence, point 3 shall be the case of a reviewer or a person who is not responsible for the treatment. In accordance with § 12 of the Psychotherapy Agreement, in accordance with § 12 of the Psychotherapy Agreement, in accordance with § 12 of the Psychotherapy Agreement, in accordance with § 12 of the Psychotherapy Agreement, the Federal Association of the German Federal Association for Health and Sickness Insurance (Bundesvereinigung) shall be required The Federal Association (www.kbv.de) has been appointed. For persons who are eligible under § 3 or are eligible for a person entitled under § 3, the opinion can be found at the Health Service of the Federal Foreign Office or at one or more of the Health Service of the Federal Foreign Office (5) If persons who are eligible under § 3 or are able to take into account a person entitled to the assistance under § 3, do not have a personal access to native-language versions of the person at the place of work. psychotherapeutic treatments, the expenses for the following Benefits also eligible for assistance if the services are provided on a telecommunications basis:

1.

Psychotherapy based on depth psychology as specified in point 861 of the system of fees for doctors or

2.

Behavioural therapy in accordance with point 870 of the system of fees for doctors.

In the case of telecommunication-based therapy, up to 15 sessions are eligible for assistance. If a psychotherapy or behavioural therapy in groups or an analytical psychotherapy as a single or group therapy is used as individual or group therapy for a telecommunication-based therapy, the expenses are for the purposes of telecommunications-based therapy, if the enforcement body has recognised the eligibility of the aid after obtaining an opinion on the need for change. Expenses for benefits in accordance with the first sentence are only eligible if they are necessary in the context of a psychotherapeutic treatment begun in Germany for the further stabilization of the success achieved. (6) Expenditure for a Eye-Movement-Desensitization-and-Reprocessing-treatment are only for persons who are the 18. With post-traumatic stress disorder in the context of a comprehensive treatment concept of behavioural therapy, psychotherapy based on deep psychology or analytical psychotherapy can be considered as eligible for aid. Unofficial table of contents

Section 19 Psychoanalytically based procedures

(1) expenses for psychoanalytically based procedures with their two forms of treatment, psychotherapy based on psychotherapy and analytical psychotherapy (numbers 860 to 865 of the system of fees for doctors), are each Case of illness to the following extent eligible for assistance:

1.

Psychotherapy of persons who are in depth psychologically based on the 18. Year of life completed:

Single Treatment groups- treatment

as a rule	50 meetings	40 meetings
in special cases	30 other meetings	20 other meetings
if the treatment objective has not yet been reached in the said meetings	Maximum 20 Other meetings	Maximum 20 Other meetings

2.

analytical psychotherapy of persons who are the 18. Year of life completed:

Single Treatment groups- treatment

as a rule	80 meetings	40 meetings
in the case of renewed detailed reasoning of the therapist	80 other meetings	40 other meetings
in special cases	once again 80 Other meetings	once again 40 Other meetings
if the treatment objective has not yet been reached in the said meetings	Maximum 60 Other meetings	Maximum 30 Other meetings

3.

in-depth psychologically sound or analytic psychotherapy of persons who are the 14. Life year, but not yet 18. Year of life completed:

Single Treatment groups- treatment

as a rule	90 meetings	40 meetings
in the case of renewed detailed reasoning of the therapist	50 more Sessions	20 more Sessions
in special cases	Maximum 40 Other meetings	Maximum 30 Other meetings

4.

in-depth psychologically sound or analytic psychotherapy of persons who are the 14. Have not yet completed a year of life:

Single Treatment groups- treatment

as a rule	70 meetings	40 meetings
in the case of renewed detailed reasoning of the therapist	50 more Sessions	20 more Sessions
in special cases	Maximum 30 Other meetings	Maximum 30 Other meetings

In special cases, the supreme service authority may also recognise the eligibility of expenditure for the treatment beyond the maximum number of meetings laid down in the first and fourth sentences of the first subparagraph, if the medical need is (2) In the case of medical necessity, the need for the inclusion of reference persons in the therapy of persons, which is the 18. In the case of individual treatment, the eligibility of expenditure in respect of individual treatment of up to a quarter and, in the case of group treatment, up to half of the approved number of meetings may, in addition to completion, be added to the aid capacity of the (3) In the context of psychoanalytically based procedures, the simultaneous combination of single and group therapy is fundamentally excluded. Expenses for the services of such a combination are only eligible if they are provided in the field of psychotherapy in depth psychologically in the case of low-frequency therapies on the basis of a particularly well-founded initial application. (4) Expenses for catathymic image life are only eligible for assistance in the context of a superordinate depth psychological therapy concept. Unofficial table of contents

§ 20 Behavioral Therapy

(1) expenses for a behavioural therapy (numbers 870 and 871 of the annex to the fees regulations for doctors) are eligible for the following extent per case of illness:

Single Treatment groups- treatment

Rule Case	45 meetings	45 meetings
if the treatment target has not been reached within 45 sessions	15 more Sessions	15 more Sessions
in special cases	20 more Sessions	20 more Sessions

(2) Paragraph 19 (2) shall apply. (3) A recognition pursuant to Section 18a (3), first sentence, point 3, shall not be required if, after the probatorical meetings, the point of detention is determined by the therapist or therapist according to section 4 of the Appendix. 3.

1.

in the case of individual treatment, no more than ten meetings,

2.

for group treatment no more than 20 sessions

are required. If, in special cases, the treatment has to be extended, the place of detention shall be notified without delay. Expenses for further meetings are only available after prior recognition of the medical necessity by the site of the arrest. For this purpose, the body has to obtain an opinion according to § 18a paragraph 3 sentence 1, point 3. (4) expenses for a rational-emotional therapy are only eligible for assistance in the context of a comprehensive behaviorally therapeutic treatment concept. Unofficial table of contents

§ 21 Basic Psychosomatic Care

(1) The basic psychosomatic supply within the meaning of this Regulation shall be:

1.

verbal interventions within the framework of the number 849 of the list of fees for medical services of the doctors ' fees and fees

2.

Hypnosis, autogenic training and relaxation therapy according to Jacobson according to points 845 to 847 of the system of fees regulations for doctors.

(2) Eligible expenditure for each case shall be:

1.

verbal intervention as a single treatment with up to 25 sessions, both over a shorter period of time and in the course of chronic diseases over a longer period of time in low-frequency form,

2.

Hypnosis as a single treatment with up to twelve sessions as well as

3.

Autogenic training and relaxation therapy according to Jacobson as single or group treatment with up to twelve sessions; a combination of individual and group treatment is possible here.

Charges for benefits under the first sentence of 1 (1) shall not be eligible if they have been incurred together with expenses incurred in the same sitting for the benefit of the services referred to in the first sentence of the first sentence of the first subparagraph and point 3. In addition to the expenditure on services referred to in paragraph 1 (1), expenditure on somatic medical examinations and treatments for diseases and their effects is eligible for aid. (3) expenses for an outpatient outpatient for up to six months. Psychosomatic aftercare after a steady-state psychosomatic treatment is eligible for assistance.

Section 2
Other expenses

Unofficial table of contents

Section 22 Medicine and association products

(1) Aid eligible for medical or dental expenses in accordance with the type and extent of treatment prescribed in writing or used during treatment

1.

Medicinal products according to § 2 of the Medicinal Products Act, which are subject to pharmacovigilanship,

2.

Means of fading,

3.

Harp and blood test strips, as well as

4.

Substances and preparations of substances which are listed as medical devices in accordance with § 3 (1) and (2) of the Medical Devices Act for use on or in the human body, are listed in Appendix 4 and fulfil the measures referred to therein.

(2) Non-eligible expenditure shall be incurred in respect of:

1.

Medicinal products which are mainly intended to increase the quality of life (Annex 5), unless the purpose stated in Appendix 5 is not the case in individual cases, but the treatment of another body dysfunction, which is a disease and, and

a)

there are no other medicinal products authorised for the treatment of this disease; or

b)

the other authorised medicinal products are unbearable on a case-by-case basis or have proved to be not effective;

2.

Medicinal products subject to medical prescription for the treatment of

a)

Cold and flu-like infections, including the musts to be used in these diseases, painkillers, coughing and coughing agents, provided that they are minor health disorders,

b)

Oral and pharyngeal disorders, except in the case of

aa)

fungal infections,

bb)

Ulcers in the oral cavity or

cc)

After surgical interventions in the neck, nose and throat area,

c)

Constipation, except for the treatment of diseases associated with tumors, megacolone, diverticuloses, diverticulitus, cystic fibrosis, neurogenic intestinal paralysis, pre-diagnostic interventions, in the case of phosphate-binding medication, in the case of chronic diseases Renal insufficiency, opiate and opioid therapy, and in the terminal phase, or

d)

Travel diseases, except in the case of use for vominating in the case of tumour therapy and other diseases, for example Menièrescher symptom complex,

in so far as the medicinal products are not intended for minors,

3.

non-prescription medicinal products, unless they are

a)

are intended for persons who have not yet completed the twelfth year of life or for persons who have not completed the 18 years of age. years have not yet been completed and suffer from developmental disorders,

b)

have been required for diagnostic purposes, examinations and outpatient treatments, and are settled in the invoice as outlays, or

c)

shall be considered as a standard of treatment in the treatment of a serious illness and shall, exceptionally, be prescribed for this reason; the exceptions eligible for aid shall be set out in Annex 6,

4.

hormonal agents for contraception; this does not apply to persons under 20 years of age, or if these funds are prescribed for the treatment of a disease, irrespective of the authorisation of the medicinal product.

(3) expenditure on medicinal products which are to be attributed to medicinal products for which a fixed amount may be fixed in accordance with Article 35 (1) of the Fifth Book of Social Code in accordance with Annex 7 shall only be up to the amount of the fixed amounts in accordance with the provisions of the Overviews in accordance with § 35 (8) of the Fifth Book of the Social Code. (4) Expenditure on medicinal products in which, according to the generally accepted state of medical knowledge, the diagnostic or therapeutic benefit, the medical the necessity or the economic viability is not established, shall be determined in accordance with the Annex 8 eligible for aid. Medicinal products as defined in the first sentence may also be recognised as eligible for assistance on a case-by-case basis, if a medical opinion is submitted that the medicinal product is necessary for treatment. (5) Expenditure on medical prescription Amino acid mixtures, protein hydrolysates, elemental diets and probe food are suitable for enteral nutrition in the absence of or limited ability to sufficiently feed in a natural way, if a modification of the natural Nutrition or other medical, nursing or Nutrition-therapeutic measures to improve the nutrition situation are not sufficient. Expenditure on elemental diets shall be eligible for aid to persons who have not completed the third year of life, with cow ' s milk protein allergy; this shall also apply to neurodermatitis for a period of half a year, provided that element diets are available for are used for diagnostic purposes. In addition, expenditure on food, food supplements, health foods and dietary foods is not eligible for aid. (6) Paragraphs 1 to 4 shall apply by analogy to expenses relating to medical and association equipment, test strips and Medical devices that have consumed a healing practitioner or a health practitioner during a treatment. Unofficial table of contents

§ 23 remedies

(1) Expenditure on medicinal products prescribed for medical use and the substances consumed in this case shall be eligible for aid if they are listed in Annex 9 and are applied by members of the health or medical profession referred to in Annex 10. In the case of speech therapy, expenses for the achievements of state-approved speech therapists as well as comparably qualified persons are also eligible for assistance. The eligible expenses are limited to the maximum amounts mentioned in Annex 9. (2) In the case of persons who are eligible under § 3 or are eligible for a person entitled under § 3, the following shall be assessed: Appropriateness of the costs of medical medicinal products instead of the maximum amounts referred to in the third sentence of paragraph 1, in accordance with the local fees, taking into account the special circumstances of the country. The eligible expenditure shall be less than 10 per cent of the costs exceeding the maximum amounts referred to in the third sentence of paragraph 1, but not more than 10 euro. This reduction shall not apply to persons who are the 18. They have not completed their life year. Unofficial table of contents

§ 24 Complex therapy and integrated care

(1) In contrast to § 6 (3) and § 23 (1), expenses for services which are provided in the form of outpatient, full or part-time complex therapies and are calculated on a flat-rate basis shall be eligible for aid at an appropriate level. The eligibility of the aid requires that the complex therapy be provided by a team of therapists who cross the professional group, including doctors, doctors, psychological psychotherapists, psychological psychotherapists. (2) expenditure on social education services is not eligible for aid under paragraph 1. (3) expenditure on services which are considered as integrated care and are calculated on a flat-rate basis, are at the level of Flat-rate amounts eligible for aid when contracts have been concluded between the service providers and the private health insurance undertakings or contracts with integrated supply forms according to § 140b of the Fifth Book of the Social Code. Unofficial table of contents

§ 25 Tools for self-treatment and self-control, body replacement parts

(1) expenses for medical aids, self-treatment and self-control equipment, as well as body replacement items, are eligible for assistance if they are necessary in individual cases in order to ensure the success of the medical treatment, an imminent threat of Preventing or compensating for a disability. Subject to the provisions of paragraph 4, aid shall be eligible for purchase, repair, replacement, operation, instruction in the use and maintenance of the aids referred to in Appendix 11, self-treatment and self-control equipment, and Body replacement parts subject to the conditions mentioned there. Expenses for the replacement of an item which has become unusable within the meaning of the first sentence are eligible for aid after the expiry of six months if a new medical prescription is available. (2) Non-eligible expenses are not eligible for Aids and devices for self-treatment and self-control, which

1.

have a low or disputed therapeutic benefit,

2.

have a low delivery price,

3.

of the general standard of living, or

4.

are listed in Appendix 12.

(3) expenses for the rent of aids and equipment for self-treatment and self-regulation referred to in the first sentence of paragraph 1 shall be eligible for assistance, insofar as they are not higher than the costs of their purchase and are therefore not necessary. (4) Are: Aids and equipment for self-treatment and self-control within the meaning of the first sentence of paragraph 1 neither listed in Annex 11 or 12 nor comparable to the items listed, shall exceptionally be eligible for such expenditure if: this with regard to the duty of care in accordance with § 78 of the Federal Civil Service Act is necessary. In cases of sentence 1, the setting-up body shall decide with the consent of the supreme service authority. The supreme service authority shall establish the agreement with the Federal Ministry of the Interior prior to its approval. To the extent that the agreement of the Federal Ministry of the Interior is generally declared, the supreme service authority may delegate its responsibility to another authority. (5) Expenditure on the operation and maintenance of the aids and equipment for self-treatment and self-control within the meaning of the first sentence of paragraph 1 shall be less than the sum of the sum of EUR 100 per calendar year. be eligible for assistance. Expenses for batteries of hearing aids as well as care and cleaning agents for contact lenses are not eligible for aid. The sentences 1 and 2 shall not apply to persons who are the 18. They have not completed their life year. Unofficial table of contents

§ 26 Hospital services

(1) State aid is the expenditure on services in hospitals, which are paid under the Hospital Pay Act or the Federal Government Ordinance for the benefit of the Federal Government.

1.

Pre-hospital and post-hospital hospital treatment according to § 115a of the Fifth Book of the Social Code,

2.

general hospital services (§ 2 para. 2 of the Hospital Law and § 2 para. 2 of the Federal Order of Pflegesatzverordnung),

3.

Election benefits in the form of

a)

from separately calculated real-life services within the meaning of section 17 of the Hospital Pay Law and § 16 sentence 2 of the Federal Order of Pflegesatzverordnung (Bundespflegesatzverordnung),

b)

a separately calculated accommodation within the meaning of § 17 of the Hospital Law and the second sentence of § 16 of the Federal Government Ordinance on the Provisions of the Federal Government of Germany up to the amount of the costs of a two-bed room minus an amount of 14.50 euros per day and

c)

other expenses incurred in connection with the services referred to in (a) and (b) for medical services and benefits pursuant to § 22, and

4.

the accommodation of an accompanying person in the hospital, as far as this is necessary for medical reasons (§ 2 para. 2 sentence 2 no. 3 of the hospital pay law).

(2) expenses for treatment in hospitals that meet the requirements of § 107 (1) of the Fifth Book of Social Code, but are not permitted under section 108 of the Fifth Book of Social Code, are eligible for assistance as follows:

1.

in the case of indications which may be settled by means of a case flat rate under the Hospital Charges Act, the general hospital benefits (paragraph 1 (2)) up to the amount which shall apply when applying the case-flat-rate catalogue in accordance with Article 9 (1), first sentence Point 1 of the Hospital Pay Law for the Department, which underlies the upper limit of the uniform base case value corridor to be agreed under Article 10 (9) of the Hospital Pay Law;

2.

in all other cases, the basic deposit rate and the percentage of the distribution of the distribution, in so far as the total daily amount does not exceed the following amounts:

a)

at full-time Investigation and treatment of persons who are the 18. have completed their life year,

EUR 293.80,

b)

in the case of Investigation and treatment of persons who are the 18. have completed their life year,

225,60 Euro,

c)

at full-time Investigation and treatment of persons who are the 18. have not yet completed their life year,

EUR 462.80,

d)

in the case of Investigation and treatment of persons who are the 18. have not yet completed their life year,

EUR 345.80,

3.

Separately calculated elective benefits for accommodation in a double room up to 1.5 percent of the upper limit of the uniform base case value corridor to be agreed pursuant to § 10 paragraph 9 of the Hospital Pay Law minus 14,50 Euro daily,

4.

for emergency care, when the nearest hospital had to be visited.

Paragraph 1 (3) (a) and (4) shall apply accordingly. Non-eligible expenses are expenses for services which are additionally charged and which are the components of the services referred to in paragraph 1 (2). Before being admitted to a hospital in accordance with the first sentence, an overview of the expected costs may be submitted to the enforcement body for the purpose of examining the eligibility of the aid. (3) In the case of persons who are eligible under § 3 or with the aid of of a person entitled to the assistance according to § 3, the expenses incurred shall be eligible for the expenses incurred for accommodation and catering in foreign hospitals, taking into account the special circumstances at the place of treatment, as far as the accommodation of those in a double room in the country is Paragraph 1 (3) (b) shall be in accordance with the provisions of paragraph 1 (3) (b), unless otherwise provided for medical reasons. The deduction amount referred to in paragraph 1 (3) (b) shall be taken into account. Eligible costs are also expenses incurred for the use of companies operating in the invoicing of inpatient services rendered abroad. Unofficial table of contents

§ 27 Häusliche Krankenpflege

(1) Aid cases are expenses for home nursing care, as far as they are appropriate and medically necessary under medical prescription, and the home nursing care

1.

lasted no more than four weeks,

2.

can neither be carried out by the person eligible or eligible for consideration, nor by any other person living in the household, and

3.

is provided in its own household or in another appropriate place.

In exceptional cases, expenses for home nursing may be recognised for a longer period of time when a medical opinion is submitted that domestic nursing is necessary over a longer period of time. If a treatment is required to ensure that the objective of the medical treatment is achieved, the first sentence of the first subparagraph shall not apply. (2) The hospital care referred to in paragraph 1 shall include:

1.

treatment care, basic care and domestic care,

2.

direction-related disease-specific care measures; and

3.

Outpatient psychiatric nursing care.

(3) Where domestic health care within the meaning of paragraphs 1 and 2 is carried out by the spouse, the spouse, the life partner, the life partner, the parents or the children of the cared-in person, only eligible persons shall be eligible:

1.

Expenses for travel expenses of the person carrying out the home nursing care and

2.

a remuneration paid to the person carrying out the care of the home, up to the level of the income received as a result of the home nursing care.

Unofficial table of contents

Section 28 Family and budgetary aid

(1) The expenses for family and household assistance shall be equal to 2.5 per cent of the monthly reference quantity resulting from § 18 of the Fourth Book of the Social Code, rounded up to full euro, eligible if:

1.

the person entitled to the budget or capable of taking account of the budget shall not continue the budget because of the necessary extra-domestic accommodation (§ § 26 and 32 (1), § 34 and 35 (1) (1) to (5), § § 39 and 40 (2)) may or may have died,

2.

shall remain in the household at least one person entitled to care or taken into account, who is in need of care or who has not completed the twelfth year of his life, and

3.

no other person living in the household can carry on the budget.

In special exceptional cases, with regard to the duty of care pursuant to Section 78 of the Federal Civil Service Act, with the consent of the top service authority, these conditions may be waived. (2) expenses for a family and household help are for the first 28 days after the end of a non-domestic accommodation, if the need for such accommodation has been certified by a medical certificate. Sentence 1 shall also apply to single persons. In the event of death of the person responsible for the budget, the expenditure referred to in paragraph 1 shall be eligible for six months, in exceptional cases where exceptional circumstances are justified, for twelve months. Section 27 (3) shall apply mutas. (3) If, instead of the use of a family and household aid, those persons who have not yet completed the twelfth year of life shall be taken into account or have to be taken into account in need of care or even persons entitled to assistance in a home or in a foreign household, the expenses for this purpose are eligible for assistance up to the otherwise necessary costs of a family and household aid. Unofficial table of contents

Section 29 Family and household assistance abroad

(1) expenses of persons entitled to assistance under § 3 for a family and household help are also eligible if:

1.

An outpatient medical treatment of the eligible or eligible person who carries the household alone is required in a country other than the host country,

2.

at least one eligible person who has not yet completed the fourth year of life shall remain in the household and

3.

the treatment requires at least two nights.

(2) In the case of birth, the expenses for family and household help are also eligible if proper medical care at the place of employment is not guaranteed and if the place of service is to leave early due to later flight incompatibility must be. (3) If, instead of the use of a family and household aid, those persons who have not yet completed the fourth year of life will be taken into account when leaving the country. The necessary travel expenses shall be eligible for the necessary travel expenses. If the spouse, the spouse, the life partner, the life partner, the parents or the children of the family and household aid in claim take over the management of the household, the related travel expenses are up to the level of the otherwise, expenditure incurred for family and household assistance. Unofficial table of contents

§ 30 Sociotherapy

Expenses for sociotherapy are eligible for assistance if the person entitled to the benefit or the eligible person is not able to receive medical or medical services on account of a serious mental illness. and to avoid or shorten hospital treatment by sociotherapy. This also applies if the hospital treatment is offered, but cannot be carried out. The content and design of the sociotherapy are based on § 37a of the Fifth Book of the Social Code. Unofficial table of contents

§ 30a Neuropsychological therapy

(1) expenses for ambulatory neuropsychological therapy are eligible if they are

1.

the treatment of acutely acquired brain damage or brain diseases, in particular after stroke or skull-brain trauma and

2.

are carried out by medical specialists or specialists

a)

for neurology,

b)

for neurology, psychiatry, psychiatry and psychotherapy,

c)

Children's and adolescent medicine with a focus on Neuropdiatrics or

d)

Neurosurgery and child and adolescent psychiatry and psychotherapy,

which, in addition to their territorial designation, have a neuropsychological additional qualification.

The first sentence shall also apply to treatments carried out by:

1.

medical psychotherapists or psychotherapists,

2.

psychological psychotherapists or psychotherapists, or

3.

Children's and adolescents ' psychotherapists,

if they have a neuropsychological additional qualification. The amount of the eligible expenses is determined in accordance with paragraph 3. (2) Non-eligible expenses are expenses for an outpatient neuropsychological therapy if:

1.

only congenital restrictions or obstructions of brain power functions are treated without secondary organic brain damage, in particular attention deficit syndrome with or without hyperactivity (ADHD or ADS), -Intelligence reduction,

2.

it is about brain diseases with progredient progression at an advanced stage, especially medium-and high-grade dementia of the Alzheimer's type,

3.

the brain injury or the brain disease with neuropsychological deficits in adult patients is less than five years ago.

(3) expenses for neuropsychological treatments shall be eligible for the following amounts:

1.

up to five probatoric meetings, and

2.

in the case of individual treatment, including, where appropriate, reference persons



when a Treatment unit at least 25 minutes long when a Treatment unit at least 50 minutes

Rule Case	120 Treatment units	60 Treatment units
Exceptional case	40 other treatment units	20 other treatment units

3.

in the case of group treatment, in children and adolescents, where appropriate with the involvement of reference persons





when a Treatment Unit at least 50 minutes duration when a Treatment Unit at least 100 minutes

80 Treatment Units	40 Treatment Units

In the case of a combination of individual and group treatment, the whole of the treatment referred to in the first sentence of paragraph 2 shall be eligible. Unofficial table of contents

§ 31 Travel costs

(1) expenses for rescue journeys and flights are eligible for assistance, even if a stationary treatment is not required. (2) Aid cases are expenses for medical prescribed journeys.

1.

in the context of hospitalised medical treatments,

2.

on the occasion of a transfer to another hospital, if:

a)

it is necessary for compelling medical reasons, or

b)

has agreed to the place of detention,

3.

on the occasion of an outpatient medical treatment in exceptional exceptional cases, after approval by the place of detention,

4.

on the occasion of pre-or post-inpatient treatment, if it is possible to shorten or avoid inpatient treatment which is otherwise medically necessary,

5.

on the occasion of an ambulatory operation in the hospital or in the medical practice, including pre-treatment and post-treatment,

6.

in the case of transport by ambulance, if, during the journey, professional care or the use of the special facilities of a ambulance is required; and

7.

of the parents on the occasion of the visit of their child under the age of 18, the 18. Year of age has not yet been completed, in justified exceptional cases.

(3) Not eligible for assistance

1.

Costs of repayment due to illness during a holiday trip or other private trips, as well as

2.

Travel expenses, including flight costs, on the occasion of investigations and treatments outside the European Union.

The costs referred to in the first sentence of paragraph 2 shall be exceptionally eligible if there are compelling medical reasons in respect of the duty of care in accordance with Section 78 of the Federal Civil Service Act. In cases of sentence 2, the body of the detention shall decide with the consent of the supreme service authority. The approval of the Federal Ministry of the Interior requires the consent of the Federal Ministry of the Interior. (4) For the reimbursement of travel expenses, the Federal Travel Costs Act shall apply in accordance with the condition that the compensation for the distance shall only be granted in accordance with Section 5 (1) of the Federal Foreign Office. Federal Travel Cost Act is granted. In the case of journeys under paragraphs 1 and 2 no. 6, the amounts calculated in accordance with national or local law shall be eligible for assistance. (5) Is for persons entitled to grant pursuant to § 3 or to a person entitled to the assistance under § 3 be eligible for medical care in the host country in cases of sickness or birth, the costs of the transport to the nearest appropriate place of treatment shall be eligible for assistance if:

1.

immediate treatment was required, or

2.

the fixing body has previously recognised the eligibility of such expenditure, and in duly justified exceptional cases the recognition may be granted retrospectly.

Unofficial table of contents

§ 32 Accommodation costs

(1) expenses for accommodation on the occasion of necessary external outpatient medical, dental or psychotherapeutic services shall be eligible for assistance up to 150 per cent of the amount pursuant to § 7 (1) sentence 1 of the Federal Travel Costs Act. If an accompanying person is medically required, expenses for their accommodation are eligible at the same level. (2) Physically prescribed remedies are administered in a facility that is responsible for the care and treatment of the sick or the patient. Disabled persons are also eligible for flat-rate packages. This also applies if the packages contain a pledge. (3) Expenditure under paragraphs 1 and 2 shall also apply to persons who are eligible under § 3 or are eligible for a person entitled under § 3. then eligible for assistance if they are provided outside the host country. Expenses for accommodation abroad are eligible for assistance up to the amount of 150 percent of the international overnight stay (§ 3 (1) of the Foreign Travel Cost Ordinance). Unofficial table of contents

§ 33 Life-threatening or regularly fatal diseases

Expenses for medical services on the occasion of a life-threatening or regularly fatal illness, for which a generally accepted treatment corresponding to the medical standard is not available, are be eligible for aid if there is a not quite distant prospect of healing or a noticeable positive effect on the course of the disease. In the case of the first sentence, the body shall decide in agreement with the supreme service authority. The supreme service authority shall establish the agreement with the Federal Ministry of the Interior prior to its approval.

Section 3
Rehabilitation

Unofficial table of contents

§ 34 Connection and addiction treatments

(1) Expenses for medical follow-up treatment treatments, which are carried out as medical rehabilitation measures, are eligible for assistance. A follow-up treatment within the meaning of sentence 1 is available if the rehabilitation measure is followed by a hospital stay for the treatment of a serious illness or in the context of hospital treatment. In exceptional cases, a follow-up treatment within the meaning of sentence 1 is also available if the rehabilitation measure is carried out after an outpatient treatment. (2) expenses for medical treatment of addictive treatments, which are considered as medical treatment. Rehabilitation measures or deforestation are eligible for aid. Expenses for outpatient aftercare after inpatient deforestation treatment are eligible for an adequate amount of aid. (3) The eligibility for aid under paragraphs 1 and 2 requires that the medical prescription be the rehabilitation measure depending on the type, duration and content. The device must be suitable for the implementation of the connection part or addiction treatment. The measures referred to in paragraph 2 shall be eligible for aid only after the approval of the site. In duly substantiated exceptional cases, consent may be granted retrospectly. (4) § 26 (1) (3), § 31 (2) and § 35 (2) sentence 1 and 2 (1) to (4) and (5) (a) and (b) shall apply accordingly without the time limit of sentence 2 Point 5 (a) and (b) to 21 days. Unofficial table of contents

Section 35 Rehabilitation measures

(1) Aid cases are expenses for:

1.

in-patient rehabilitation measures in preventive or rehabilitation facilities with which there is a supply contract in accordance with § 111 (2) sentence 1 of the Fifth Book of the Social Code,

2.

Mother-child-or father-child-rehabilitation measures in preventive or rehabilitation facilities with which a supply contract according to § 111a of the Fifth Book of the Social Code exists,

3.

medically prescribed family-oriented rehabilitation for children who are eligible for consideration and who suffer from severe chronic diseases, in particular cancers or cystic fibrosis, or whose condition after surgery at the heart or after surgery Organ transplants require such a measure,

4.

Outpatient rehabilitation measures under medical supervision following a rehabilitation plan in a recognised health resort for the restoration or maintenance of the serviceability and for the prevention or prevention of diseases or their aggravation. for persons entitled to the assistance pursuant to § 2 (1) (1),

5.

physicians prescribed outpatient rehabilitation measures in rehabilitation facilities or by institutions close to the place of residence, and

6.

Physicians prescribed rehabilitation sport in groups under medical supervision and supervision.

(2) In the case of rehabilitation measures referred to in paragraph 1, expenses shall be eligible under sections 12, 13, 18 and 22 to 25 and 26 (1) (3). In addition, in the case of benefits under paragraph 1 (1) (1) to (4), eligible benefits are:

1.

Travel expenses for the arrival and departure, including baggage costs

a)

with regular means of transport in the amount of the actual expenses up to the costs incurred in the lowest class; and

b)

with private motor vehicles in the appropriate application of Section 5 (1) of the Federal Travel Cost Act,

total, however, not more than 200 euros for the overall measure,

2.

expenses and a proven loss of earnings of accompanying persons, if the medical necessity of an escort has been certified by a physician,

3.

Expenses for tourist tax, also for the accompanying persons,

4.

Expenses for a medical final report,

5.

Expenses for accommodation and catering

a)

in the case of inpatient rehabilitation measures, including nursing services, up to the lowest rate of the institution for a maximum of 21 days (excluding days of arrival and departure), unless an extension is due to health reasons urgently needed,

b)

for accompanying persons in the case of inpatient rehabilitation measures for a maximum of 21 days (excluding days of arrival and departure) 70 per cent of the lowest rate, unless an extension is urgent for health reasons of the or the accompanying person required,

c)

in the case of mother-child or father-child-rehabilitation measures, for a maximum of 21 days (excluding days of arrival and departure) equal to the fees charged by the institution to a social security institution,

d)

in the case of outpatient rehabilitation measures referred to in point 4 of paragraph 1, EUR 16 per day for a maximum of 21 days (excluding days of arrival and departure), and

e)

the accompanying persons in the case of outpatient rehabilitation measures referred to in paragraph 1, point 4, in the amount of 13 euros per day for a maximum of 21 days (excluding days of arrival and departure).

In the case of benefits referred to in paragraph 1, point 5, the second sentence of paragraph 1 shall Expenses for services referred to in paragraph 1 (6) shall be eligible for assistance up to the amount of EUR 6.20 per practice unit.

Unofficial table of contents

§ 36 Conditions for rehabilitation measures

(1) expenses for rehabilitation measures in accordance with § 35 (1) (1), (2) and (4) shall only be eligible if the appellant has recognized the eligibility of the aid before the beginning of the rehabilitation measure. In this connection, the Commission has to obtain an opinion from a medical officer, a medical officer, a doctor appointed by her or a doctor appointed by her, which contains statements that:

1.

the rehabilitation measure is medically necessary,

2.

An outpatient medical treatment and the use of medicinal products at the place of residence are not sufficient for the achievement of the rehabilitation objectives because of a significant adverse health effect; and

3.

In the case of inpatient rehabilitation measures in accordance with § 35 para. 1 no. 1, an equivalent success cannot also be achieved by an outpatient rehabilitation measure in accordance with § 35 para. 1 no. 4.

For the recognition of a rehabilitation measure in accordance with § 35 (1) (1), an opinion shall not be necessary if the person entitled to grant or taking into account the decision on the need for care shall be notified of a decision concerning the need for care. Has received a rehabilitation recommendation indicating that the implementation of such a rehabilitation measure has been indicated. If the rehabilitation measure is not commenced within four months of recognition, the entitlement to the aid shall not be granted in respect of the recognised rehabilitation measure. The recognition of rehabilitation measures referred to in paragraph 1 shall not be permitted if, in the current or three previous calendar years, one recognised as eligible for aid is eligible for recognition of the rehabilitation measures referred to in paragraph 1. The rehabilitation measure referred to in paragraph 1 shall be carried out unless, according to the opinion, a rehabilitation measure as referred to in paragraph 1 is urgently required for medical reasons. (3) For persons who are subject to the provisions of § 3 Eligible or in the case of a person entitled to the assistance under § 3 , expenses for a rehabilitation measure within the meaning of Section 35 (1) (1) in a foreign institution outside the European Union shall also be eligible if, before the date of the commencement of the measure, the or the In the case of a doctor or doctor, the institution has declared that it is appropriate and that the inpatient rehabilitation measure cannot be carried out in a Member State of the European Union. The application for recognition of the eligibility of the aid shall be accompanied by a dossier on the institution which is envisaged. If a rehabilitation measure is carried out in a State of the European Union in accordance with Article 35 (1) Nos. 1 to 4, the transport costs between the place of work and the place of treatment shall be eligible if the arrival and departure are not carried out with a A trip to the home or a different officially paid trip can be connected. This shall also apply if a rehabilitation measure is granted on the basis of the legislation or contractual agreements referred to in § 9 (1), to the extent that the cost carrier costs the travel expenses for the departure from and the journey to the foreign service. , and the authorities have previously recognised the eligibility of the cost of the cost of the journey.

Chapter 3
Expenses in nursing care cases

Unofficial table of contents

§ 37 Care counseling, entitlement to care allowance for care services

(1) The Federation shall participate in the personal costs of the institutions for a care consultation in accordance with § 7a of the Eleventh Book of the Social Code, if:

1.

Persons entitled to receive care insurance and eligible persons

a)

, or

b)

have requested assistance and advice, and

2.

a corresponding agreement of the Federal Government and the institutions of the nursing advice according to § 7a of the Eleventh Book of Social Law.

The amount to be paid by the fixing body shall be announced by circulars of the Federal Ministry of the Interior. (2) Aid entitled and eligible persons shall receive aid for care, if they:

1.

In accordance with § 14 of the Eleventh Book of Social Code, they are in need of care in accordance with § 15 of the Eleventh Book of the Book of Social Code, in accordance with § § 38 and 39, or

2.

meet the requirements of § 45a of the Eleventh Book of the Social Code, in accordance with § 38 (8) and (9).

Unofficial table of contents

§ 38 Häusliche Care, day care and night care

(1) expenses for home care assistance are eligible in the amount of the rates mentioned in § 36 (3) of the Eleventh Book of the Social Code, insofar as they are subject to the directions in § 14 (4) of the Eleventh Book of Social Code in order to ensure the Basic and domestic care as well as the care services in accordance with § 36 (1) sentence 5 and § 124 (1) to (3) of the Eleventh Book of Social Code and are created for suitable nursing staff who are in a contractual relationship to the care insurance fund or to an outpatient care facility, with which the respective Care fund has concluded a supply contract. Expenses for benefits according to the first sentence are excluded, insofar as they are eligible for aid in accordance with § 27. Section 36 (4), first sentence, of the Eleventh Book of the Social Code applies accordingly. (2) Instead of the aid referred to in paragraph 1, a flat-rate allowance may also be granted to the extent that domestic care by nurses other than those referred to in the first sentence of paragraph 1 of this Article is done. The amount of the flat-rate allowance is determined in accordance with Article 37 (1) of the Eleventh Book of Social Code. A care allowance from the private or the social care insurance scheme and the corresponding refunds or benefits in kind under other legislation shall be applied to flat-rate aid. For persons who are not insured against the risk of the need for care, the expenses incurred are taken into account in the context of the flat-rate aid. Flat-rate aid shall not be granted to the extent that the right to compensation is provided in accordance with Section 35 of the Federal Supply Act. The granting of flat-rate aid does not affect the right to care packages under the provisions of Section 26c of the Federal Law for the Protection of War in the context of the provision of care packages. Social security benefits in accordance with § 44 (1) of the Eleventh Book of the Social Code, as well as the additional benefits in the case of long-term care and the maintenance support allowance referred to in § 44a of the Eleventh Book of the Social Code of Short-term work prevention including the associated social security benefits shall be eligible for assistance. (3) In accordance with paragraph 1, home care assistance shall only be partially provided by one of the nurses referred to in the first sentence of paragraph 1. in addition, flat flat-rate aid referred to in paragraph 2. The flat-rate aid shall be reduced by the percentage to which aid referred to in paragraph 1 is granted. During the prevention or short-term care referred to in paragraph 7, half of the flat-rate aid previously paid shall be granted for up to four weeks per calendar year. Persons in need of care in full-time institutions of assistance for disabled persons receive undiminished flat-rate aid in proportion to the days in which they are in domestic care. (4) If the conditions laid down in paragraph 2 are not met for a full calendar month, the flat-rate aid shall be reduced by one-thirtieth for each of the non-eligible days. During the prevention or short-term care referred to in paragraph 7, half of the flat-rate aid previously paid shall be granted for up to four weeks per calendar year. If the person in need of care dies, the flat-rate allowance shall be granted by the end of the calendar month in which the death occurred. (5) The benefits provided for in paragraphs 1 to 3 shall be provided in outpatient residential groups, § 38a of the Eleventh Book the Book of Social Code accordingly. In addition, the costs of start-up financing for the establishment of outpatient housing groups according to § 45e of the Eleventh Book of Social Code are eligible. (6) expenses for part-time care in facilities of day care or night care are in the case of home care not being sufficiently ensured, or if partial inpatient care is required to supplement or strengthen home care. The partially inpatient care also includes the necessary transport of the person in need of care from the apartment for the establishment of the day care or night care and back. Section 41 (2) of the Eleventh Book of the Social Code applies accordingly. Expenses for services of part-time day care and night care are eligible for assistance in addition to the expenses according to paragraphs 1 to 3. (7) In case of prevention of the caring person and in the case of short-term care, § § 39 and 42 of the Eleventh Book apply. Pursuant to § 37 (2) (2) with or without assignment to a nursing level pursuant to § 15 of the Eleventh Book of the Social Code (Social Code), aid is granted in accordance with § § 45b, 123 Paragraph 2 (1) to (3), (3) and (4), Article 124 (1) to (3) of the Eleventh Book of the Social Code, (10) and in the case of the prevention of the carer referred to in paragraph 7. Additional care and relief benefits under § 45b (1) of the Eleventh Book of Social Code up to an amount of 104 euros are required for care-poor who do not meet the requirements of § 45a of the Eleventh Book of the Social Code. (9) Aid is also granted in respect of expenses for consultation visits within the meaning of Article 37 (3) of the Eleventh Book of the Social Code, to the extent that, for the respective advice visit, entitlement to payment of a grant by the private or private sector is granted. social care insurance. Section 37 (4) sentence 1 of the Eleventh Book of the Social Code remains unaffected. The scope of the eligible expenses is determined in accordance with § 37 (3) of the Eleventh Book of Social Code. Section 37 (6) of the Eleventh Book of the Social Code applies accordingly. (10) Aid is also paid in respect of expenses for care aids in accordance with § 40 (1) to (3) and (5) of the Eleventh Book of the Social Code and for measures to improve the individual's individual Living environment of the person in need of care pursuant to § 40, Section 4 of the Eleventh Book of Social Code. The expenses in accordance with the first sentence are only eligible if there is also an entitlement to pro-rata grants for the respective benefits against private or social care insurance. In the case of private care insurance, the amount of the application is basically eligible for the grant of the pro rata grant. Unofficial table of contents

§ 39 Full-time care

(1) expenses for full-time care in an approved care facility within the meaning of § 72 (1) sentence 1 of the Eleventh Book of the Social Code or in a comparable care facility shall be eligible for assistance if domestic or part-inpatient care Care is not possible or because of the peculiarity of the individual case is not possible. The following are eligible for aid:

1.

care-related expenses,

2.

medical treatment expenses in so far as this is not granted in accordance with § 27 aid, and

3.

Expenditure on social care.

Section 43 (2), (3) and (5) of the Eleventh Book of the Social Code shall apply accordingly. (2) expenditure on maintenance services exceeding the costs eligible for assistance under paragraph 1 shall be provided for and accommodation including investment costs. on a special request eligible for aid, to the extent that the care facility pays off monthly and does not remain at least an amount equal to the sum of the following monthly amounts from the average monthly income referred to in paragraph 3:

1.

8% of the basic salary of grade 8 of grade A 13 for each person entitled to grant and each eligible person, as well as for each spouse, spouse, life partner or partner, for the person or persons concerned pursuant to paragraph 1 or section 43 of the Eleventh Book of the Social Code,

2.

30% of the basic salary of grade 8 of grade A 13 for an eligible person and for a spouse, a spouse, a life partner or a life partner for which no claim under paragraph 1 or according to § 43 of the Eleventh Book of the Social Code,

3.

3 per cent of the basic salary of grade 8 of grade A 13 for each child taking into account, for which there is no entitlement to aid pursuant to paragraph 1 or section 43 of the Eleventh Book of the Social Code, and

4.

3 per cent of the basic salary of the last grade for the person entitled to the aid.

Sentence 1 shall apply in the case of other accounting periods. Sentence 1 shall not apply to additional services in accordance with § 88 of the Eleventh Book of the Social Code. If a person entitled to grant or an eligible person is entitled to a grant to the accommodation, investment and catering costs in accordance with national law, the expenses shall be equal to the amount actually paid in the case of the first sentence. (3) In the case of revenue within the meaning of the first sentence of paragraph 2, the following income shall apply in the calendar year prior to the application:

1.

the gross deductions pursuant to § 1 (2) (1) and (3) and (3) of the Bundesbesoldungsgesetz (Bundesbesoldungsgesetz) and the partial-time allowance (s) after application of the flaw, reduction and settlement rules, except for child-related family surcharges,

2.

the gross deductions in accordance with § 2 of the Staff Regulations of Officials, with the exception of the difference pursuant to section 50 (1), second sentence, of the civil service provision law, after application of the rules on flaw, reduction and settlement of payments, to the extent that the not to be entitled to lower pension benefits in accordance with § 57 of the Staff Services Act; the accident compensation according to § 35 of the Staff Regulations and the Accident Compensation according to § 43 of the Staff Regulations of Officials remain unaccounted for,

3.

the payment amount of the pensions from the statutory pension insurance scheme and from an additional old-age and survivor ' s pension to the person entitled to the benefit, the spouse, the spouse, the life partner or the partner of the life partner; the amount resulting from the deduction of contributions to the sickness and nursing care insurance and without taking into account the contribution subsidy, the benefits of the child-rearing remain unaccounted for in accordance with § 294 of the Sixth Book of Social Code and

4.

the total amount of income of the spouse, spouse, life partner or partner, other than the proportion of a statutory pension subject to taxation, covered by Section 2 (3) of the Income Tax Law.

The revenue shall be shown annually. If the person entitled to grant is creditable that the revenue in the year of application is likely to be significantly lower than in the calendar year before that, the current revenue should be based on. (4) Aid cases are also expenses for: Care and care in a full-time facility of assistance for disabled people, in which participation in working life and life in the community, school education or the upbringing of disabled people in the foreground of the furnishing purpose. § 43a of the Eleventh Book of the Social Code applies accordingly. (5) Aid cases are expenses according to § 87a (4) of the Eleventh Book of the Social Code, if the dependent person is in charge of activating or rehabilitating measures in accordance with the implementation of the Social Code. a lower level of care or of significant too little need for care has been downgraded. (6) Expiry surcharges in accordance with § 87b of the Eleventh Book of the Social Code are eligible for assistance. Unofficial table of contents

§ 40 Palliative Care

(1) expenses for specialised outpatient palliative care are eligible for aid if, due to a non-curable, progressive and far advanced disease, a particularly burdensome life expectancy at the same time is limited. Supply is necessary. § 37b (1) sentences 3 and 4 as well as § 37b (2) and (3) of the Fifth Book of the Social Code apply accordingly. (2) Expenses for inpatient or partial-inpatient care in hospices in which palliative-medical treatment is provided shall be subject to the following conditions: A medical certificate and a reasonable amount of aid can be provided if an outpatient care in the home or in the family cannot be provided. (3) The federal government takes part in the personal costs of outpatient care. Hospice services for assisted dying, including palliative care Advice to persons who are eligible for assistance and who are eligible for consideration. The prerequisite for a cost-sharing is an agreement between the Federal Government and the leading organisations for the performance of the interests of the outpatient hospice services. The amount to be paid by the fixed office is announced by circulars of the Federal Ministry of the Interior.

Chapter 4
Expenditure in other cases

Unofficial table of contents

Section 41 Early detection and preventive measures

(1) expenses for medical early diagnosis and medical care benefits are eligible for assistance. § § 20d, 25 and 26 of the Fifth Book of the Social Code shall apply accordingly. In addition, the early detection tests, preventive measures and vaccinations listed in Appendix 13 are eligible for assistance. (2) Expenditure on dental early diagnosis and prevention services are eligible for assistance in the case of:

1.

Early detection studies on dental, oral and jaw diseases,

2.

Measures for the prevention of dental diseases (individual prophylaxis) and

3.

Prophylactic dental services in accordance with Section B and the numbers 0010, 0070, 2000, 4050, 4055 and 4060 of the system of fees for dentists and number 1 of the system of fees regulations for doctors.

(3) expenditure on risk assessment and interdisciplinary advice, genetic diagnosis and early detection in the context of the early detection programme for hereditary persons with an increased family breast or ovarian cancer risk are only (4) The Federal Ministry of the Interior may grant the eligibility of expenses for measures for early detection, Monitoring and prevention of diseases that do not comply with other requirements (5) § 31 (5) in respect of which the granting of aid is necessary in respect of the duty of care in accordance with Section 78 of the Federal Civil Service Act. (5) The connection with section 49 (4) (3) shall apply accordingly. Unofficial table of contents

§ 42 Pregnancy and Birth

(1) In the case of pregnancy and in the case of birth, the benefits provided for in Chapter 2 shall be eligible for assistance.

1.

medical care during pregnancy and after birth,

2.

the midwife or the de-bindment plagiarist,

3.

institutions managed by midwives or debindungspflegers within the meaning of Section 134a of the Fifth Book of the Social Code,

4.

a home and weekly care power for up to two weeks after birth in household or outpatient deprivation. Section 27 (3) shall apply accordingly.

(2) In the case of persons who are eligible under § 3 or are able to take into account a person entitled to the assistance under § 3, the costs of the accommodation which are incurred before admission to a hospital at the place of birth are additionally incurred in the case of birth. be eligible for assistance. Section 32 (3), second sentence, shall apply accordingly. This does not apply to the accommodation in the household of the spouse, the life partner, the parents or the children of the pregnant women. Unofficial table of contents

§ 43 Artificial insemination, sterilization, contraception and abortion

(1) Expenditure on artificial insemination, including medicinal products, which are prescribed in connection with this, shall be eligible for aid in so far as their content and design are based on the principles laid down in § 27a of the Fifth Book of Social Code (2) Expenditure on sterilisation carried out by a doctor or a doctor is eligible if it is necessary because of a disease. (3) expenses for medical advice on the subject of the contraception including the necessary medical examinations and medically prescribed Eligible funds shall be eligible for assistance. Expenses for medical devices for contraception as well as for their application are only for persons who are eligible for assistance and are eligible for consideration up to the age of 20. It must be eligible for the treatment of an illness, unless it is necessary after a medical certificate to treat a disease. Expenses for general sex education or sexual counselling are not eligible. (4) For a non-unlawful abortion, expenses according to § § 12, 22, 26, 28, 29, 31 and 32 are eligible for aid. In addition, the expenses for medical advice on the maintenance of pregnancy and the medical examination and evaluation to determine the conditions of a non-illegal abortion are also eligible. Unofficial table of contents

Section 44 Transfer Costs

(1) If an eligible person has died during a business trip, assignment, assignment or prior to a service-related move outside the place of her main residence pursuant to Section 12 (2) sentence 2 of the Reporting Framework Act, the Costs of the transfer eligible for aid. (2) For persons who are eligible under § 3 or are eligible for a person entitled under § 3, the costs of the transfer to the country to the place of apportion shall be eligible. If the conformation site is not domestiy, expenses shall be eligible for aid up to the amount of the transfer costs incurred for a transfer to the country. Unofficial table of contents

Section 45 First aid, decontamination, communication aid, organ donation and clinical cancer registry

(1) State aid is the expenditure incurred in respect of:

1.

First aid,

2.

an officially disposed decontamination and the substances consumed in the process; and

3.

Necessary communication aids for deaf, highly serious or deaf persons or persons who are eligible for assistance or are capable of taking into account in cases of medically necessary outpatient or inpatient examination and treatment, when administered by Medicinal products, in the case of supplies of aid, dental services or nursing care, where administrative procedures have the right to use a communication aid in accordance with § 9 of the Act on Equal Opportunities for Disabled Persons.

The need to use a communication aid shall be necessary if, in individual cases, the flow of information between the service provider or service provider and the persons entitled to the assistance or the persons entitled to take account of the information is only so (2) Aid cases are expenses incurred in the case of post-mortem organ donations for the placement, removal, supply, organisation of the provision and transport of the organ for transplantation, as far as the organ recipients of the organ donation are persons entitled to grant or taking into account persons who are eligible for assistance. (3) Expenses for a donor or donor of organs, tissues, blood stem cells or other blood components shall be eligible for assistance in accordance with Chapter 2 if the recipient or recipient of the donation is a contributor or is entitled to the person who is eligible for consideration. The proven failure of work income is also eligible for assistance.

1.

the donor or donor,

2.

of persons who have been designated as donors or donors, but are not eligible.

On request, the employer of the donor or the donor shall be reimbursed for the payment of the payment in accordance with the rate of assessment of the recipient or the recipient. (4) expenses for the registration of eligible persons and Eligible persons for the search for an unrelated blood stem cell donor or an unrelated blood stem cell donor in the Central Bone Marrow Donor Register are eligible for assistance. (5) The Federation shall participate in the search for a the personal costs of cancer registration, and Directly in relation to the clinical cancer registry for any person who can be considered

1.

Report on the new disease in a tumor according to § 65c (4) sentence 2 to 4 and paragraph 5 sentence 1 of the Fifth Book of the Social Code, as well as

2.

Notification of the clinical data to be transmitted to a clinical cancer registry according to § 65c (6) sentence 1 of the Fifth Book of Social Code.

A prerequisite for the participation in costs is an agreement between the federal government and the clinical cancer registry. The amount to be paid by the fixed office is announced by circulars of the Federal Ministry of the Interior.

Chapter 5
Amount of aid

Unofficial table of contents

Section 46 Measurement of aid

(1) Aid shall be granted as a percentage (rate of assessment) of eligible expenditure. The tax rate at the time of service provision is decisive. In terms of care, as far as this is expressly provided for in this Regulation, flat-rate payments may also be paid. (2) Unless otherwise specified in paragraph 3, the rate of assessment shall be:

1.

persons entitled to the assistance of 50%,

2.

Recipients of pensions with the exception of orphans 70 per cent,

3.

eligible persons under § 4 (1) 70 per cent and

4.

Eligible children and orphans 80 per cent.

(3) If two or more children are eligible for consideration, the rate of assessment for the person entitled to be eligible shall be 70 per cent. This applies to a number of persons entitled to the allowance only for those who receive the family surcharge in accordance with § § 39 and 40 of the Bundesbesoldungsgesetz (Bundesbesoldungsgesetz) or the international surcharge pursuant to § 53 (4) (2) and (2a) of the Bundesbesoldungsgesetz (Bundesbesoldungsgesetz). § 5 (4) sentences 2 to 4 shall apply accordingly. Sentence 2 shall be applied only if a person entitled to the assistance is not already entitled to a rate of assessment of 70 per cent for other reasons. Eligible persons who take parental leave will receive during that period the rate of assessment which they state the day before the start of the parental leave. The rate of assessment for paid university teachers amounts to 70 percent if they otherwise have a tax rate of 70 percent on the basis of a subordinated state aid entitlement according to § 5. (4) For persons who are entitled under § 28 (2) of the Eleventh Book of Social Code benefits of the nursing care insurance are in principle half received, the rate of assessment in respect of this expenditure is 50 per cent. Unofficial table of contents

Section 47 Deviation rate

(1) The supreme service authority or a authority designated by it may, with regard to the duty of care in accordance with § 78 of the Federal Civil Service Act, increase the rate of charge for expenses incurred during a service damage in a reasonable way, if not (2) The rate of assessment of beneficiaries, beneficiaries and persons taking into account persons with low overall income may be the highest office authority for a maximum of three years by a maximum of 10 percentage points if the contribution costs for A private health insurance company, which is in the form of aid, exceeds 15% of its total income or its total income. The low total income amounts to 150 per cent of the pension pursuant to § 14 (4) sentence 2 and 3 of the civil service provision law. The amount shall be increased by EUR 255.65 if contributions to private health insurance are also paid for the person eligible under Section 4 (1). A supply balance to be paid by the recipient or the recipient of the supply does not diminish the total income to be calculated. In the case of a new application, the fictitious contributions to the health insurance are to be assumed, which would result from the basis of a tax rate according to § 46. (3) The top service authority may also apply the assessment rate in the following cases: In exceptional circumstances, in agreement with the Federal Ministry of the Interior, if this is imperative in view of the duty of care in accordance with § 78 of the Federal Civil Service Act. Here, a very strict scale is to be applied. In the case of long-term care, an increase is excluded. (4) For eligible expenses, for which, in spite of adequate and timely insurance, due to an individual exclusion due to congenital suffering or certain In the absence of insurance benefits, or for which the benefits have been permanently discontinued (control), the rate of assessment shall be increased by 20 percentage points, but not more than 90 per cent. This applies only if the insurance company complies with the conditions laid down in § 257 (2a), first sentence, no. 1 to 4 of the Fifth Book of Social Code. (5) The rate of assessment shall be increased for persons who are entitled under § 3 or in the case of a person pursuant to § 3 persons entitled to the assistance, in the cases pursuant to § 31 (5) and § 41 (5) to 100 per cent of the eligible expenses for the transport to the nearest appropriate treatment, examination or birth place, insofar as these expenses exceed 153 euros and in cases pursuant to § 36 para. 3, to the extent that this (6) In cases of § 39 (2) and § 44, the rate of assessment shall be increased to 100 per cent. (7) For persons who are eligible under § 3 or are eligible for a person entitled under § 3. , the rate of assessment for eligible expenses in accordance with § § 38 and 39 shall be increased to 100 per cent if a nursing level is available and during the period of service abroad no benefits of private or social care insurance (8) The Federal Ministry of the Interior may be responsible for groups of Persons entitled to receive aid Derogations from § § 46 and 47 if they are entitled to state aid under national law and the change in the basis of entitlement to an aid under this Regulation up to the date of receipt of an aid claim under this Regulation. the federal legislation is based. The derogations should be determined in such a way as to compensate for the economic disadvantages resulting from different rules on the rate of assessment. It is necessary to determine the agreement of the Federal Ministry of Finance and the Federal Ministry of Finance, which is responsible for the interests of the persons entitled to the assistance concerned after the business distribution of the Federal Government. Unofficial table of contents

Section 48 Limit of aid

(1) The aid may be granted, together with the benefits on the same occasion, from sickness insurance, care insurance, other legal provisions or contractual agreements to which the aid may be granted. Do not exceed the amount of expenditure eligible for aid. Benefits from sickness allowance, hospital allowance, nursing care allowance, nursing allowance, nursing care and caregiver's pension insurance shall not be taken into account unless they are exempt from the obligation to provide insurance in accordance with § 22 of the Eleventh Book Social Code. The death allowance is also not taken into consideration in accordance with Section 18 (2) (2) of the Civil Service Act. Expenses in accordance with § § 35 to 39 shall be charged separately. (2) The person entitled to the assistance has to prove:

1.

the scope of the existing health and care insurance cover, and

2.

the benefits granted.

The first subparagraph of point 2 shall not apply to reimbursements from sickness insurance or nursing care insurance after a percentage. Unofficial table of contents

Section 49 Private contents

(1) The eligible expenditure shall be reduced by 10% of the costs, at least by 5 euro and not more than EUR 10, but not by more than the actual cost of:

1.

Medical and association means within the meaning of § 22,

2.

Tools for self-treatment and self-control and body replacement parts,

3.

Journeys, with the exception of cases pursuant to section 35 (2),

4.

Family and household assistance per calendar day and

5.

Sociotherapy per calendar day.

The amount of the deduction referred to in the first sentence of the first subparagraph shall be the rate of release of the pharmacy or the fixed amount of the respective packing of the prescribed medicinal product and the association of the medicinal product. This also applies in the case of multiple regulations or in the delivery of the prescribed quantity in several packs. In the case of aid intended for consumption, the total amount of the aid is 10 per cent of the total eligible expenditure, but not more than 10 euro for the total monthly requirement. (2) The eligible expenses are reduced by EUR 10 per calendar day

1.

full-time hospital services in accordance with section 26 (1) (2), (2) and in-patient treatment in rehabilitation facilities in accordance with § 34 (1) and (2) sentence 1, for a maximum of 28 days in the calendar year, and

2.

Rehabilitation measures in accordance with § 35 (1) (1) and (2).

(3) In the case of home nursing care, the eligible expenses are 10% of the costs for the first 28 days of use in the calendar year and EUR 10 per regulation. (4) My own contents should not be deducted from expenses for:

1.

People who are the 18. have not yet been completed, except for travel expenses,

2.

pregnant women in connection with pregnancy or disconnection,

3.

out-patient medical and dental care services, as well as benefits for the early detection of diseases, including related medicinal products,

4.

Medical and association means in accordance with Article 22 (1) (1) and (2),

a)

which are required for diagnostic purposes, examinations and out-patient treatment, and which have been settled as outlays in the invoice, or

b)

whose pharmacy purchase price, including sales tax, is at least 30 per cent lower than the fixed amount which is based on that price;

5.

Heating and auxiliary equipment, insofar as the maximum amounts eligible for aid have been fixed by the Federal Ministry of the Interior, and

6.

Harp and blood test strips.

(5) The Federal Ministry of the Interior may, by means of administrative provisions for persons entitled to grant and take account of persons who are particularly aware of their health, by regularly providing them with preventive programmes or measures to be taken into account, To participate in the early detection of diseases, to set lower levels of self-content. Unofficial table of contents

Section 49 Private contents

(1) The eligible expenditure shall be reduced by 10% of the costs, at least by 5 euro and not more than EUR 10, but not by more than the actual cost of:

1.

Medical and association means within the meaning of § 22,

2.

Tools for self-treatment and self-control and body replacement parts,

3.

Journeys, with the exception of cases pursuant to section 35 (2),

4.

Family and household assistance per calendar day and

5.

Sociotherapy per calendar day.

The amount of the deduction referred to in the first sentence of the first subparagraph shall be the rate of release of the pharmacy or the fixed amount of the respective packing of the prescribed medicinal product and the association of the medicinal product. This also applies in the case of multiple regulations or in the delivery of the prescribed quantity in several packs. In the case of aid intended for consumption, the total amount of the aid is 10 per cent of the total eligible expenditure, but not more than 10 euro for the total monthly requirement. (2) The eligible expenses are reduced by EUR 10 per calendar day

1.

full-time hospital services in accordance with section 26 (1) (2), (2) and in-patient treatment in rehabilitation facilities in accordance with § 34 (1) and (2) sentence 1, for a maximum of 28 days in the calendar year, and

2.

Rehabilitation measures in accordance with § 35 (1) (1) and (2).

(3) In the case of home nursing care, the eligible expenses are 10% of the costs for the first 28 days of use in the calendar year and EUR 10 per regulation. (4) My own contents should not be deducted from expenses for:

1.

People who are the 18. have not yet been completed, except for travel expenses,

2.

pregnant women in connection with pregnancy or disconnection,

3.

out-patient medical and dental care services, as well as benefits for the early detection of diseases, including related medicinal products,

4.

Medical and association means in accordance with Article 22 (1) (1) and (2),

a)

which are required for diagnostic purposes, examinations and out-patient treatment, and which have been settled as outlays in the invoice, or

b)

whose pharmacy purchase price, including sales tax, is at least 30 per cent lower than the fixed amount which is based on that price;

5.

Heating and auxiliary equipment, insofar as the maximum amounts eligible for aid have been fixed by the Federal Ministry of the Interior, and

6.

Harp and blood test strips.

(5) The Federal Ministry of the Interior may, by means of administrative provisions for persons entitled to grant and take account of persons who are particularly aware of their health, by regularly providing them with preventive programmes or measures to be taken into account, To participate in the early detection of diseases, to set lower levels of self-content. Unofficial table of contents

§ 50 Load limits

(1) Upon request, the limit of charge shall be exceeded in accordance with sentence 5

1.

no deductibles pursuant to § 49 of the eligible expenses for a calendar year,

2.

Expenses for medicinal or dental medicinal products not subject to medical prescription pursuant to Section 22 (2) (3), which are not subject to the derogations, to be recognised in full as eligible for aid if the expenditure per unit of expenditure per person is The following amounts shall be available:

a)

for eligible persons Persons of the Besoldungs- groups A 2 to A 8 and Contenders and Warmer and berückvisii- eligible persons

8 Euro,

b)

for persons entitled to the assistance of Class A 9 to A 12 as well as persons eligible for consideration

12 Euro,

c)

for persons entitled to assistance higher , as well as Persons eligible for consideration

16 Euro.

An application must be made no later than the end of the year following the year in which the contents of the application have been withheld in accordance with § 49. The amounts in accordance with section 49 (1) to (3) shall be taken into account in accordance with the level of the actual withdrawal and the expenditure on medicinal products referred to in point 2 of the corresponding tax rate. The person entitled to the grant must prove the income in accordance with § 39 (3), the amount of the eligible income and the expenses for medicinal products not subject to medical prescription. The charge limit for persons eligible for assistance and persons eligible for consideration shall be 2 per cent of the annual revenue in accordance with § 39 (3) sentence 1 as well as for chronically ill persons according to the Chronicle Directive in the version of 22. January 2004 (BAnz. 1343), most recently on 19 June 2008 (BAnz. 3017), 1 per cent of the annual revenue in accordance with § 39 (3) sentence 1. (2) The date of the creation of expenses shall be decisive. The income of the spouse, the spouse, the life partner or the life partner is not taken into account if she or he is a member of the statutory health insurance or herself entitled to help. The income shall be reduced by 15 per cent in the case of married persons or persons entitled to the benefit living in a life partnership and by the amount for each child under § 4 (2) of the Income Tax Act of § 32 (6) sentence 1 to 3 of the Income Tax Act results. The annual revenue of the previous calendar year shall be determined in each case for the purpose of determining the limit of charge. (3) The costs of accommodation in a home or similar institution shall be borne by a social assistance institution or by the institution of the For the purpose of calculating the limit of the burden of war, the rule of law to be determined in accordance with the rule-on-law investigative law shall be applied.

Chapter 6
Procedures and jurisdiction

Unofficial table of contents

Section 51 Grants procedure

(1) The necessity and the economic appropriateness of expenses in accordance with § 6 shall determine the position of the apporation. The person entitled to grant assistance shall be obliged to participate. § 60 (1), first sentence, § § 62 and 65 to 67 of the First Book of the Social Code shall be applied accordingly. At its own expense, the party can obtain an expert opinion. If the participation of the person concerned is not required for the preparation of the expert opinion, the necessary health data shall be anonymized prior to transmission in such a way that the reviewer does not produce a reference to the person (2) In terms of care, the site of the detention shall, as a rule, be based on the opinion drawn up for the private or social care insurance for the presence of long-term care, as well as on the nature and necessary scope of the care has been made. If the person entitled to grant or taking into account is not insured in the private or social care insurance, the place of detention shall be issued with a corresponding opinion. The second sentence shall apply in the case of persons who are eligible under § 3 or are eligible for a person entitled under § 3 if no expert opinion has been drawn up for the private or social care insurance for these persons. At the request of the applicant, the aid for expenses in terms of care (§ § 37 to 39) can be paid for up to twelve months on a regular basis, if the person entitled to the assistance is obliged to do so in the application,

1.

to notify the fixing body of any change in the information in the aid application without delay and without delay; and

2.

-to reimburse the payment of the aid.

(3) The aid shall be granted on the written or electronic request of the person entitled to the aid at the place of detention. The supporting documents on which the application is based shall be submitted to the place of detention as a second copy or in copy with the application or separately. If there is concrete evidence that filed documents are falsified or falsified, the site of the arrest may obtain information on the authenticity of the document with the consent of the person entitled to the assistance. If the consent is refused, the aid shall be rejected for the expenditure in question. Prescriptions must indicate the pharmaceutical central number of the prescribed medicinal product, unless it is not necessary due to the purchase of the product abroad. The supporting documents may also be transmitted electronically, provided that the place of arrest permits this. The body may request a signed aid application in paper form. (4) The supporting documents relating to expenses abroad must in principle comply with the requirements in force in Germany. If the person entitled to the aid fails to provide the information necessary for the comparison of costs, the determining body shall determine the appropriateness of the expenditure. On request, a translation must be submitted at least for a certificate of the clinical picture and the services provided. (5) The decision on the authorization or the rejection of the requested aid (state aid notice) shall be submitted by the Fixing point in writing or electronically. To the extent that evidence is needed to check the right to waste for medicinal products, they may be withheld. To the extent that the place of arrest produces electronic documents for the reproduction of documents, these documents shall be retained. They shall be destroyed no later than six months after the date on which the aid decision has been unquestionable or after the date on which the supporting documents are no longer required for audits of any rebate granted under Section 3 of the Act on Discounts for Medicinal Products and electronic images without trace. (6) In order to avoid unreasonable hardship, the site may, after consulting the person entitled to the assistance, allow persons to take account of or their legal status. Representatives or representatives without the consent of the person entitled to the assistance (7) Aid shall only be granted if the total expenditure claimed in the application is more than 200 euro. The place of detention may, in the event of a looming period of limitation, or in order to avoid other unreasonable hardship, allow exceptions. (8) The place of detention may, at the request of the person entitled to the assistance, make a payment of the amount of the cash. It may, in exceptional cases, pay the aid to third parties with the consent of the person entitled to grant aid. Unofficial table of contents

Section 52 Allocation of expenses

Eligible expenses are allocated:

1.

for a family and household help for the person who is not domestically housed,

2.

for an accompanying person to the or the accompanying person,

3.

for a family-oriented rehabilitation measure for the sick child and

4.

in the case of birth, including expenses incurred by the hospital for the mother's healthy newborn.

Unofficial table of contents

§ 53 (omitted)

- Unofficial table of contents

Section 54 Application deadline

(1) Aid shall only be granted if it is requested within one year of the date of the invoice. For the beginning of the period, maintenance services shall be the last day of the month in which the care has been provided. If a social assistance carrier or in the care of the institution of the victims of war has been responsible, the period shall begin with the first of the month following the month in which the welfare institution or the institution of the victims of the war shall (2) The time limit shall also be maintained if the application by persons entitled to the assistance pursuant to § 3 is submitted to the competent employment office abroad within the period referred to in paragraph 1. Unofficial table of contents

Section 55 Confidentiality

(1) The personal data which have become known in the course of the processing of the aid application shall be kept secret. They may only be used for the purpose for which they have been disclosed, unless there is a legal authority to use the data for a different purpose or the person concerned has written to the purpose in writing. (2) Personal data from the State aid file may be sent to the place of treatment without the consent of the person concerned, in so far as the knowledge of the data for the determination and calculation of the remuneration or supply or for the purpose of the data is available for the purposes of the examination of the eligibility of the child is necessary. Unofficial table of contents

Section 56 Detention centres

(1) Detention centres

1.

the supreme service authorities for the applications of their staff and of the heads of the authorities immediately following them,

2.

the authorities directly subordinated to the supreme service authorities in respect of the requests by the staff of their business unit; and

3.

the supply points for the applications submitted by the suppliers of the supply and the beneficiaries.

(2) The highest service authorities may settle the responsibility for their business unit. The processing of the aid may only be carried over to the authorities of the respective dientherrn. The transfer is to be published in the Joint Ministerial Gaz.3 The Detention Centres have to invoke the discounts on medicinal products under the Law on Discounts for Medicinal Products. Unofficial table of contents

§ 57 (omitted)

Chapter 7
Transitional and final provisions

Unofficial table of contents

Section 58 Transitional provisions

(1) On expenditure incurred before 14 February 2009, the state aid rules of 1 November 2001, as last amended by Article 1 of the general administrative provision of 30 January 2004 (GMBl p. 379), continue to apply. (2) For spouses, spouses, life partners in which the total amount of income exceeds the limit provided for in Article 4 (1), but by 13 February 2009 below the income limit in accordance with § 5 (4) (3) of the Article 5 (4) of the Treaty establishing the European Community for the first time has been subject to state aid rules (3) Children who are at least until the completion of the 25. In the winter semester 2006/2007, they have been enrolled at a university or university of applied sciences, until the completion of the 27th year. In addition to the periods of time provided by the statutory basic service or civil service as persons eligible for consideration. The transitional arrangement shall have no effect on the rate of assessment of the person entitled to be eligible. (4) § 46 (3) sentence 2 shall apply from 1 January 2010. In the meantime, § 14 of the state aid rules is to be applied further in the version valid until 13 February 2009 (paragraph 1). (5) For voluntary members of statutory health insurance available on 20 September 2012, § 47 (6) is in the up to on 19 September 2012, in connection with Section 9 (1) sentence 1 in the version valid since 26 July 2014, until 20 September 2017. Subsequently, § 6 (7) applies accordingly to the increase in the rate of assessment. (6) Aid for expenses of a life partner or a life partner and their children, who meet the requirements of § 4, will be retroactive from the 14. February 2009. For expenses incurred in the period from 1 January to 13 February 2009, the state aid rules shall be applied in the version valid up to 13 February 2009 (paragraph 1), subject to the proviso that the spouse shall be subject to the conditions laid down in paragraph 1. are equal. The period of application in accordance with § 54 shall begin at the earliest on 2 January 2009. Unofficial table of contents

Section 59 Entry into force

This Regulation shall enter into force on the day following the date of delivery. Unofficial table of contents

Appendix 1 (to § 6 (2))
Excluded and partially excluded examinations and treatments

(Fundstelle: BGBl. I 2012, 1944-1946;
with regard to of the individual amendments. Footnote)

Section 1

Total exclusion

1.1

Application of sound-modulated methods, Audio-Psycho-Phonology-Therapy (for example, after Tomatis, hearing-training after Volf, audiovocal integration and therapy, psychophony-procedure for the treatment of migraine)

1.2

Atlastherapy by Arlen

1.3

autohomologous immunotherapies

1.4

Autologous Target Cytokine Therapy by Klehr

1.5

ayurvedic treatments, for example to Maharishi

2.1

Treatment with non-accelerated electrons according to Nuhr

2.2

Biophotons-Therapy

2.3

Bioresonator tests

2.4

Blood crystallization tests for the detection of cancers

2.5

Bogomoletz-Serum

2.6

Refractive surgery of the cornea of the eye (keratomileusis) according to Barraquer

2.7

Fracture healing without surgery

3.1

Chelate Therapy

3.2

Colon-Hydro-Therapy and its modifications

3.3

computer-aided mechanical distraction procedures, for non-operative segmental distraction on the spine (for example, SpineMED method, DRX 9000, Accu-SPINA)

3.4

computer-aided visual field training for treatment after a neurological disease or injury

3.5

cytotoxic food tests

4.1

DermoDyne-Therapy (DermoDyne Light vaccination)

5.1

Electron treatments by Croon

5.2

Electron neuraldiagnosis

5.3

epidural spinal catheteria technique after Racz

6.1

Fresh cell therapy

7.1

All-round treatments based on bioelectric medicine (for example, bioresonance therapy, Decoderdermography, electroacupuncture after full, electronic system diagnostics, drug tests after bioelectric function diagnostics, Moratherapy)

7.2

Targeted vegetative rearrangement treatment or targeted vegetative total switching through negative static electricity

8.1

Heileurhythmy

8.2

Altitude flights for asthma or herb coughing

8.3

(dropped)

9.1

immunoaugmentative therapy

9.2

Immours (Serocytol-preparations)

9.3

isobare or hypertensive inhalation therapies with ionized or non-ionised oxygen or ozone, including oral, parenteral or percutaneous uptake (for example, hematogenous oxidation therapy, oxygen-intestinal remediation, Oxygen-Multi-Step Therapy after Ardenne)

10.1

(free)

11.1

Caries detector treatment

11.2

kinesiological treatment

11.3

Kirlian-Photography

11.4

combined serumtherapy (e.g. Wiedemann-Kur)

11.5

konductive promotion to Petö

12.1

Laser treatment in the field of physical therapy

13.1

modified autohaemic treatment (for example, according to Garthe, blood-crystal analysis using the preparations of autohaemin, antihaemin and anhaemin) and other procedures in which the patient or patient has individual substances from the body's own substances. Preparations are made (for example, counter-sensitization according to Theurer, Clustermedizin)

14.1

Neurotopical diagnosis and therapy

14.2

low dosed, pulsed ultrasound

15.1

osmotic drainage therapy

16.1

Psycotron therapy

16.2

pulsating signal therapy

16.3

Pyramid energy irradiation

17.1

(free)

18.1

Radial shock wave therapy

18.2

Regenerative therapy

18.3

Cleaning program with Megavitamines and sweating

18.4

Rolfing treatment

19.1

Vibration field therapy

20.1

Thermoregulatory Diagnostics

20.2

Dry cell therapy

21.1

(free)

22.1

Vaduril injections against parodontosis

22.2

Vibratory massage of the cross leg

23.1

(free)

24.1

(free)

25.1

(free)

26.1

Cell milieu-therapy

Section 2

Partial exclusion

1.

Surgical corneal correction by laser treatment expenses are only eligible if a correction by eyeglasses or contact lenses is not possible according to eye medical determination. Prior to receiving the treatment, the approval of the place of detention shall be obtained.

2.

Extracorporeal shock wave therapy (ESWT) in orthopaedic and pain-therapeutic area expenses are only eligible for treatment of Tendinosis calcarea, pseudarthrosis, fasciitis plantaris and therapy-fractal Achillodynia. On the basis of the decision of the Bundesärztekammer zur analogue evaluation of the ESWT, fees in accordance with point 1800 of the annex to the fees regulations for doctors are eligible for aid. In addition, no surcharges are eligible for assistance.

3.

Hypertensive oxygen therapy (overpressure treatment) expenses are only eligible for the treatment of carbon monoxide poisoning, gas gangrene, chronic bone infections, septicaemia, severe burns, gasembolias, peripheral ischaemia or from Tinnitus sufferers associated with perceptive disorders of the inner ear.

4.

Hyperthermia treatment
Expenses are only eligible for tumour treatments in combination with chemotherapy or radiotherapy.

5.

Air-conditioning treatment expenses are only eligible for aid if other conventional treatment methods have not been successful and the site of the arrest is due to the opinion of a doctor or a doctor who determines it, before the start of the treatment. of the treatment.

6.

Lanthasol aerosol inhalation expenses are only eligible if the aerosol inhalation courses are carried out with highly effective drugs, for example Aludrin.

7.

Magnetic field therapy expenses are only eligible for the treatment of atrophic pseudarthrosis, endoprosthesis loosening, idiopathic hip necrosis and delayed bone fracture healing when the magnetic field therapy in conjunction with a proper surgical treatment, as well as in psychiatric disorders.

8.

Ozone therapy expenses are only eligible for gas insufflations if they are treated with arterial occlusive diseases. Prior to receiving the treatment, the approval of the place of detention shall be obtained.

9.

Therapeutic riding (hippotherapy) expenses are only eligible for severe cerebral movement disorders (spasticity) or severe mental retardation, provided that the physician prescribed treatment of health care or health care workers is not necessary. Medical profession (for example, physiotherapy or physiotherapy) with appropriate additional training is performed. Expenditure shall be eligible for aid under points 3 to 5 of Annex 9.

10.

Thymus therapy and treatment with thymus preparations are only eligible for cancer treatments if other conventional treatment methods have not been successful.

Unofficial table of contents

Appendix 2 (to § 6, paragraph 3, sentence 4)
Maximum amounts for the appropriateness of expenditure on medical practitioners ' benefits

(Fundstelle: BGBl. I 2012, 1947-1952;
with regard to of the individual amendments. Footnote)


Number Performance DescriptionAgreements Maximum amount

1-10	General benefits
1	For the in-depth investigation, which overtakes the ordinary measure		12,50 €
2a	Collection of homeopathic hereditary history with a minimum duration of one hour per treatment case		80.00 €
2b.	Implementation of the complete medical examination with repertorisation according to the rules of classical homeopathy Note: The performance referred to in point 2b shall be calculated in a session only once and at most three times within six months.		35,00 €
3	Short information, also by means of a telephone, or an exhibition of a repeal ordinance, as the only benefit per claim by the medical practitioner/the alternative practitioner		3.00 €
4	In-depth advice exceeding the normal level of at least 15 minutes, including, where appropriate, an investigation Note: A performance in accordance with point 4 shall be eligible for assistance only as a sole benefit or in the context of a performance referred to in point 1 or point 17.1.		18,50 €
5	Advice, including by means of a telephone, including, where appropriate, a brief investigation Note: A performance according to point 5 is eligible only once per treatment case in addition to a different benefit.		9,00 €
6	For the same services as in point 5, but outside the normal hours of office hours		13,00 €
7	For the same services as in point 5, but at night, between 20 and 7 o'clock		18,00 €
8	For the same services as in point 5, but on Sundays and holidays Note: As a general consultation hour, the time fixed by the suspended period shall apply, even if it is fixed after 8 p.m. A calculation of the fee according to points 6 to 8 can therefore only be carried out if the consultation took place outside the stipulated periods and the patient was not present in the waiting room before the end of the same period. Likewise, for Sundays and public holidays, the increased fees provided for this can not come to the calculation if the alternative practitioner habitually holds office hours on Sundays and public holidays.		20.00 €
9	House visit including advice
9.1	by day		24,00 €
9.2	in urgent cases (Eilvisit, immediately executed)		26.00 €
9.3	at night and on Sundays and holidays		29,00 €
10	Additional fees for house visits
10.1	for every hour of the day up to 2 km distance between the place of practice and the place of visit		4.00 €
10.2	for each hour at night up to 2 km distance between the place of practice and the place of visit		€ 8.00
10.5	for every kilometre covered by day from 2 to 25 km distance between the place of practice and the place of visit		€ 1.00
10.6	for each km travelled by night from 2 to 25 km distance between the place of practice and the place of visit		€ 2.00
10.7	If it is a long-distance visit of more than 25 km between the place of practice and the place of visit, it is possible to take account of the travel costs per kilometre. Note: The mileage is calculated according to the most convenient travel route. If the medical practitioner visits several patients during a visit, the travel expenses will be allocated accordingly.		0,20 €
10.8	If a visit to the hospital is a journey that lasts longer than 6 hours, then the medical practitioner/health practitioner can charge the travel expenses actually incurred instead of the commuting money and also for the travel expenses. Calculate travel time per hour. The patient The patient must be informed of this beforehand.		16,00 €
11	Written omissions and sickness certificates
11.1	Short illness certificate or letter in the patient's interest		€ 5.00
11.2	Detailed disease report or expert opinion (DIN A4 engine-written in English)	Detailed written disease and findings report (including information on the history of history, on the findings, on the epicritic evaluation and, if appropriate, on the therapy)	15,00 €
		Written expert statement	16,00 €
11.3	Individually prepared written diet plan for nutritional and metabolic disorders		€ 8.00
12	Chemical-physical investigations
12.1	Urinary examinations qualitatively by using a multiple reagent carrier (test strip) by visual colour comparison Note: The simple qualitative study of sugar and protein, as well as the determination of the ph and the specific weight, are not capable of calculating.		3.00 €
12.2	Urinary examination quantitatively (it is necessary to indicate which substance has been studied, for example sugar, etc.)		4.00 €
12.4	Urinary examination, only sediment		4.00 €
12.7	Blood status (not in addition to numbers 12.9, 12.10, 12.11)		10,00 €
12.8	Blood sugar determination		€ 2.00
12.9	Haemoglobin determination		3.00 €
12.10	Differentiation of the dyed blood tribe		$6.00
12.11	Counting of leukocytes and erythrocytes	Erythrocyte count and/or haematocrit and/or haemoglobin and/or medium cell volume (MCV) and the calculated parameters (e.g. MCH, MCHC) and the erythrocyte distribution curve and/or leukocyte count and/or platelet count	3.00 €
		Differentiation of leukocytes, electronically-cytometrically, cytochemical-cytometric or by means of mechanised pattern recognition (image analysis)	€ 1.00
12.12	The blood cell rate is included in the blood cell rate. Blood sampling		3.00 €
12.13	Simple microscopic and/or chemical investigations of bodily fluids and excretions, even with simple or difficult dyeing procedures as well as dark field, per examination Note: The type of investigation shall be indicated.		$6.00
12.14	Complex chemograms of bodily fluids and excretions depending on the extent per individual examination Note: The type of investigation shall be indicated.		7,00 €
13	Other studies
13.1	Other studies with the aid of special apparatus or dyeing processes of a particularly difficult nature, for example, ph measurements in the flowing blood or examinations according to v. Bremer, Enderlein, etc. Note: The type of investigation shall be indicated.		$6.00
14	Special investigations
14.1	Binocular microscopic examination of the eye foreground Note: A performance in accordance with point 14.1 may not be calculated in addition to a performance in accordance with point 1 or number 4. Services according to points 14.1 and 14.2 cannot be calculated side by side.		€ 8.00
14.2	Binocular reflection of the ocular fundus Note: A performance in accordance with point 14.1 may not be calculated in addition to a performance in accordance with point 1 or number 4. Services according to points 14.1 and 14.2 cannot be calculated side by side.		€ 8.00
14.3	Basic rate determination by Read		€ 5.00
14.4	Determination of the basic principle with the help of the respiratory gas investigation		20.00 €
14.5	Examination of lung capacity (Spirometric investigation)		7,00 €
14.6	Electrocardiogram with phonocardiogram and ergometry, complete program		41,00 €
14.7	Electrocardiogram with standard derivations, Goldberger derivations, Nehbsche discharge lines, chest wall derivations		14,00 €
14.8	Oscillogram methods		11,00 €
14.9	Special cardiovascular examinations Note: Not entitled to number 1 or number 4.		€ 8.00
14.10	Ultrasound vascular doppler investigation into peripheral vein pressure and/or flow measurements		9,00 €
17	Neurological investigations
17.1	Neurological examination		21,00 €
18-23	Special treatments
20	Respiratory therapy, massages
20.1	Respiratory therapy		€ 8.00
20.2	Nerve point massage according to Cornelius, Aurelius u. A., Special nerves massage		$6.00
20.3	Connective tissue massage		$6.00
20.4	Partial massage (massage of individual body parts)		4.00 €
20.5	Large massage		$6.00
20.6	Special massages	Underwater pressure jet massage (bath contents at least 400 litres, performance of the apparatus at least 4 bar)	€ 8.00
20.6	Special massages	Massage in the extramuscular area (for example, connective tissue massage, periostmassage, manual lymphatic drainage)	$6.00
		Extension-treatment with sloping bed, extension-table, pearl device	$6.00
20.7	Treatment with physical or medicomechanical apparatus		$6.00
20.8	Enrolment for therapeutic purposes in the skin		4.00 €
21	Acupuncture
21.1	Acupuncture including pulse diagnosis		23.00 €
21.2	Moxibustions, injections and quadrifications in acupuncture points		7,00 €
22	Inhalations
22.1	Inhalations, as far as they are executed by the practitioner of the Heilpraktiker with the various apparatus in the consultation hour		3.00 €
24-30	Blood withdrawal-injections-Infusions-Skin discharge procedures
24	Own blood, self-harp
24.1	Self-blood injection		11,00 €
25	Injections, infusions
25.1	Injection, subcutaneously		€ 5.00
25.2	Injection, intramuscular		€ 5.00
25.3	Injection, intravenous, intraarterial		7,00 €
25.4	Intracutane Irritation Therapy (QuaddelTreatment), per session		7,00 €
25.5	Injection, intraarticular		11,50 €
25.6	Neural-or segment-specific injections according to Hunecke		11,50 €
25.7	Infusion		€ 8.00
25.8	Continuous drip infusion Note: The eligibility of the medicinal products introduced by the infusion is based on the state aid rules of the aid.		12,50 €
26	Blood withdrawal
26.1	Blood sampling		3.00 €
26.2	Wire lass		12,00 €
27	Skin discharge procedure, skin irritation procedure
27.1	Setting of blues, if necessary including Federation		€ 5.00
27.2	Skarification of the skin		4.00 €
27.3	Setting of Schröpfköpfen, unbloody		€ 5.00
27.4	Setting of Schröpfköpfen, bloody		€ 5.00
27.5	Cuphead massage. Lubricant		€ 5.00
27.6	Application of large suction devices for whole extremities		€ 5.00
27.7	Setting Fontanelles		€ 5.00
27.8	Set of Cantharidenbubbles		€ 5.00
27.9	Pure injection of the bladder inhalation (from point 27.8)		€ 5.00
27.10	Application of Pustulantien		€ 5.00
27.12	Beer spreads		€ 5.00
28	Infiltrations
28.1	Treatment by means of paravertebral infiltration, unique		9,00 €
28.2	Treatment by means of paravertebral infiltration, multi-morally		15,00 €
29	Roedersches Procedure
29.1	Roedersche treatment and almond extraction process		€ 5.00
30	Other business
30.1	Flushing the Ohres		€ 5.00
31	Wound care, associations and relatives
31.1	Opening of a superficial abscess		9,00 €
31.2	Removal of acne pustules per session		€ 8.00
32	Supply of a fresh wound
32.1	at a little wound		€ 8.00
32.2	for a larger and polluted wound		13,00 €
33	Associations (except for wound treatment)
33.1	Associations, every time		€ 5.00
33.2	Elastic support and paving dressings		7,00 €
33.3	Compression or zinc gluing Note: The eligibility of the equipment used for the association is based on the state aid rules of the state aid.		10,00 €
34	Joint and spinal treatment
34.1	Chiropractic treatment		4.00 €
34.2	Targeted chiropractic intervention on the spinal column Note: The performance referred to in point 34.2 is only capable of being calculated once per session.		17,00 €
35	Osteopathic treatment
35.1	of the lower jaw		11,00 €
35.2	of the shoulder joint and the spinal column		21,00 €
35.3	the wrists, the thigh, the lower leg, the front arm and the ankle joints		21,00 €
35.4	of the key leg and the knee joint		12,00 €
35.5	of the thumb		10,00 €
35.6	single finger and toes		10,00 €
36	Hydro-and electrotherapy, medical baths and other hydrotherapeutic applications Note: All non-listed bathrooms are not eligible for assistance.
36.1	Line of a rising full bath		7,00 €
36.2	Line of an ascending sub-bath		4.00 €
36.3	Special bath (subaqual darmbad)		13,00 €
36.4	Kneipp's Güsse		4.00 €
37	Electric baths and hot air baths Note: All non-listed bathrooms are not eligible for assistance.
37.1	Partial hot air bath, for example head or arm		3.00 €
37.2	All-hot air bath, for example hull or legs		€ 5.00
37.3	Hot air bath in closed box		€ 5.00
37.4	Electric four-cell bath		4.00 €
37.5	Electric full bath (Stangerbad)		€ 8.00
38	Special packages Note: All packages not listed are not eligible for aid.
38.1	Catch opackings		3.00 €
38.2	paraffin packings, local		3.00 €
38.3	Paraffinganzpackungen		3.00 €
38.4	Kneipp wraps and full packs, Prießnitz-and Schlenzpackungen		3.00 €
39	Electro-physical healing methods
39.1	Simple or local light irradiations		3.00 €
39.2	Full irradiations		€ 8.00
39.4	Faradisation, electroplating and related processes (threshold current equipment)		4.00 €
39.5	Application of the Influence Machine		4.00 €
39.6	Use of heating sun (infrared)		4.00 €
39.7	Blurred with hot air and hot vapours		€ 8.00
39.8	Treatment with high-voltage currents, high-frequency currents in connection with various apparatus		3.00 €
39.9	Long-wave treatment (Diathermie), Short-wave and microwave treatment		3.00 €
39.10	Magnetic field therapy with special special equipment		4.00 €
39.11	Electromechanical and electro-thermal treatment (depending on the time and time required)		4.00 €
39.12	Low frequency stimulation therapy, for example Jono modulator		4.00 €
39.13	Ultrasound treatment		4.00 €

Unofficial table of contents

Appendix 3 (to § § 18 to 21)
Ambulant psycho-therapeutic treatments and psychosomatic basic care measures

(Fundstelle: BGBl. I 2012, 1953-1955;
with regard to of the individual amendments. Footnote)

Section 1
Psychotherapeutic services

1.

Non-eligible expenses are:

a)

Family therapy,

b)

Functional relaxation according to Marianne Fuchs,

c)

Discussion sychotherapy (for example, according to Rogers),

d)

design therapy,

e)

Body-related therapy,

f)

Concentrative motion therapy,

g)

Logotherapy,

h)

Music therapy,

i)

Heileurhythmy,

j)

Psychodrama,

k)

Respiratory Biofeedback,

l)

Transaction analysis.

2.

Non-psychotherapeutic services within the meaning of § § 18 to 21 belong:

a)

treatments intended for school, professional or social adjustment or promotion,

b)

Measures of educational, marriage, life or sexual counselling,

c)

Curative pedagogical and similar measures, and

d)

Psychological measures that are used to work up and overcome social conflicts.

Section 2
Psychosomatic Basic Care

1.

Expenses for verbal intervention are only eligible if the treatment is carried out by a specialist or a specialist in

a)

General medicine,

b)

Ophthalmology,

c)

Gynaecology and obstetrics,

d)

skin and sexually transmitted diseases,

e)

Internal medicine,

f)

Children's and adolescents ' medicine,

g)

Children's and adolescent psychiatry and psychotherapy,

h)

Neurology,

i)

Phoniatrics and paediatric diology,

j)

Psychiatry and psychotherapy,

k)

Psychotherapeutic medicine or psychosomatic medicine and psychotherapy or

l)

Urology.

2.

Expenses for performing and suggestive interventions (autogenic training, Jacobsonian relaxation therapy, hypnosis) are only eligible if the treatment is carried out by

a)

of a doctor, or a doctor,

b)

a psychological psychotherapist, or a psychological psychotherapist,

c)

a child and youth psychotherapist or a child and youth psychotherapist.

The person treating the treatment must have knowledge and experience in the application of the relevant intervention.

Section 3
Depth psychology-based and analytical psychotherapy

1.

If the treatment is carried out by a medical psychotherapist or a medical psychotherapist, this person must be a specialist doctor or specialist in one of the following subjects:

a)

Psychotherapeutic medicine,

b)

Psychiatry and Psychotherapy or Psychosomatic Medicine and Psychotherapy,

c)

Children's and adolescent psychiatry and psychotherapy, or

d)

Doctor or physician with the area or additional name "Psychotherapy" or "Psychoanalysis".

A specialist in psychotherapeutic medicine, psychiatry and psychotherapy or child and adolescent psychiatry and psychotherapy, as well as a doctor or a doctor with the area name "Psychotherapy" can only Psychotherapy based on deep psychology (numbers 860 to 862 of the system of fees for doctors). A doctor or a doctor with the area or additional name "Psychoanalysis" or with the term "Psychotherapy" conferred before 1 April 1984 can also use analytical psychotherapy (numbers 863 and 864 of the facility for the treatment of psychotherapy). Fees for doctors).

2.

A psychological psychotherapist or a psychological psychotherapist with an Approbation according to § 2 of the Psychotherapist Law (PsychThG) can provide benefits for the recognized psychotherapy form (profound psychologically sound or analytical psychotherapy), for which she or he has experienced an in-depth education.

3.

If the treatment is carried out by a psychological psychotherapist or a psychological psychotherapist with an Approbation according to § 12 PsychThG, this person must:

a)

be admitted to the statutory health insurance scheme,

b)

be entered in the doctor's register, or

c)

have completed a completed training in psychotherapy in depth psychology and analytical psychotherapy at a psychotherapeutic training institute recognized by the Federal Association of Statesmen of Health Care until 31 December 1998.

4.

A psychological psychotherapist or a psychological psychotherapist can only provide services for the form of psychotherapy (psychotherapy based on depth psychology or analytical psychotherapy), for which she or he is the contract doctor. Supply to the statutory health insurance companies or is registered in the doctor's register. A psychological psychotherapist or a psychological psychotherapist who or who has completed a completed training on a psychotherapeutic treatment recognized by the Federal Association of Statesmen until 31 December 1998 The training institute can carry out both in-depth psychotherapy and analytical psychotherapy (numbers 860, 861 and 863 of the annex to the medical fees regulations for doctors).

5.

A psychotherapist for children and adolescents and a psychotherapist for children and adolescents with an Approbation in accordance with § 2 PsychThG can provide benefits for the psychotherapy form in the case of persons who are 18 years old. Have not yet completed life, (psychologically profound or analytical psychotherapy), for which she or she has experienced an in-depth education.

6.

Will be the treatment of persons who are the 18. Have not yet completed their life year, performed by a children's and youth psychotherapist or a child and youth psychotherapist with an Approbation according to § 12 PsychThG, this person must

a)

be admitted to the statutory health insurance scheme,

b)

be entered in the doctor's register, or

c)

on a completed training in psychotherapy in depth psychology and analytical psychotherapy at a psychotherapeutic training institute for children, recognised by the Federal Association of Statesmen until 31 December 1998, Adollichenpsychotherapy.

7.

A psychotherapist or a psychotherapist of children and adolescents can only provide services for the form of psychotherapy (psychotherapy based on depth psychology or analytical psychotherapy), for which she or she is responsible for the treatment of psychotherapy. be admitted to the statutory health insurance company or entered into the doctor's register. A psychotherapist, a psychotherapist of children and adolescents, or a psychotherapist who has completed a course of studies at a recognised psychotherapeutic training institute for child and adolestic-psychotherapy. , can carry out both in-depth psychotherapy and analytical psychotherapy (numbers 860, 861 and 863 of the system of fees regulations for doctors).

8.

Will be the treatment of persons who are the 18. Have not yet completed their life, carried out by a person who is not a specialist in the field of child and adolescent psychiatry and psychotherapy, or a psychotherapist for children and adolescents, or a psychotherapist of children and adolescents. , in addition to the authority referred to in points 1, 2 or 3, the person treating the treatment shall also be able to verify the professional competence of the person in question by means of a corresponding authorization of a medical insurance association. who is not a specialist doctor for psychotherapeutic medicine or psychosomatic medicine, the person in charge of the treatment shall, in addition to the authority referred to in points 1, 2 or 3, also have to prove their professional competence by means of a corresponding entitlement of a cash medical association.

9.

In exceptional exceptional cases (Section 20 (1) (3) and (4)), the condition for the eligibility of the expenditure shall be that a new detailed reasoning of the therapist or therapist be submitted before the start of the treatment and that the The body has agreed to be established before the start of the treatment. If therapy shows that the treatment objective is not achieved within the prescribed number of sessions, a further limited duration of treatment can be recognised in medical cases which are particularly well-founded. Recognition must not take place until the last part of the treatment. The prerequisite for recognition is an indication in accordance with Article 20 (1), which requires, according to its special symptoms and structure, a special depth-psychologically sound or analytical treatment and a sufficient prognosis on the Reach of the treatment target allowed.

Section 4
Behavioral therapy

1.

If the treatment is carried out by a medical psychotherapist or a medical psychotherapist, this person must be a specialist doctor or specialist in one of the following subjects:

a)

Psychotherapeutic medicine or psychosomatic medicine,

b)

Psychiatry and psychotherapy,

c)

Children's and adolescent psychiatry and psychotherapy, or

d)

Doctor or doctor with the area or additional name "Psychotherapy".

Medical psychotherapists or medical psychotherapists who are not specialist physicians can carry out the treatment if they provide evidence that they have a particular knowledge of the subject during their further education and training. have gained experience in behavioural therapy.

2.

A psychological psychotherapist or a psychological psychotherapist with an Approbation according to § 2 PsychThG can conduct behavioural therapy if she or she has experienced an in-depth education for this.

3.

Is the treatment of a psychological psychotherapist, a psychotherapist, a psychotherapist of children and adolescents, or a psychotherapist of children and adolescents with an Approbation according to § 12 of the PsychThG , this person must be

a)

be admitted to the statutory health insurance scheme,

b)

be entered in the doctor's register, or

c)

have completed a training course in behavioural therapy on a behavioural therapeutic training institute recognized by the Federal Association of Statesmen and Health until 31 December 1998.

4.

Will be the treatment of persons who are the 18. Have not yet completed the life year, carried out by a person who is not a specialist doctor or specialist in child and adolescent psychiatry and psychotherapy, children's and adolescents 'psychotherapists or children's and adolescents' and In addition to the authority referred to in points 1, 2 or 3, the person treating the young person is also psychotherapist who has the right to emulate his/her professional competence by means of a corresponding authorization of a medical insurance association. of a person who does not have a medical specialist or a specialist in psychotherapeutic Medicine or psychosomatic medicine and psychotherapy, in addition to the authority referred to in points 1, 2 or 3, the person treating the treatment must also prove their professional competence by means of a corresponding entitlement of a cash medical association.

Unofficial table of contents

Appendix 4 (to section 22 (1))
Medical devices eligible for aid

(Fundstelle: BGBl. I 2015, 846-852)

Nr.Product Label Use Cases

1	1xklysma salinisch	For the rapid and sustainable emptying of the end intestine before surgery and diagnostic interventions; not for use in infants and young children.
2.1	AMO ENDOSOL	For intraocular and topical flushing of the eye in surgical procedures and for diagnostic and therapeutic measures.
2.2	Ampuwa for flushing purposes	For humidification of tamponades and dressings; for airway humidification only for use in closed systems in medically necessary cases; in each case in a quantity which is suitable exclusively for one-off application.
2.3	Amvisc	For use as surgical assistance in ophthalmic interventions at the anterior section of the eye.
2.4	Amvisc Plus	For use as surgical assistance in ophthalmic interventions at the anterior section of the eye.
2.5	Aqua B. Braun	For rinsing and cleaning during surgical operations, for rinsing wounds and burns, for moistening of wound tamponades, cloths and dressings, for checking the permeability of bladder catheters and for mechanical eye flushing.
3.1	Bausch & Lomb Balanced Salt Solution	For irrigation in the context of extraocular and intraocular interventions.
3.2	BSS DISTRA-SOL	For the flushing of the anterior chamber during cataract surgery and other intraocular interventions.
3.3	BSS NL250/NL500	For flushing the surgical extraocular or intraocular surgical area.
3.4	BSS PLUS (Alcon Pharma GmbH)	As an intraocular rinsing solution in surgical interventions in which intraocular perfusion is required.
3.5	BSS STERILE RINSING SOLUTION (Alcon Pharma GmbH)	For irrigation in the context of extraocular and intraocular interventions.
4.1	Dimet 20	Treatment of the head hair in Pediculosis capitis in persons who a) the twelfth year of life has not yet completed, b) the twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
4.2	Dk-line	For use as surgical aid in ophthalmic surgery, for mechanical retina folding according to retinal detachments/PVR/PDR, giant cracks or ocular trauma, and for the simplified removal of subluxated lenses and foreign bodies from the Vitreous body room.
4.3	Dr. Deppe EndoStar-Lavage	Intestinal cleansing for the preparation of a colonoscopy in persons who have completed the twelfth year of life.
4.4	DuoVisc	For use as an operational aid in ophthalmosurgery of the anterior eye section in cataract extraction and implantation of an intraocular lens.
5.1	EtoPril	Treatment of the head hair in Pediculosis capitis in persons who a) the twelfth year of life has not yet completed, b) the twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
5.2	Eye-Lotion BSS	For irrigation in the context of extraocular and intraocular interventions.
6.1	Freka-Clyss	Treatment a) obstipation in connection with tumors, megacolone (with the exception of toxic megacolons), diverticuloses, diverticulitis, cystic fibrosis or neurogenic intestinal paralysis, b) before diagnostic intervention, c) for opiate and opioid therapy, and d) in the terminal phase in the case of persons who have completed the twelfth year of life. Treatment of constipation, rapid and sustainable emptying of the end intestine before operations, preparation of urological, radiological and gynaecological examinations as well as pre-rectoscopy a) in the case of persons who have completed the fourth year, but not yet the twelfth year of life, and b) in the case of persons who are the twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
6.2	Freka Drain Jet NaCl 0.9%	For internal and external use such as perfusion of the extracorporeal system in haemodialysis, post-operative bladder flushing in all urological interventions, flushing in the gastrointestinal tract and of fistulas and drains. Also for wound treatment and for moisturing cloths and dressings.
6.3	Freka Drain Jet Purisole SM diluted	For intraoperative and postoperative bladder flushing in urological interventions.
7.1	Globance Lavage	For the treatment before diagnostic interventions in persons who are the 18. Have completed their life year.
7.2	Globance Lavage Apfel	For the treatment before diagnostic interventions in persons who are the 18. Have completed their life year.
8.1	Healon	For intraocular use in eye surgery.
8.2	Healon5	As a viscoelastic solution for intraocular use in operations at the front eye section.
8.3	HEALON GV	As a viscoelastic solution for intraocular use in operations at the front eye section.
8.4	HSO	For use as surgical assistance in ophthalmic interventions at the anterior and posterior section of the eye.
8.5	HSO Plus	For use as surgical assistance in ophthalmic interventions at the anterior and posterior section of the eye.
8.6	Hylo-Gel	As a synthetic tear fluid in autoimmune diseases (Sjögren syndrome with distinct dysfunctions [dry eye Grade 2], epidermolysis bulosa, ocular pemphigoid), lack of or damage to the tears, facial paralysis or Lagophthalmus.
9.1	IsoFree	As a carrier solution in the use of inhalants in nebulisers or aerosol devices, if the addition of an isotonic carrier solution in the subject information of the drug-containing inhalant is mandatory.
9.2	Isotonic saline solution for inhalation (Eifelfango)	As a carrier solution in the use of inhalants in nebulisers or aerosol devices, if the addition of an isotonic carrier solution in the subject information of the drug-containing inhalant is mandatory.
10.1	Jacutin Pedicul Fluid	Treatment of the head hair in Pediculosis capitis in persons who a) the twelfth year of life has not yet completed, b) the twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
11.1	Klistier Fresenius	Treatment a) obstipation in connection with tumors, megacolone (with the exception of congenital megacolons), diverticuloses, diverticulitis, cystic fibrosis, or neurogenic intestinal paralysis, b) before diagnostic intervention,
		c) for opiate and opioid therapy, and d) in the terminal phase in the case of persons who have completed the twelfth year of life. Treatment of constipation, rapid and sustainable emptying of the end intestine before operations, preparation of urological, radiological and gynaecological examinations as well as pre-rectoscopy a) in the case of persons who have completed the fourth year, but not yet the twelfth year of life, and b) in the case of persons who are the twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
12.1	Lubricano	For use in persons with catheterization.
13.1	Macrogol 1A Pharma	Treatment a) obstipation in connection with tumors, megacolone (with the exception of toxic megacolons), diverticuloses, diverticulitis, cystic fibrosis or neurogenic intestinal paralysis, b) in the case of phosphate-binding medications in chronic renal insufficiency, c) for opiate and opioid therapy, and d) in the terminal phase in the case of persons who have completed the twelfth year of life. Treatment of constipation in persons who are twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
13.2	Macrogol AbZ	Treatment a) obstipation in connection with tumors, megacolone (with the exception of toxic megacolons), diverticuloses, diverticulitis, cystic fibrosis or neurogenic intestinal paralysis, b) in the case of phosphate-binding medications in chronic renal insufficiency, c) for opiate and opioid therapy, and d) in the terminal phase in the case of persons who have completed the twelfth year of life. Treatment of constipation in persons who are twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
13.3	Macrogol AL	Treatment a) obstipation in connection with tumors, megacolone (with the exception of toxic megacolons), diverticuloses, diverticulitis, cystic fibrosis or neurogenic intestinal paralysis, b) in the case of phosphate-binding medications in chronic renal insufficiency, c) for opiate and opioid therapy, and d) in the terminal phase in the case of persons who have completed the twelfth year of life. Treatment of constipation in persons who are twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
13.4	Macrogol-CT Abduction powder	Treatment a) obstipation in connection with tumors, megacolone (with the exception of toxic megacolons), diverticuloses, diverticulitis, cystic fibrosis in neurogenic intestinal paralysis, b) in the case of phosphate-binding medications in chronic renal insufficiency, c) for opiate and opioid therapy, and d) in the terminal phase in the case of persons who have completed the twelfth year of life. Treatment of constipation in persons who are twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
13.5	Macrogol dura	Treatment a) obstipation in connection with tumors, megacolone (with the exception of toxic megacolons), diverticuloses, diverticulitis, cystic fibrosis or neurogenic intestinal paralysis, b) in the case of phosphate-binding medications in chronic renal insufficiency, c) for opiate and opioid therapy, and d) in the terminal phase in the case of persons who have completed the twelfth year of life. Treatment of constipation in persons who are twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
13.6	Macrogol HEXAL	Treatment a) obstipation in connection with tumors, megacolone (with the exception of toxic megacolons), diverticuloses, diverticulitis, cystic fibrosis or neurogenic intestinal paralysis, b) in the case of phosphate-binding medications in chronic renal insufficiency, c) for opiate and opioid therapy, and d) in the terminal phase in the case of persons who have completed the twelfth year of life. Treatment of constipation in persons who are twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
13.7	Macrogolratiopharm	Treatment a) obstipation in connection with tumors, megacolone (with the exception of toxic megacolons), diverticuloses, diverticulitis, cystic fibrosis or neurogenic intestinal paralysis, b) in the case of phosphate-binding medications in chronic renal insufficiency, c) for opiate and opioid therapy, and d) in the terminal phase in the case of persons who have completed the twelfth year of life. Treatment of constipation in persons who are twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
13.8	Macrogol Sandoz	Treatment a) obstipation in connection with tumors, megacolone (with the exception of toxic megacolons), diverticuloses, diverticulitis, cystic fibrosis or neurogenic intestinal paralysis, b) in the case of phosphate-binding medications in chronic renal insufficiency, c) for opiate and opioid therapy, and d) in the terminal phase in the case of persons who have completed the twelfth year of life. Treatment of constipation in persons who are twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
13.9	Macrogol STADA	Treatment a) obstipation in connection with tumors, megacolone (with the exception of toxic megacolons), diverticuloses, diverticulitis, cystic fibrosis or neurogenic intestinal paralysis, b) in the case of phosphate-binding medications in chronic renal insufficiency, c) for opiate and opioid therapy, and d) in the terminal phase in the case of persons who have completed the twelfth year of life. Treatment of constipation in persons who are twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
13.10	Macrogol TAD	Treatment a) obstipation in connection with tumors, megacolone (with the exception of toxic megacolons), diverticuloses, diverticulitis, cystic fibrosis or neurogenic intestinal paralysis, b) in the case of phosphate-binding medications in chronic renal insufficiency, c) for opiate and opioid therapy, and d) in the terminal phase in the case of persons who have completed the twelfth year of life. Treatment of constipation in persons who are twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
13.11	Medicoforum Laxativ	Treatment a) obstipation in connection with tumors, megacolone (with the exception of toxic megacolons), diverticuloses, diverticulitis, cystic fibrosis or neurogenic intestinal paralysis, b) in the case of phosphate-binding medications in chronic renal insufficiency, c) for opiate and opioid therapy, and d) in the terminal phase in the case of persons who have completed the twelfth year of life. Treatment of constipation in persons who are twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
13.12	Mosquito med Late-Shampoo 10	Treatment of the head hair in Pediculosis capitis in persons who a) the twelfth year of life has not yet completed, b) the twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
13.13	MucoClear 6%	For the symptomatic inhalation treatment of cystic fibrosis in persons who have completed the sixth year of life.
13.14	MOVICOL	Treatment a) obstipation in connection with tumors, megacolone (with the exception of toxic megacolons), diverticuloses, diverticulitis, cystic fibrosis or neurogenic intestinal paralysis, b) in the case of phosphate-binding medications of chronic renal insufficiency, c) in opioid or opioid therapy, and d) in the terminal phase in the case of persons who have completed the twelfth year of life. Treatment of constipation in persons who are twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
13.15	MOVICOL Liquid Orange	Treatment a) obstipation in connection with tumors, megacolone (with the exception of toxic megacolons), diverticuloses, diverticulitis, cystic fibrosis or neurogenic intestinal paralysis, b) in the case of phosphate-binding medications in chronic renal insufficiency, c) for opiate and opioid therapy, and d) in the terminal phase in the case of persons who have completed the twelfth year of life. Treatment of constipation in persons who are twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
13.16	MOVICOL Junior Aromafrei	Treatment of constipation in persons who have completed the second, but not the eleventh year of life. Treatment of the coprovase in persons who have completed the fifth but not the eleventh year of life.
13.17	MOVICOL Junior Schoko	Treatment of constipation in persons who have completed the second, but not the eleventh year of life.
14.1	NaCl 0.9% B. Brown	For rinsing and cleaning during surgical operations, for rinsing wounds and burns, for moistening of wound tamponades, cloths and dressings, for checking the permeability of bladder catheters and for mechanical eye flushing.
14.2	NaCl 0.9% Fresenius Kabi	For internal and external use such as perfusion of the extracorporeal system in haemodialysis, post-operative blistering in all urological interventions, flushing in the gastrointestinal tract and fistulas and drains. Also for wound treatment and for moistening of cloths and dressings; in each case in a quantity which is suitable exclusively for one-off application.
14.3	Nebusal 7%	For the symptomatic inhalation treatment of cystic fibrosis in persons aged six years and over.
14.4	NYDA	Treatment of the head hair in Pediculosis capitis in persons who a) the twelfth year of life has not yet completed, b) the twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
15.1	OcuCoat	For use as surgical aid in ophthalmosurgery of the anterior eye section.
15.2	Oculentis BSS	For irrigation in the context of extraocular and intraocular interventions.
15.3	Octa-line	For use as surgical aid in ophthalmic surgery, for mechanical retina folding according to retinal detachments/PVR/PDR, giant cracks, ocular trauma as well as for the simplified removal of subluxated lenses and foreign bodies from the vitreous space.
15.4	Oxane 1300	For intraocular tamponade in severe forms of retinal detachment and all retinal detachment, which cannot be treated with other forms of therapy. Excluded is the use of central foramina with detachment and in case of severe diabetic retinopathies.
15.5	Oxane 5700	For intraocular tamponade in severe forms of retinal detachment and all retinal detachment, which cannot be treated with other forms of therapy. Excluded is the use of central foramina with detachment and in case of severe diabetic retinopathies.
16.1	Padiasaline Inhalation solution	As a carrier solution in the use of inhalants in nebulisers or aerosol devices. This applies only to the cases in which the addition of a carrier solution in the subject information of the inhalant containing the drug is mandatory.
16.2	Paranix without Nissenkamm	Treatment of the head hair in Pediculosis capitis in persons who a) the twelfth year of life has not yet completed, b) the twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
16.3	PARI NaCl inhalation solution	As a carrier solution in the use of inhalants in nebulisers or aerosol devices. This applies only to the cases in which the addition of a carrier solution in the subject information of the inhalant containing the drug is mandatory.
16.4	ParkoLax	Treatment a) obstipation in connection with tumors, megacolone (with the exception of toxic megacolons), diverticuloses, diverticulitis, cystic fibrosis or neurogenic intestinal paralysis, b) in the case of phosphate-binding medications in chronic renal insufficiency, c) for opiate and opioid therapy, and d) in the terminal phase in the case of persons who have completed the twelfth year of life. Treatment of constipation in persons who are twelfth, but not yet 18. They have completed their lives and suffer from developmental disorders.
16.5	Pe-Ha-Luron 1.0%	For use as surgical aid in ophthalmosurgery of the anterior eye section.
16.6	Pe-Ha-Visco 2.0%	For use as surgical aid in ophthalmosurgery of the anterior eye section.
16.7	Polyvisc 2.0%	For use as surgical aid in ophthalmosurgery of the anterior eye section.
16.8	Polysol	For irrigation in the context of extraocular and intraocular interventions.
16.9	ProVisc	For use as an operational aid in ophthalmosurgery of the anterior eye section in cataract extraction and implantation of an intraocular lens.
16.10	PURI CLEAR	For irrigation in the context of extraocular and intraocular interventions.
16.11	Purisole SM diluted	For intraoperative and postoperative bladder flushing in urological interventions, each in a quantity that is suitable exclusively for one-off use.
17.1	Ringer B. Braun	For flushing and cleaning during surgical interventions, for flushing wounds and burns as well as for intraoperative and postoperative flushing during endoscopic surgery.
17.2	Ringer Fresenius Rinse solution	For rinsing and cleaning the operating area, for moistening the tissue, for wound flushing in the case of external traumas and burns, for flushing in diagnostic examinations and for moistening wounds and associations; in each case in a quantity, which is suitable only for one-off use.
18.1	Saliva natura	For the treatment of disease-induced oral dryness in oncological or autoimmune diseases.
18.2	Sentol	For irrigation in the context of extraocular and intraocular interventions.
18.3	Serag BSS	For irrigation in the context of extraocular and intraocular interventions.
18.4	Serumwerk-Augenrinsing Solution BSS	For irrigation in the context of extraocular and intraocular interventions.
19.1	VISCOAT	For use in ophthalmological interventions at the anterior segment of the eye, in particular in the case of cataract extraction and implantation of an intraocular lens.
19.2	Visco HYAL 1.0	For use as surgical aid in ophthalmosurgery of the anterior eye section.
19.3	Viso HYAL 1.4+	For use as surgical aid in ophthalmosurgery of the anterior eye section.
19.4	VISMED	As a synthetic tear fluid in autoimmune diseases (Sjögren syndrome with distinct dysfunctions [dry eye Grade 2], epidermolysis bullosa, ocular pemphigoid), lack of or damage to the tears, facial paresis or in the case of Lagophthalmus.
19.5	VISMED MULTI	As a synthetic tear fluid in autoimmune diseases (Sjögren syndrome with distinct dysfunctions [dry eye Grade 2], epidermolysis bullosa, ocular pemphigoid), lack of or damage to the tears, facial paresis or in the case of Lagophthalmus.
20.1	Z-HYALIN	For the support of intraocular interventions at the anterior segment of the eye during cataract surgery.

Footnote

Appendix 4 No. 6.2 italic print: IdF d. Art. 1 No. 52 Buchst. e V v. 18.7.2014 I 1154 mWv 26.7.2014; the change directive should be correct: "... the word" extracorporeal "(not: extracorporal) is replaced by the word" extracorporeal " (not: extracorporal) Unofficial table of contents

Appendix 5 (to § 22 (2) (1))
Medicines that mainly serve to increase the quality of life

(Fundstelle: BGBl. I 2015, 853-855)

Section 1
Regulation of body weight (centrally acting)

Active substance pre-active medicinal products, all active strengths

A 08 AA 01 Phentermin
A 08 AA 02 Fenfluramin
A 08 AA 03 Amfepramon	REGENON TENUATE Retard
A 08 AA 04 Dexfenfluramin
A 08 AA 05 Mazindol
A 08 AA 06 Etilamfetamine
A 08 AA 07 Cathin	ALVALIN
A 08 AA 08 Clobenzorex
A 08 AA 09 Mefenorex
A 08 AA 10 Sibutramin	REDUCTIL
A 08 AA 13 phenylpropanolamine	Antiadipositum Riemser BOXOGETTEN S RECATOL mono
A 08 AX 01 Rimonabant

Section 2
Body weight regulation (peripherals)

Active substance pre-active medicinal products, all active strengths

A 08 AB 01 Orlistat	alli XENICAL all generic orlistat ready-to-use medicinal products

Section 3
Treatment of sexual dysfunction

Active substance pre-active medicinal products, all active strengths

G 04 BE 01 Alprostadil (except as diagnostic)	CAVERJECT CAVERJECT impulse MUSE VIRIDAL
G 04 BE 02 Papaverin
G 04 BE 03 Sildenafil	VIAGRA all generic sildenafil-ready-to-use medicinal products
G 04 BE 04 Yohimbin	Procomil YOCON GLENWOOD YOHIMBIN MIRROR
G 04 BE 05 Phentolamine
G 04 BE 06 Moxisylyt
G 04 BE 07 Apomorphine
G 04 BE 08 Tadalafil (except Taldafil 5 mg for the treatment of benign prostate cancer in men, which is the 18. Year of life completed)	CIALIS
G 04 BE 09 Vardenafil	LEVITRA
G 04 BE 10 Avanafil	SPEDRA
G 04 BE 30 combinations
G 04 BE 52 Papaverin combinations
G 04 BX 14 Dapoxetine hydrochloride	Priligy
Turnera diffusa Dil. D4	DESEO

Section 4
Control of nicotine dependence

Active substance pre-active medicinal products, all active strengths

N 07 BA 01 Nicotin	NIQUITIN Nicopass Nicopatch Nicorette Nicotinell Nikofrenon
N 07 BA 02 Bupropion N 06 AX 12	ZYBAN
N 07 BA 03 Varenicline	Champix

Section 5
Increase of sexual orientation

Active substance pre-active medicinal products, all active strengths

G 03 BA 03 Testosterone	Intrinsa
Turnera diffusa Dil. D4	DESEO

Section 6
Promotion of hair growth

Active substance pre-active medicinal products, all active strengths

D 11 AX 01 Minoxidil	ALOPEXY 5% REGAINE
D 11 AX 10 Finasterid	PROPECIA Finahair Finapil all generic Finasteride ready-to-use medicinal products
Estradiol benzoate; prednisolone, salicylic acid	ALPICORT F
Alfatradiol	ELL CRANELL alpha PANTOSTIN
Dexamethasone; Alfatradiol
Thiamine; Calcium pantothenate; yeast, medically; L-Cystin; Keratin	Pantovigar

Section 7
Improvement of appearance

Active substance pre-active medicinal products, all active strengths

M 03 AX 21 Clostridium botulinum Toxin Type A	Azzalure Vistabel Bocouture Vial

Unofficial table of contents

Appendix 6 (to § 22 (2) (3) (c))
Aid for non-prescription medicines

(Fundstelle: BGBl. I 2012, 1964-1967;
with regard to of the individual amendments. Footnote))

Serious diseases and standard therapeutics for their treatment are:

1.

Abductive agents only for the treatment of diseases associated with tumors, megacolone, diverticuloses, diverticulitis, cystic fibrosis, neurogenic intestinal paralysis, before diagnostic interventions, in the case of phosphate-binding medications in the case of chronic diseases. Renal insufficiency, opiate and opioid therapy and in the terminal phase.

2.

Acetylsalicylic acid (up to 300 mg/dose unit) as a platelet aggregation inhibitor in coronary heart disease (secured by symptoms and complementary non-invasive or invasive diagnosis) and in the aftercare of myocardial infarction and stroke, and after arterial intervention.

3.

Acetylsalicylic acid and paracetamol are only used for the treatment of severe and severe pain in co-medication with opioids.

4.

Acidosetherapeutics for the treatment of nephropathy and chronic renal insufficiency as well as for neoblase, ileal conduit, umbilical pouch and implantation of the ureter in the small intestine.

5.

Topical anesthetics and/or antiseptics only for the self-treatment of serious generalised bladder-forming skin diseases (for example, epidermolysis bullosa, hereditaria; pemphigus).

6.

Antihistamines in emergency kits for treatment in bee, wasp, hornissengift-allergies, only for the treatment of severe recurrent urticaria, only in the case of severe persistent pruritus, only for treatment with severe allergic reactions Rhinitis, in which topical nasal treatment with glucocorticoids is not sufficient.

7.

Anti-fungal agents only for the treatment of fungal infections in the mouth and throat area.

8.

Antiseptics and glidants only for persons with catheterization.

9.

Drug-free injections/infusion, carrier and electrolyte solutions as well as parenteral osmodiuretics in cerebral oedema (mannitol, sorbitol).

10.

Calcium compounds (at least 300 mg calcium-ion/dose unit) and vitamin D (free or fixed combination) as well as vitamin D as a monopreate with sufficient calcium intake via the food only for the treatment of the manifesto osteoporosis, only at the same time as Steroid therapy for diseases likely to require at least six months of steroid therapy in a dose unit of at least 7.5 mg prednisolone equivalent, in the case of bisphosphonate treatment as specified in the relevant specialist information with compelling necessity.

11.

Calcium compounds as monoprists in the case of pseudohypo and hypoparathyrodism, in the case of bisphosphonate treatment according to the indication in the relevant subject information, with a compelling necessity.

12.

Levocarnitine only for the treatment of endogenous carnitine deficiency.

13.

Citrate only for the treatment of urinary concretions.

14.

Disodium cromoglycate (DNCG) containing medicinal products (oral) only for symptomatic treatment of systemic mastocytosis.

15.

E. coli strain Nissle 1917 only for the treatment of ulcerative colitis in the remission phase in the case of intolerance of mesalazine.

16.

Iron (II) compounds only for the treatment of secure iron deficiency anaemia.

17.

Flea seeds and flea seed shells only for supportive swelling agent treatment in Crohn's disease, short intestine syndrome and HIV-associated diarrhoea.

18.

Folic acid and folinates only in therapy with folic acid antagonists and for the treatment of colorectal carcinoma.

19.

Gingko-biloba-leaves extract (acetone-water extract, standardized 240 mg daily dose unit) only for the treatment of dementia.

20.

Urea-containing dermatics with a urea content of at least 5 percent only when diagnosed with Ichthyosen, if no therapeutic alternatives are indicated for the respective patient or the respective patient.

21.

Iodide only for the treatment of thyroid diseases.

22.

Iod compounds only for the treatment of ulcers and decubital ulcers.

23.

Potassium compounds as a monopriparate only for the treatment of hypokalaemia.

24.

Lactulose and lactitol only for the reduction of enteral ammonia absorption in hepatic failure related to hepatic encephalopathy.

25.

Solutions and emulsions for parenteral nutrition, including the necessary vitamins and trace elements.

26.

Magnesium compounds, orally, only in congenital magnesium loss disorders.

27.

Magnesium compounds, parenterally, only for treatment in case of proven magnesium deficiency and for treatment with increased risk of eclampsis.

28.

(free)

29.

Metixenhydrochloride only for the treatment of Parkinson's syndrome.

30.

Mistletoe preparations, parenterally, normalised to mistletoe lectin, only in the palliative treatment of malignant tumors to improve the quality of life.

31.

Niclosamide only for the treatment of tapeworm infestation.

32.

Nystatin only for the treatment of mycoses in immunocompromised persons.

33.

Ornithine aspartate only for the treatment of the hepatic (pre-) coma and episodic, hepatic encephalopathy.

34.

Pancreatic enzymes only for the treatment of chronic, exocrine pancreatic insufficiency or cystic fibrosis as well as for the treatment of functional pancreatic insufficiency after gas rectomy in the presence of a steatorrhoea.

35.

Phosphate binder only for the treatment of hyperphosphataemia in chronic renal insufficiency and dialysis.

36.

Phosphate compounds in hypophosphataemia, which cannot be remedied by a corresponding diet.

37.

Salicylic acid-containing preparations (at least 2% salicylic acid) in dermatotherapy as part of the treatment of psoriasis and hyperkeratotic eczema.

38.

Synthetic saliva only for the treatment of disease-induced oral dryness in oncological or autoimmune diseases.

39.

Synthetic tear fluid in autoimmune diseases (Sjögren's syndrome with distinct dysfunctions [dry eye Grade 2], epidermolysis bullosa, ocular pemphigoid), absence or damage to the tears, facial paralysis or Lagophthalmus.

40.

Vitamin K as a monopreate only in case of proven, severe vitamin deficiency, which cannot be remedied by a corresponding diet.

41.

Water-soluble vitamins, also in combinations, only in dialysis.

42.

Water-soluble vitamins, benfotiamine and folic acid as a monopreate only in the case of proven serious vitamin deficiency, which cannot be remedied by a corresponding diet (folic acid: 5 mg/dose unit).

43.

Zinc compounds as a monopreate only for the treatment of enteropathic acrodermatitis and proven zinc deficiency due to haemodialysis treatment as well as for the inhibition of copper uptake at Morbus Wilson.

44.

Medicinal products for immediate use antidotes in acute poisoning, local anesthetics for injection, pharmacogically non-prescription medicines available in practice for immediate use in the context of medical treatment , may be prescribed if appropriate agreements are made between the associations of the sickness funds and the associations of the health insurance companies.

Unofficial table of contents

Annex 7 (to section 22 (3))
Summary of group of medicinal products for which a fixed amount is applicable

(Fundstelle: BGBl. I 2015, 856-884)

1.	Fixed-rate groups for medicinal products with the same active substances
1.00.1	5-Fluorouracil: parenteral administration forms
1.01.1	Acetazolamide: solid oral forms of administration, normal release
1.01.2	Acetylcysteine: oral forms of administration
1.01.3	Aciclovir: oral administration forms
1.01.4	Aciclovir: topical forms of administration
1.01.5	Aciclovir: Ophthalmika
1.01.6	Aciclovir: parenteral administration
1.01.7	Allopurinol: oral dosage forms
1.01.8	Alpha-lipoic acid: solid oral dosage forms
1.01.9	Alpha-lipoic acid: parenteral administration forms
1.01.10	Amantadine: divided oral forms of administration
1.01.11	Ambroxol: oral dosage forms
1.01.12	Ambroxol: inhalative administration forms
1.01.13	Ambroxol: parenteral administration forms
1.01.14	Ambroxol + Doxycycline: solid oral dosage forms
1.01.15	Amilorid + Hydrochlorothiazide: oral dosage forms
1.01.16	Amiodarone: oral forms of administration
1.01.17	Amisulprid: secondhand oral administration forms
1.01.18	Amitriptyline: oral administration forms
1.01.19	Ammonium bituminosulfonate: topical dosage forms
1.01.20	Amoxicillin: divided oral forms of administration
1.01.21	Amoxicillin: liquid oral administration forms
1.01.22	Amoxicillin + Clavulanic acid: solid oral forms of administration, in the ratio 7: 1
1.01.23	Amoxicillin + Clavulanic acid: solid oral forms of administration, in the ratio 4: 1
1.01.24	Anastrozole: oral dosage forms
1.01.25	Atenolol: solid oral forms of administration
1.01.26	Atenolol + Chortalidon: solid oral forms of administration
1.01.27	Azathioprine: oral administration forms
1.02.1	Bemetizid + triamenteres: solid oral dosage forms
1.02.2	Benzoyl peroxide: topical forms of administration
1.02.3	Beta-acetyldigoxin: solid oral dosage forms
1.02.4	Betahist: oral dosage forms
1.02.5	Bicalutamide: oral dosage forms
1.02.6	Biperiden: solid oral dosage forms, normal release
1.02.7	Biperiden: solid oral dosage forms, delayed release
1.02.8	Bisoprolol + Hydrochlorothiazide: divided oral administration forms
1.02.9	Bromazepam: oral forms of administration
1.02.10	Bromhexine: solid oral dosage forms
1.02.11	Bromhexine: Liquid oral dosage forms
1.02.12	Buprenorphine: oral administration forms
1.02.13	Buprenorphine: transdermal dosage forms
1.02.14	Buspiron: secondhand orale dosage forms
1.02.15	Butylscopolamine: solid oral administration forms
1.02.16	Butylscopolamine: parenteral administration forms
1.03.1	Calcium for substitution and therapy: oral forms of administration
1.03.2	Carbamazepine: solid oral dosage forms, normal release
1.03.3	Carbamazepine: solid oral dosage forms, delayed release
1.03.4	Carbimazole: solid oral dosage forms
1.03.5	Choriongonadotropoin: parenteral administration forms
1.03.6	Ciclopirox: topical forms of administration
1.03.7	Ciclosporin: oral forms of administration
1.03.8	Ciclosporin: oral dosage forms, micro/nanoemulsion based or colloidally dispersed
1.03.9	Cimetidine: oral administration forms
1.03.10	Cimetidine: parenteral administration forms
1.03.11	Clindamycin: oral forms of administration
1.03.12	Clodronic acid: oral administration forms
1.03.13	Clomifen: solid oral dosage forms
1.03.14	Clonidine: solid oral dosage forms, normal release
1.03.15	Clonidine: solid oral dosage forms, delayed release
1.03.16	Clonidine: Ophalmika
1.03.17	Clopidogrel: oral administration forms
1.03.18	Clotrimazole: Cream, ointment
1.03.19	Clotrimazole: Liquidum, Solution, Pump spray, Spray, Tropical solution
1.03.20	Clotrimazole: vaginal topical forms of administration
1.03.21	Clozapine: secondhand orale dosage forms
1.03.22	Colecalciferol: solid oral forms of administration (400 to 1000 IU)
1.03.23	Colecalciferol + fluoride: solid oral dosage forms (500 to 1 000 I. E. Colecalciferol + 0.25 mg fluoride)
1.03.24	Co-trimoxazole: solid oral dosage forms
1.03.25	Co-trimoxazole: liquid oral administration forms
1.03.26	Cromoglicinic acid: eye drops, single dose pipettes
1.03.27	Cromoglicinic acid: nasal spray, nasal drops, sprays
1.03.28	Cromoglicinic acid: eye drops/nasal spray (combi pack)
1.03.29	Cromoglicinic acid: inhalative dosage forms
1.03.30	Cromoglicinic acid: oral forms of administration
1.03.31	Cyanocobalamin: parenteral administration forms
1.03.32	Cyclophosphamide: solid oral administration forms
1.03.33	Cyproteron acetate: solid oral forms of administration
1.04.1	Dexamethasone: oral dosage forms, normal release, low dose ≤ 2 mg
1.04.2	Dexamethasone: oral administration forms, normal release, high doses ≥ 4 mg
1.04.3	Dexamethasone: parenteral administration forms, water-soluble, low dose ≤ 20 mg
1.04.4	Dexamethasone: parenteral administration forms, water-soluble, high-dose ≥ 40 mg
1.04.5	Dexpanthenol: local forms of administration
1.04.6	Dexpanthenol: Ophthalmika and Rhinologika
1.04.7	Diazepam: oral dosage forms
1.04.8	Diazepam: parenteral administration forms (alcoholic solution)
1.04.9	Diazepam: parenteral administration forms (other solution)
1.04.10	Diclofenac: solid oral forms of administration, normal release
1.04.11	Diclofenac: solid oral forms of administration, delayed release
1.04.12	Diclofenac: rectal forms of administration
1.04.13	Diclofenac: parenteral administration
1.04.14	Diclofenac: topical forms of administration (concentration range ca. 1 to 5%)
1.04.15	Digitoxin: solid oral dosage forms
1.04.16	Digoxin: solid oral dosage forms
1.04.17	Dihydroergotamine: oral dosage forms
1.04.18	Dihydroergotoxin: oral dosage forms
1.04.19	Diltiazem: oral dosage forms, normal release
1.04.20	Diltiazem: oral dosage forms, delayed release
1.04.21	Dimenhydrinate: solid oral dosage forms, normal release
1.04.22	Dimenhydrinate: rectal forms of administration
1.04.23	Diphenhydramine: solid oral dosage forms, normal release
1.04.24	Domperidone: divided oral administration forms
1.04.25	Doxorubicin: parenteral administration forms
1.04.26	Doxycycline: solid oral dosage forms
1.04.27	Doxylamine: oral dosage forms, normal release
1.05.1	Erythromycin: divided oral forms of administration
1.05.2	Erythromycin: liquid oral administration forms
1.05.3	Erythromycin: local forms of administration
1.05.4	Estradiol: oral forms of administration
1.05.5	Estradiol: transdermal dosage forms
1.05.6	Estramustin: solid oral forms of administration
1.05.7	Estriol: solid oral forms of administration
1.05.8	Estriol: vaginal topical forms of administration
1.05.9	Ethambutol: solid oral dosage forms
1.05.10	Etilefrin: oral dosage forms, normal release
1.05.11	Exemestan: oral dosage forms
1.06.1	Fentanyl: transdermal dosage forms
1.06.2	Flecainide: secondhand orale dosage forms
1.06.3	Flunarizin: oral forms of administration
1.06.4	Flutamide: oral dosage forms
1.06.5	Folinic acid: parenteral administration forms
1.06.6	Folic acid: solid oral dosage forms
1.06.7	Folic acid: parenteral administration forms
1.06.8	Furosemide: tablets ≤ 80 mg
1.06.9	Furosemide: tablets ≥ 125 mg
1.06.10	Furosemide: ampoules, injection solutions (20 mg, 40 mg)
1.06.11	Furosemide: ampoules, infusion solutions (250 mg)
1.06.12	Furosemide: oral administration forms, delayed release
1.06.13	Furosemid + Spironolactone: solid oral dosage forms
1.06.14	Fusidic acid: topical forms of administration
1.07.1	Gabapentin: secondhand orale dosage forms
1.07.2	Gentamicin: parenteral administration forms
1.07.3	Gentamicin: Ophthalmika
1.07.4	Gentamicin: topical forms of administration
1.07.5	Gingko-biloba-Dry extract: oral dosage forms, standardized on flavone glycosides in a ratio of 50: 1 enriched dry extract
1.07.6	Glibenclamide: tablets ≥ 1 mg to ≤ 3.5 mg
1.07.7	Glyceroltrinitrate: transdermal therapeutic systems
1.07.8	Glyceroltrinitrat: Spray, Pumpspray
1.07.9	Gold: oral forms of administration
1.07.10	Griseofulvin: solid oral forms of administration
1.08.1	Haloperidol: oral forms of administration
1.08.2	Haloperidol: parenteral administration forms, normal release
1.08.3	Haloperidol: parenteral administration forms, with depot effect
1.08.4	Heparin: Heparin-Natrium, topical forms of administration
1.08.5	Heparin: Unfractionated heparin, parenteral administration forms
1.08.6	Human insulin: fast-acting, parenteral forms of administration, except for ready-to-use medicinal products, which are authorised only for use in insulin pumps
1.08.7	Human insulin: intermediate and long-acting, parenteral administration forms
1.08.8	Human insulin: intermediate acting in combination with fast-acting parenteral administration forms
1.08.9	Hydromorphon: dismissed oral dosage forms, delayed release
1.08.10	Hydroxocobalamin: parenteral administration forms
1.09.1	Ibuprofen: oral dosage forms, normal release
1.09.2	Ibuprofen: solid oral forms of administration, delayed release
1.09.3	Ibuprofen: Suppositories
1.09.4	Ibuprofen: topical forms of administration
1.09.5	Indapamide: oral administration forms
1.09.6	Indometacin: divided oral dosage forms, normal release
1.09.7	Indometacin: solid oral dosage forms, delayed release
1.09.8	Indometacin: rectal forms of administration
1.09.9	Indometacin: topical forms of administration
1.09.10	Isosorbide dinitrate: solid oral forms of administration, normal release
1.09.11	Isosorbide dinitrate: solid oral forms of administration, delayed release
1.09.12	Isosorbide mononitrate: solid oral forms of administration, normal release
1.09.13	Isosorbide mononitrate: solid oral forms of administration, delayed release
1.09.14	Isotretinoin: secondhand orale dosage forms
1.10.1	Iodide for Strumaprophylaxis: oral forms of administration
1.11.1	Potassium salts: oral administration forms, normal release
1.11.2	Potassium salts: solid oral forms of administration, delayed release
1.12.1	Lactulose: oral dosage forms
1.12.2	Lamotrigine: secondhand oral administration forms
1.12.3	Leflunomide: oral forms of administration
1.12.4	Letrozole: oral administration forms
1.12.5	Levetiracetam: solid oral forms of administration
1.12.6	Levodopa + Benserazide: dismissed oral dosage forms, normally releasing
1.12.7	Levodopa + Benserazide: dismissed oral dosage forms, delayed release
1.12.8	Levodopa + Carbidopa: oral administration forms, normally releasing, in a ratio of 4: 1
1.12.9	Levodopa + Carbidopa: oral administration forms, normally releasing, in a ratio of 10: 1
1.12.10	Levodopa + carbidopa: dismissed oral dosage forms, delayed release, in ratio 4: 1
1.12.11	Levothyroxine sodium: oral administration forms
1.12.12	Lithium: solid oral forms of administration, delayed release
1.12.13	Loperamide: oral administration forms
1.12.14	Lorazepam: oral dosage forms
1.13.1	Magaldrat: oral forms of administration
1.13.2	Magnesium: oral dosage forms
1.13.3	Magnesium: parenteral administration forms
1.13.4	Maprotilin: solid oral dosage forms, normal release
1.13.5	Mebeverine: divided oral forms of administration
1.13.6	Medroxyprogesterone: tablets, oral suspension (100 to 500 mg)
1.13.7	Mesalazine: solid oral dosage forms
1.13.8	Mesalazine: rectal forms of administration
1.13.9	Mesalazine: other rectal forms of administration
1.13.10	Metamizol: oral dosage forms, normal release
1.13.11	Metamizol: rectal forms of administration
1.13.12	Metamizol: parenteral administration forms
1.13.13	Metformin: oral dosage forms
1.13.14	Methotrexate: oral forms of administration
1.13.15	Methyldopa: oral dosage forms
1.13.16	Methylphenidate: dialed oral dosage forms
1.13.17	Metoclopramide: oral administration forms, normal release
1.13.18	Metoclopramide: oral administration forms, delayed release
1.13.19	Metoclopramide: parenteral administration
1.13.20	Metoprolol + hydrochlorothiazide: solid oral dosage forms, normal release
1.13.21	Metoprolol + Hydrochlorothiazide: oral dosage forms, delayed release
1.13.22	Metronidazole: oral dosage forms
1.13.23	Metronidazole: vaginal topical forms of administration
1.13.24	Metronidazole: parenteral administration forms
1.13.25	Midodrin: oral dosage forms
1.13.26	Minocycline: oral forms of administration
1.13.27	Mirtazapine: oral dosage forms
1.13.28	Moclobemide: secondhand oral administration forms
1.13.29	Molsidomin: solid oral dosage forms, normal release
1.13.30	Molsidomin: solid oral dosage forms, delayed release
1.13.31	Montelukast: oral forms of administration
1.13.32	Morphine: dismissed oral dosage forms, delayed release
1.13.33	Moxonidine: seconded oral administration forms
1.14.1	Night candle seed oil: oral dosage forms, standardized to gamma-enoic acid
1.14.2	Naftidrofuryl: oral forms of administration
1.14.3	Nicergolin: oral forms of administration
1.14.4	Nifedipine: solid oral dosage forms, normal release
1.14.5	Nifedipine: fixed oral forms of administration, delayed release
1.14.6	Nifedipine: Liquid oral dosage forms
1.14.7	Nimodipine: seconded oral administration forms
1.14.8	Nitrazepam: oral dosage forms
1.14.9	Nitrofurantoin: oral administration forms, normal release
1.14.10	Nitrofurantoin: solid oral forms of administration, delayed release
1.14.11	Nystatin: solid oral dosage forms
1.14.12	Nystatin: Liquid oral dosage forms
1.14.13	Nystatin: vaginal topical dosage forms
1.14.14	Nystatin: topical forms of administration
1.14.15	Nystatin + Zinc oxide: topical dosage forms
1.15.1	Olanzapine: divided oral forms of administration
1.15.2	Oxazepam: oral dosage forms, normal release
1.15.3	Oxybutynin: oral dosage forms
1.15.4	Oxycodone: dismissed oral dosage forms, delayed release
1.16.1	Pancreatin: enteric polydisperse dosage forms
1.16.2	Pancreatin: gastro-resistant monolithic dosage forms
1.16.3	Paracetamol: oral administration forms
1.16.4	Paracetamol: Suppositories
1.16.5	Pentoxifylline: solid oral dosage forms
1.16.6	Pentoxifylline: parenteral administration forms
1.16.7	Phenoxymethylpenicillin: divided oral administration forms
1.16.8	Phenoxymethylpenicillin: liquid oral administration forms
1.16.9	Phenytoin: oral forms of administration
1.16.10	Pilocarpin: water-based eye drops, single dose pipettes
1.16.11	Pindolol: oral dosage forms
1.16.12	Piracetam: oral forms of administration
1.16.13	Piracetam: parenteral administration
1.16.14	Polyvidon-iodine: Cream, Gel, Salbe
1.16.15	Pramipexole: oral dosage forms
1.16.16	Prednisolone: oral dosage forms, normal release, low dose ≤ 20 mg
1.16.17	Prednisolone: oral dosage forms, normal release, high dose ≥ 50 mg
1.16.18	Prednisolone: parenteral administration forms, water-soluble, low dose ≤ 100 mg
1.16.19	Prednisolone: parenteral dosage forms with depot effect
1.16.20	Prednisone: oral administration forms, normally liberated, low dose ≤ 20 mg
1.16.21	Prednisone: oral administration forms, normally liberated, high-dose ≥ 50 mg
1.16.22	Primidon: oral forms of administration
1.16.23	Promethazine: oral administration forms
1.16.24	Promethazine: parenteral administration forms
1.16.25	Propafenone: oral forms of administration
1.16.26	Propranolol: oral dosage forms, normal release
1.16.27	Propranolol: oral dosage forms, delayed release
1.16.28	Pyrazinamide: solid oral dosage forms
1.16.29	Pyridoxine: solid oral administration forms
1.16.30	Pyridoxine: parenteral administration forms
1.17.1	(free)
1.18.1	Retinol: oral forms of administration
1.18.2	Ropinirole: oral forms of administration
1.19.1	Saccharomyces boulardii: oral forms of administration
1.19.2	Sawpalate fruits: oral administration forms
1.19.3	Selegiline: oral dosage forms
1.19.4	Sertraline: oral forms of administration
1.19.5	Sotalol: solid oral forms of administration
1.19.6	Spironolactone: oral forms of administration
1.19.7	Sucralfate: oral forms of administration
1.19.8	Sulfasalazine: oral dosage forms
1.19.9	Sulpiride: oral dosage forms
1.20.1	Tamoxifen: oral forms of administration
1.20.2	Temozolomide: oral dosage forms
1.20.3	Terbinafin: divided oral forms of administration
1.20.4	Tetracycline: solid oral dosage forms
1.20.5	Theophylline: oral dosage forms, normal release
1.20.6	Theophylline: oral administration forms, delayed release
1.20.7	Theophylline: Ampoules
1.20.8	Thiamazol: solid oral forms of administration
1.20.9	Thiamine hydrochloride for substitution and therapy: oral forms of administration
1.20.10	Thiamine hydrochloride for substitution and therapy: parenteral administration forms
1.20.11	Tiapride: oral forms of administration
1.20.12	Ticlopidin: divided oral forms of administration
1.20.13	Tilidine with the addition of naloxone: oral dosage forms, normal release
1.20.14	Tilidine with the addition of naloxone: oral dosage forms, delayed release
1.20.15	Tolperison: oral dosage forms
1.20.16	Topiramate: oral forms of administration
1.20.17	Tramadol: divided oral forms of administration, normal release
1.20.18	Tramadol: fixed oral forms of administration, delayed release
1.20.19	Tramadol: Liquid oral dosage forms
1.20.20	Tramadol: parenteral administration forms
1.20.21	Tramadol: rectal forms of administration
1.20.22	Tretinoin: topical forms of administration
1.20.23	Triamteric + hydrochlorothiazide: oral dosage forms
1.20.24	Trospium chloride: oral dosage forms
1.20.25	Troxerutin: oral dosage forms, normal release
1.21.1	Urea: topical forms of administration
1.21.2	Urea pura + Tretinoin: topical forms of administration
1.21.3	Ursodeoxycholic acid: oral dosage forms
1.22.1	Valproic acid: oral dosage forms, delayed release
1.22.2	Venlafaxine: oral forms of administration
1.22.3	Verapamil: solid oral forms of administration, normal release
1.22.4	Verapamil: solid oral forms of administration, delayed release
1.22.5	Verapamil: parenteral administration forms
1.23.1	(free)
1.24.1	Xylometazoline: nasal topical forms of administration
1.25.1	(free)
1.26.1	Zinc for substitution and therapy: oral forms of administration
2.	Fixed-rate groups for medicinal products containing pharmacologically-therapeutically comparable active substances, in particular with chemically related substances
2.00.1	(free)
2.01.1	ACE inhibitors: solid, divided oral forms of administration
	Active substance:
	Benazepril: Benazeprilhydrochloride
	Captopril
	Cilazapril: Cilazapril-1-water
	Enalapril: Enalapril maleate
	Fosinopril: Fosinopril sodium
	Imidapril: imidapril hydrochloride
	Lisinopril: Lisinopril-2-water
	Moexipril: Moexipril hydrochloride
	Perindopril: Perindopril arginine; perindopril
	Quinapril: Quinapril hydrochloride
	Ramipril
	Spirapril: Spirapril hydrochloride; Spirapril hydrochloride 1-water
	Trandolapril
	Zofenopril: Zofenopril-Calcium
2.01.2	Alpha-receptor blockers: other alpha-receptor blocker, alpha1-selective, divided oral dosage forms
	Active substance:
	Bunazosin: Bunazosin hydrochloride
	Indoramin: Indoramin hydrochloride
	Urapidil
2.01.3	Alpha-receptor blockers: other alpha-receptor blocker, alpha1-selective, divided oral dosage forms
	Active substance:
	Alfuzosin: Alfuzosin hydrochloride
	Doxazosin: Doxazosin mesilate
	Silodosin
	Tamsulosin: Tamsulosin hydrochloride
	Terazosin: Terazosin hydrochloride2-water
2.01.4	Aminoquinolines: oral forms of administration
	Active substance:
	Chloroquine diphosphate
	Hydroxychloroquinsulfate
2.01.5	Angiotensin II antagonists: dissent oral dosage forms
	Active substance:
	Azilsartan: Azilsartan medoxomil Potassium salts
	Candesartan: Candesartan cilexetil
	Eprosartan: Eprosartan mesilate
	Irbesartan hydrochloride irbesartan hydrochloride
	Losartan: Losartan kalium
	Olmesartan: Olmesartan medoxomil
	Telmisartan
	Valsartan
2.01.6	Anion exchange resins: oral administration forms
	Active substance:
	Colestipol
	Colestyramine
2.01.7	Antianaemia, other: parenteral administration forms
	Active substance:
	Darbepoetin: Darbepoetin alfa
	Erythropoietin: epoetin alfa, epoetin beta, epoetin delta, epoetin theta, epoetin zeta
	PEG-erythropoietin: methoxy polyethylene glycol-epoetin beta, PEG-epoetin beta
2.01.8	Antidiabetic agents of the sulphonylurea type: other antidiabetic agents of the sulphonylurea type, solid, divided oral forms of administration
	Active substance:
	Carbutamide
	Glibornurid
	Gliclazide
	Glimepiride
	Glipizid
	Gliquidon
	Glisoxepid
	Tolbutamide
2.01.9	Anticoagulants, oral: solid oral forms of administration
	Active substance:
	Phenprocoumon
	Warfarin sodium
2.01.10	Antipsychotics, other: oral forms of administration
	Active substance:
	Paliperidone
	Risperidone
2.01.11	Azole-antimycotics: cream, gel, paste
	Active substance:
	Bifonazole
	Croconazole
	Econazole nitrate
	Fenticonazole nitrate
	Isoconazole
	Ketoconazole
	Miconazole nitrate
	Omoconazole
	Oxiconazole
	Sertaconazole
	Tioconazole
2.01.12	Azole-antimycotics: Bag, Solution, Spray, Lotion, Pumpspray
	Active substance:
	Bifonazole
	Econazole nitrate
	Fenticonazole nitrate
	Isoconazole
	Ketoconazole
	Miconazole nitrate
	Oxiconazole
	Tioconazole
2.01.13	Azole-antimycotics: vaginal topically-dosage forms
	Active substance:
	Econazole nitrate
	Fenticonazole nitrate
	Miconazole nitrate
	Oxiconazole
2.02.1	Benzodiazepines: other benzodiazepines, predominantly anxiolytically effective, oral forms of administration
	Active substance:
	Alprazolam
	Chlordiazepoxide
	Clobazam
	Clorazepate
	Clotiazepam
	Ketazolam
	Medazepam
	Metaclazepam
	Northazepam
	Oxazolam
	Prazepam
2.02.2	Benzodiazepines: other benzodiazepines, predominantly sedative-hypnotically effective, oral forms of administration
	Active substance:
	Brotizolam
	Flunitrazepam
	Flurazepam
	Loprazolam
	Lormetazepam
	Temazepam
	Triazolam
2.02.3	Benzodiazepine-related agents: secondhand oral administration forms
	Active substance:
	Zaleplon
	Zolpidem: Zolpidem tartrate
	Zopiclon
2.02.4	Beta-sympathomimetics, inhalative oral: inhalative administration forms
	Active substance:
	Formoterol: Formoterol hemifumarate-(x)-water
	Indacaterol: Indacaterol maleate
	Olodaterol: Olodaterol hydrochloride
	Salmeterol: Salmeterol xinafoat
2.02.5	Beta2 sympathomimetic antiasthmatics: solid, divided oral dosage forms, normal release
	Active substance:
	Bambuterol: Bambuterol hydrochloride
	Carbuterol
	Clenbuterol: Clenbuterol hydrochloride
	Fenoterol
	Pirbuterol
	Procaterol
	Reproterol
	Salbutamol
	Terbutaline: Terbutaline sulphate
	Tulobuterol
2.02.6	Beta2 sympathomimetic antiasthmatics: solid oral dosage forms, delayed release
	Active substance:
	Isoetarin
	Salbutamol
	Terbutaline
2.02.7	Beta2 sympathomimetic antiasthmatics: liquid inhalative dosage forms
	Active substance:
	Fenoterol
	Salbutamol
	Terbutaline
2.02.8	Beta2 sympathomimetic antiasthmatics: short-term beta-2 sympathomimetics, inhalative oral administration forms
	Active substance:
	Fenoterol: Fenoterol hydrobromide
	Salbutamol: Salbumatol sulphate
	Terbutaline: Terbutaline sulphate
2.02.9	Beta-receptor blockers: other beta-receptor blockers, non-selective, divided oral dosage forms, normally release-free
	Active substance:
	Alprenolol
	Bopindolol
	Bupranolol: Bupranolol hydrochloride
	Carazolol
	Carteolol: Carteolol hydrochloride
	Carvedilol
	Mepindolol: Mepindolol sulphate
	Metipranolol
	Nadolol
	Oxprenolol: Oxprenolol hydrochloride
	Penbutolol: Penbutolol sulphate
	Tertatolol
	Timolol
2.02.10	Beta-receptor blockers: other beta-receptor blockers, beta-selective, dissent oral dosage forms, normally releasing
	Active substance:
	Acebutolol: Acebutolol hydrochloride
	Betaxolol: Betaxolol hydrochloride
	Bisoprolol: Bisoprolol hemifumarate
	Celiprolol: Celiprolol hydrochloride
	Metoprolol: metoprolol fumarate, metoprolol succinate, metoprolol tartrate
	Nebivolol: Nebivolol hydrochloride
	Talinolol
2.02.11	Beta-receptor blocker: other beta-receptor blockers, beta-selective, oral dosage forms, delayed release
	Active substance:
	Metoprolol
2.02.12	Beta-receptor blockers: other beta-receptor blocker, Ophthalmika
	Active substance:
	Befunolol
	Betaxolol
	Bupranolol
	Carteolol
	Levobunolol
	Metipranolol
	Timolol
2.03.1	Calcitonine: parenteral administration
	Active substance:
	Human calcitonin
	Salmon scalcitonin
	Pigecalcitonin
2.03.2	Calcium antagonists: other calcium antagonists (1 ,4-dihydropyridines), solid, divided oral dosage forms, normally releasing
	Active substance:
	Amlodipine: Amlodipine besilate, Amlodipine maleate; Amlodipine mesilate-(x)-water
	Isradipin
	Lacidipine
	Lercanidipine: Lercanidipine hydrochloride
	Manidipine: Manidipine dihydrochloride
	Nicardipine: Nicardipine hydrochloride
	Nisoldipine
	Nitrendipine
2.03.3	Calcium antagonists: other calcium antagonists (1 ,4-dihydropyridines), solid oral forms of administration, delayed release
	Active substance:
	Felodipine
	Isradipin
	Nilvadipin
	Nisoldipine
2.03.4	Cefalosporine: oral forms of administration
	Active substance:
	Cefadroxil: Cefadroxil-1-water
	Cefalexin: Cefalexin-1-water
2.03.5	Cefalosporine: oral forms of administration
	Active substance:
	Cefaclor: Cefaclor-1-Water
	Cefuroxim: Cefuroxim axetil
	Loracarbef: Loracarbef-1-Water
2.03.6	Cefalosporine: oral forms of administration
	Active substance:
	Cefixim: Cefixim-(x)-water
	Cefpodoxim: Cefpodoxim proxetil
	Ceftibuten: Ceftibuten-(x)-water
2.03.7	Clofibrin acid derivatives and structural analogues: solid oral dosage forms
	Active substance:
	Bezafibrat
	Clofibrat
	Etofibrat
	Etofyllinclofibrat
	Fenofibrat
	Gemfibrocil
2.04.1	Dimeticon and simethicone: solid oral dosage forms
	Active substance:
	Dimeticon and Simethicone
2.04.2	Dimeticon and simethicone: liquid oral dosage forms
	Active substance:
	Dimeticon and Simethicone
2.04.3	Diuretics, other diuretics (thiazides and analogues): solid oral forms of administration
	Active substance:
	Bendroflumethiazid
	Butizid
	Chlortalidone
	Clopamide
	Hydrochlorothiazide
	Mebutizid
	Mefruside
	Metolazon
	Polythiazide
	Trichlormethiazid
	Xipamide
2.04.4	Diuretics, other: strong and fast effective, solid oral dosage forms
	Active substance:
	Bumetanid
	Etacrynic acid
	Piretanide
2.04.5	Diuretics, other: strong and slow effective, solid oral forms of administration
	Active substance:
	Azosemide
	Etozoline
	Torasemide
2.05.1	(free)
2.06.1	Fluoroquinolones: divided oral forms of administration
	Active substance:
	Enoxacin: Enoxacin-1,5-water
	Norfloxacin
2.06.2	Fluoroquinolones: divided oral forms of administration
	Active substance:
	Ciprofloxacin: Ciprofloxacin hydrochloride-1-Water, Ciprofloxacin lactate
	Levofloxacin; Levofloxacin-0,5-water
	Ofloxacin
2.07.1	Glucocorticoids, inhalation, nasal: glucocorticoids for use in respiratory tract disorders, nasal dosage forms
	Active substance:
	Beclometasondipropionate: Beclometasondipropionate, anhydrous
	Budesonide
	Dexamethasondihydrogen phosphate disodium
	FlunIsold
	Fluticason furoat
	Fluticasone propionate: fluticasone 17-propionate
	Mometason furoat: Mometason furoat-1-water
	Triamcinolone acetonide
2.07.2	Glucocorticoids, inhalative, oral: glucocorticoids for use in respiratory diseases, oral forms of administration
	Active substance:
	Beclometasondipropionate: Beclometasondipropionate, anhydrous
	Budesonide
	Ciclesonide
	Fluticasone propionate: fluticasone 17-propionate
	Mometason furoat
2.07.3	Glucocorticoids, oral: other glucocorticoids, suitable for substitution therapy, oral forms of administration, normal release
	Active substance:
	Cortisone acetate
	Hydrocortisone
2.07.4	Glucocorticoids, oral: other glucocorticoids, suitable for pharmacodynamic therapy, non-fluorinated, oral forms of administration, normal release, low dose (potency equivalence factor ≤ 40)
	Active substance:
	Cloprednol
	Deflazacort
	Methylprednisolone
	Prednylidene
2.07.5	Glucocorticoids, orally: other glucocorticoids, suitable for pharmacodynamic therapy, non-fluorinated, oral dosage forms, normally released, high-dosed (potency equivalent factor ≥ 80)
	Active substance:
	Methylprednisolone
	Prednylidene
2.07.6	Glucocorticoids, oral: other glucocorticoids, suitable for pharmacodynamic therapy, fluorinated, oral dosage forms, normally liberated, low dose (active strength equivalence factor ≤ 40)
	Active substance:
	Betamethasone
	Fluocortolon
	triamcinolone
2.08.1	H2 antagonists: other H2 antagonists, oral forms of administration
	Active substance:
	Famotidine
	Nizatidine
	Ranitidine
	Roxatidin
2.08.2	H2 antagonists: other H2 antagonists, oral forms of administration
	Active substance:
	Famotidine
	Ranitidine
2.08.3	Heparins, low molecular weight: low molecular weight heparins, parenteral administration forms, unitdose
	Active substance:
	Certoparin: Certoparin sodium natrium
	Dalteparin: Dalteparin natrium
	Enoxaparin: Enoxaparin natrium
	Nadroparin: Nadroparin calcium
	Reviparin: Reviparin natrium
	Tinzaparin: Tinzaparin natrium
2.08.4	Cardiac glycosides, other: oral administration forms
	Active substance:
	Lanatoside C
	Meproscillarin
	Metildigoxin
2.08.5	HMG-CoA reductase inhibitors: secondhand oral dosage forms
	Active substance:
	Atorvastatin: Atorvastatin calcium salts
	Fluvastatin: fluvastatin sodium salts
	Lovastatin
	Pitavastatin: Pitavastatin calcium salts
	Pravastatin: Pravastatin sodium salts
	Rosuvastatin: Rosuvastatin calcium salts
	Simvastatin
2.09.1	Insulins: Insuline (40 I. E./ml)
	Active substance:
	Insulin
2.09.2	Insulins: Insuline (100 I. E./ml)
	Active substance:
	Insulin
2.10.1	(free)
2.11.1	(free)
2.12.1	(free)
2.13.1	Macrolides, newer: oral administration forms
	Active substance:
	Azithromycin: Azithromycin 1 Water, Azithromycin-2-water
	Clarithromycin
	Roxithromycin
2.14.1	(free)
2.15.1	(free)
2.16.1	Prostaglandin-Synthetase inhibitors: keto-enoleic acids II (oxicame), rectal forms of administration
	Active substance:
	Lornoxicam
	Meloxicam: meloxicam meglumin
	Piroxicam
	Tenoxicam
2.16.2	Prostaglandin-Synthetase inhibitors: arylacetic acid derivatives, divided oral dosage forms, normally releasing
	Active substance:
	Aceclofenac
	Acemetacin
	Lonazolac: Lonazolac calcium
	Nabumeton
	Proglumetacin: Proglumetacin dimaleate
	Tolmetin
2.16.3	Prostaglandin-Synthetase inhibitors: arylacetic acid derivatives, oral dosage forms, delayed release
	Active substance:
	Acemetacin
2.16.4	Prostaglandin-Synthetase inhibitors: arylpropionic acid derivatives, oral administration forms, normal release
	Active substance:
	Fenbufen
	Fenoprofen
	Industrial Biprofen
	Ketoprofen
	Naproxen
	Tiaproic acid
2.16.5	Prostaglandin-Synthetase inhibitors: arylpropionic acid derivatives, oral administration forms, normal release
	Active substance:
	Naproxen
2.16.6	Prostaglandin-Synthetase inhibitors: keto-enolic acids I (pyrazolidinedione derivatives), oral forms of administration
	Active substance:
	Azapropazon
	Bumadizon
	Mofebutazone
	Oxyphenbutazone
	Phenylbutazone
2.16.7	Prostaglandin-Synthetase inhibitors: keto-enoleic acids II (oxicame), divided oral dosage forms
	Active substance:
	Lornoxicam
	Meloxicam: meloxicam meglumin
	Piroxicam: Piroxicam betadex
	Tenoxicam
2.16.8	Proton pump inhibitors: divided oral forms of administration
	Active substance:
	Esomeprazole: Esomeprazole Magnesium salts
	Lansoprazole
	Omeprazole: Omeprazole Magnesium salts
	Pantoprazole: Pantoprazole sodium salts
	Rabeprazole: Rabeprazole sodium salts
2.17.1	(free)
2.18.1	(free)
2.19.1	Selective serotonin 5HT1 agonists: divided oral administration forms
	Active substance:
	Almotriptan: Almotriptan malat
	Eletriptan: Eletriptan hydrobromide
	Frovatriptan: Frovatriptan succinat-1-water
	Naratriptan: Naratriptan hydrochloride
	Rizatriptan: Rizatriptan benzoate
	Sumatriptan: Sumatriptan succinate
	Zolmitriptan
2.19.2	Selective serotonin reuptake inhibitors: oral dosage forms
	Active substance:
	Citalopram: Citalopram hydrobromide
	Escitalopram: Escitalopram oxalate
2.19.3	Serotonin-5HT3 antagonists: divided oral dosage forms
	Active substance:
	Dolasetron: Dolasetron mesilat, Dolasetron mesilat-(x)-water
	Granisetron: Granisetron hydrochloride
	Ondansetron: Ondansetron hydrochloride, Ondansetron hydrochloride-(x)-water
	Tropisetron: Tropisetron hydrochloride
2.20.1	Testosterone-5-alpha-reductase inhibitors: oral forms of administration
	Active substance:
	Dutasteride
	Finasteride
2.20.2	Triazoles: divided oral forms of administration
	Active substance:
	Fluconazole
	Itraconazole
3.	Medicinal products with a therapeutically comparable effect, in particular combinations of medicinal products
3.00.1	(free)
3.01.1	Acetylsalicylic acid and combinations of acetylsalicylic acid with antacida or buffer substances: oral dosage forms, normal release
	Active substance:
	Acetylsalicylic acid
3.01.2	Acetylsalicylic acid and combinations of acetylsalicylic acid with antacida or buffer substances: oral forms of administration, delayed release
	Active substance:
	Acetylsalicylic acid
3.01.3	Antidepressants: other classical antidepressants, solid oral forms of administration, normal release
	Active substance:
	Amitriptyline oxide
	Clomipramine hydrochloride
	desipramine hydrochloride
	Dibenzepine hydrochloride
	Dosulepin hydrochloride
	Doxepin
	Imipramine hydrochloride
	Lofepramin
	Nortriptyline hydrochloride
	Noxiptilin
	Opipramol
	Trimipramin
3.01.4	Antidepressants: other classical antidepressants, solid oral forms of administration, delayed release
	Active substance:
	Clomipramine hydrochloride
	Dibenzepine hydrochloride
3.01.5	Antidepressants: other classical antidepressants, fluid oral forms of administration
	Active substance:
	Doxepin
	Imipramine hydrochloride
	Trimipramin
3.01.6	Antidepressants: other antidepressants (2. generation), solid oral forms of administration, normal release
	Active substance:
	Mianserine hydrochloride
	Trazodone
	Viloxazine
3.01.7	Antidepressants: selective serotonin uptake inhibitors, solid oral dosage forms, normal release
	Active substance:
	Fluoxetine
	Fluvoxamine hydrogen maleate
	Paroxetine
3.01.8	Antirheumatics: topical non-steroidal anti-rheumatic drugs, topical forms of administration
	Active substance:
	Etofenamat
	Felbinac
	Flufenamic acid
	Ketoprofen
	Niflumic acid
	Piroxicam
3.01.9	Antitussiva: Opium alkaloids and derivatives, oral forms of administration
	Active substance:
	Codeine
	Dextromethorphan
	Dihydrocodeine
	Levopropoxyphen
	Noscapin
3.01.10	Antitussiva: Opium alkaloids and derivatives, oral forms of administration
	Active substance:
	Dextromethorphan
3.01.11	Antitussiva: other antitussiva, oral forms of administration
	Active substance:
	Benproperin
	Clobutinol
	Dropropizin
	Pentoxyverine
	Pipazetat
3.02.1	Bisphosphonates and combinations of bisphosphonates with additiva: oral dosage forms
	Active substance:
	Alendronic acid: Alendronic acid sodium salts, alendronic acid sodium salts and additiva (alfacalcidol), alendronic acid sodium salts and additiva (calcium, colecalciferol), alendronic acid sodium salts and additiva (colecalciferol)
	Etidronic acid: etidronic acid Sodium salts, etidronic acid Sodium salts and Additiva (calcium)
	Ibandronic acid: Ibandronic acid Sodium salts
	risedronic acid: risedronic acid sodium salts, risedronic acid sodium salts and additiva (calcium), risedronic acid sodium salts and additiva (calcium, colecalciferol), risedronic acid sodium salts and additiva (colecalciferol)
3.03.1	Cholinesterase inhibitors: solid oral forms of administration
	Active substance:
	Donepezil: Donepezil hydrochloride, Donepezil hydrochloride-(x)-water
	Galantamine: Galantamine hydrobromide
	Rivastigmine: Rivastigmine (R, R)-tartrate
3.04.1	(free)
3.05.1	Iron-II-containing antianaemia with the action criterion Iron deficiency anaemia: oral dosage forms
	Active substance:
	Iron II
3.06.1	Film-forming agents: with preservatives
	Active substance:
	Film formers
3.06.2	Film-forming agents: without preservative
	Active substance:
	Film formers
3.07.1	Gestagens, further: further gestagens, solid oral forms of administration
	Active substance:
	Dydrogesterone
	Lynestrenol
	Medrogeston
3.07.2	Glucocorticoids, topical: other glucocorticoids, weakly effective, topical dosage forms
	Active substance:
	Clocortolonpivalat plus -hexanoate
	Dexamethasone
	Dexamethasone-21-isonicotinate
	Fluocortin butyl ester
	Fluorometholone
	Hydrocortisone
	Hydrocortisone acetate
	Prednisolone
	Triamcinolone acetonide
3.07.3	Glucocorticoids, topical: other glucocorticoids, weakly effective, topical dosage forms
	Active substance:
	Hydrocortisone
	Hydrocortisone acetate
3.07.4	Glucocorticoids, topical: other glucocorticoids, medium-strong effective, topical dosage forms
	Active substance:
	Alclometasondipropionate
	Betamethasone benzoate
	Betamethasonvalerate
	Clobetasonbutyrate
	Clocortolonpivalat plus -hexanoate
	desonid
	Desoximetason
	Dexamethasone
	Flumethasonpivalat
	Fluocinolonacetonide
	Fluocinonide
	Fluocortolon
	Fluocortolonpivalat plus -hexanoate
	Fluoroandrenolone fludroxycortide
	Fluprednide acetate
	Halcinonide
	Hydrocortison-17-butyrate, -21-propionate
	Hydrocortisone aceponate
	Hydrocortisone butyrate
	Methylprednisolonaceponate
	Prednicarbat
	Triamcinolone acetonide
3.07.5	Glucocorticoids, topical: other glucocorticoids, highly effective, topical forms of administration
	Active substance:
	Amcinonide
	Beta-methasone dipropionate
	Betamethasonvalerate
	Desoximetason
	Dexamethasonvalerate
	diflorasone diacetate
	Diflucortolonvalerate
	Fluocinolonacetonide
	Fluocinonide
	Fluocortolonpivalat plus -hexanoate
	Fluticasone-17-propionate
	Halcinonide
	Halometason
	Mometason
	Triamcinolone acetonide
3.07.6	Glucocorticoids, topical: other glucocorticoids, very effective, topical forms of administration
	Active substance:
	Clobetasol propionate
	Diflucortolonvalerate
	Fluocinolonacetonide
3.08.1	H1 antagonists: antihistamines, solid oral forms of administration, normal release
	Active substance:
	Bamipin
	Clemastin
	Dexchlorpheniramine
	Dimetinden
	Diphenylpyraline
	Pheniramine
	Triprolidine
3.08.2	H1 antagonists: antihistamines, solid oral forms of administration, delayed release
	Active substance:
	Brompheniramine
	Carbinoxamine
	Dimetinden
	Pheniramine
3.08.3	H1-antagonists: antihistamines, liquid oral administration forms
	Active substance:
	Alimemazine
	Carbinoxamine
	Clemastin
	Dimetinden
	Diphenylpyraline
	Mebhydrolin
	Mequitazine
	Pheniramine
3.08.4	H1 antagonists: other antihistamines, divided oral forms of administration
	Active substance:
	Astemizole
	Azelastine: Azelastine hydrochloride
	Terfenadine
3.08.5	H1 antagonists: other antihistamines, divided oral forms of administration
	Active substance:
	Cetirizine
	Loratadin
3.08.6	H1 antagonists: other antihistamines, liquid oral forms of administration
	Active substance:
	Cetirizine
	Loratadin
3.08.7	H1 antagonists: antihistamines with additional inhibition of mediator release, dissent oral dosage forms
	Active substance:
	Ketotifen
	Oxatomid
3.08.8	H1 antagonists: antihistamines with additional inhibition of mediator release, fluid oral forms of administration
	Active substance:
	Ketotifen
	Oxatomid
3.08.9	H1-antagonists: antihistamines, topical forms of administration
	Active substance:
	Bamipin
	Chlorophenoxamine
	Clemastin
	Dimetinden
	Diphenhydramine
	Pheniramine
	Tripelennamine
3.09.1	(free)
3.10.1	(free)
3.11.1	Combinations of ACE inhibitors with calcium channel blockers: divided oral dosage forms
	Active substance:
	Delapril + Manidipine: Delapril hydrochloride, Manidipine dihydrochloride
	Enalapril + Lercanidipine: Enalapril maleate, Lercanidipine hydrochloride
	Enalapril + Nitrendipine: Enalapril maleate
	Ramipril + Amlodipine: Amlodipine besilat
	Ramipril + Felodipine
	Trandolapril + Verapamil: Verapamil hydrochloride
3.11.2	Combinations of ACE inhibitors with hydrochlorothiazide: dissent oral dosage forms
	Active substance:
	Benazepril + Hydrochlorothiazide: Benazepril hydrochloride
	Captopril + Hydrochlorothiazide
	Cilazapril + Hydrochlorothiazide: Cilazapril-1-water
	Enalapril + Hydrochlorothiazide: Enalapril maleate
	Fosinopril + Hydrochlorothiazide: Fosinopril natrium
	Lisinopril + Hydrochlorothiazide: Lisinopril-2-water
	Moexipril + Hydrochlorothiazide: Moexipril Hydrochlorothiazide
	Quinapril + Hydrochlorothiazide: Quinapril hydrochloride
	Ramipril + Hydrochlorothiazide
	Zofenopril + Hydrochlorothiazide: Zofenopril calcium
3.11.3	Combinations of ACE inhibitors with further diuretics: divided oral dosage forms
	Active substance:
	Perindopril + Indapamide: Perindopril arginine, perindopril
	Ramipril + Piretanid
3.11.4	Combinations of angiotensin II antagonists with hydrochlorothiazide: dissent oral dosage forms
	Active substance:
	Candesartan + Hydrochlorothiazide: Candesartan cilexetil
	Eprosartan + Hydrochlorothiazide: Eprosartan mesilate
	Irbesartan + Hydrochlorothiazide: Irbesartan Hydrochlorothiazide
	Losartan + Hydrochlorothiazide: Losartan Kalum
	Olmesartan + Hydrochlorothiazide: Olmesartan medoxomil
	Telmisartan + Hydrochlorothiazide
	Valsartan + Hydrochlorothiazide
3.11.5	Combinations of beta-receptor blockers with diuretics and vasodilatants: oral forms of administration
	Active substance:
	Atenolol 25 mg + Chlortalidon 12.5 mg + Hydralazine-HCl 25 mg
	Atenolol 50 mg + Chlortalidone 25 mg + Hydralazine-HCl 50 mg
	Metipranolol 20 mg + Butizid 2.5 mg + Dihydralazine sulphate 25 mg
	Metipranolol 40 mg + Butizid 5 mg + Dihydralazine Sulphate 50 Mg
	Metoprololtartrate 50 mg + Hydrochlorothiazide 12.5 mg + Hydralazine-HCl 25 mg
	Metoprololtartrate 100 mg + Hydrochlorothiazide 12.5 mg + Hydralazine-HCl 25 mg
	Oxprenolol-HCl 80 mg + chlortalidone 10 mg + hydralazine-HCl 25 mg
	Propranolol-HCl 60 mg + Bendroflumethiazid 2.5 mg + Hydralazine-HCl 25 mg
3.11.6	Combinations of beta-receptor blockers and thiazide diuretics with potassium-sparing diuretics: oral forms of administration
	Active substance:
	Bupranolol-HCl 100 mg + Bemetizid 10 mg + Triamteren 20 mg
	Propranolol-HCl 80 mg + hydrochlorothiazide 12.5 mg + triamterine 25 mg
	Timololhydrogenmaleate 10 mg + Hydrochlorothiazide 25 mg + Amilorid-HCl 2.5 mg
3.11.7	Combinations of beta-receptor blockers, not selective, with further diuretics: divided oral dosage forms
	Active substance:
	Oxprenolol + Chlortalidone: Oxprenolol hydrochloride
	Penbutolol + Furosemide: Penbutolol sulphate
	Penbutolol + Piretanide: Penbutolol sulphate
	Pindolol + Clopamide
3.11.8	Combinations of cromoglicinic acid with beta-2 sympathomimetics: inhalative dosage forms
	Active substance:
	Cromoglicinic acid + fenoterol
	Cromoglicinic acid + Reproterol
3.11.9	Combinations of furosemide with potassium-sparing diuretics: oral dosage forms
	Active substance:
	Furosemid 15 mg + Triamteren 25 mg
	Furosemid 30 mg + Triamteren 50 mg
	Furosemide 40 mg + Amilorid-HCl 5 mg
	Furosemid 40 mg + Triamteren 50 mg
3.11.10	Combinations of glucocorticoids with long-acting beta2 sympathomimetics: inhalative dosage forms
	Active substance:
	Beclometasondipropionate + Formoterol: Beclometasondipropionate, anhydrous, Formoterol hemifumarate-(x)-water
	Budesonide + Formoterol: Formoterol hemifumarate-(x)-water
	Fluticason furoat + Vilanterol: Vilanterol trifenatat
	Fluticasone propionate + Formoterol: Fluticasone 17-propionate, Formoterol hemifumarate-(x)-water
	Fluticasone propionate + salmeterol: fluticasone 17-propionate, salmeterol xinafoate
3.11.11	Combinations of levothyroxine with iodide: solid oral dosage forms
	Active substance:
	Levothyroxin + iodide: Levothyroxin sodium and potassium iodide
3.11.12	Combinations of nifedipine with beta-receptor blockers: oral dosage forms
	Active substance:
	Nifedipine 10 mg + Acebutolol 100 mg
	Nifedipine 10 mg + Atenolol 25 mg
	Nifedipine 15 mg + metoprolol 50 mg
	Nifedipine 20 mg + Atenolol 50 mg
3.11.13	Combinations of paracetamol with codeine: solid oral dosage forms
	Active substance:
	Codeinphosphate 30 mg x 0.5 H2O
	Paracetamol 500 mg
3.11.14	Combinations of paracetamol with codeine: rectal forms of administration
	Active substance:
	Codeinphosphate 60 mg x 0.5 H2O
	Paracetamol 1 000 mg
3.11.15	Combinations of thiazide diuretics and analogues with potassium-sparing diuretics: oral forms of administration
	Active substance:
	Bendroflumethiazid 2.5 mg + Amilorid-HCl 4.4 mg
	Trichlormethiazid 2 mg + Amilorid-HCl 2 mg
	Xipamide 10 mg + Triamteren 30 mg
	Xipamide 5 mg + Triamteren 15 mg
3.12.1	(free)
3.13.1	Myotonolytics: centrally effective myotonolytics, oral forms of administration
	Active substance:
	Baclofen
	Tetrazepam
	Tizanidin
3.14.1	Neuroleptics: high potente neuroleptics, solid oral dosage forms, normal release
	Active substance:
	Benperidol
	Bromperidol
	Flupentixol
	Fluphenazine
	Perphenazine
	Pimozid
	Tiotix
	Trifluoperazine
3.14.2	Neuroleptics: high-potente neuroleptics, liquid oral dosage forms
	Active substance:
	Benperidol
	Bromperidol
	Fluphenazine
	Perphenazine
	Trifluperidol
3.14.3	Neuroleptics: high potente neuroleptics, parenteral administration forms, normally releasing
	Active substance:
	Benperidol
	Fluphenazine
3.14.4	Neuroleptics: medium-and low-potente neuroleptics, solid oral dosage forms, normal release
	Active substance:
	Chlorphenethazine
	Chlorpromazine
	Chlorprothixen
	Clopenthixol
	Dixyrazine
	Levomepromazine
	Melperon
	Metofenazat
	Perazine
	Promazine
	Prothipendyl
	Thioridazine
	Triflupromazine
	Zotepin
	Zuclopenthixol
3.14.5	Neuroleptics: medium-and low-potent neuroleptics, liquid oral forms of administration
	Active substance:
	Chlorpromazine
	Chlorprothixen
	Dixyrazine
	Fluanison
	Levomepromazine
	Melperon
	Perazine
	Promazine
	Prothipendyl
	Thioridazine
	Zuclopenthixol
3.14.6	Neuroleptics: medium-and low-potente neuroleptics, parenteral administration forms, normal release
	Active substance:
	Chlorpromazine
	Chlorprothixen
	Levomepromazine
	Melperon
	Perazine
	Promazine
	Prothipendyl
	Triflupromazine
3.14.7	Neuroleptics: Depository neuroleptics, parenteral administration forms
	Active substance:
	Flupentixol
	Fluphenazine
	River Piriles
	Perphenazine
	Zuclopenthixol
3.15.1	Ophthalmika, vasoconstrictoric: other ophthalmika, vasoconstrictor
	Active substance:
	Antazoline
	Naphazolin
	Oxymetazoline
	Phenylephrine
	Tetryzoline
	Tramazolin
3.16.1	Parkinsonic therapeutics: dopamine agonists, oral dosage forms
	Active substance:
	Alpha-dihydroergocriptine
	Bromocriptine
	Lisurid
	Pergolid
3.16.2	Parkinsonic therapeutics: anticholinergics, oral administration forms
	Active substance:
	Benzatropine
	Bornaprin
	Pridinol
	Procyclidine
	Trihexyphenidyl
3.16.3	Parkinsonic therapeutics: anticholinergics, oral administration forms
	Active substance:
	Metixen
3.17.1	(free)
3.18.1	(free)
3.19.1	Layered lattice antacida: oral forms of administration
	Active substance:
	Hydrotalcite
	magaldrathalic combinations
3.20.1	Thiamine + pyridoxine: oral administration forms
	Active substance:
	Thiamine + pyridoxine

Unofficial table of contents

Annex 8 (to section 22 (4))
Medicinal products excluded or limited by the aid

(Fundstelle: BGBl. I 2012, 1991-1992)

The following active substances or groups of active substances shall be eligible for aid only under the conditions mentioned:

1.

Non-alcoholic beverages are only eligible to support the

a)

Maintenance of abstinence in patients with alcohol in the context of a comprehensive therapeutic concept with accompanying psychosocial and socio-therapeutic measures,

b)

Reduction of alcohol consumption in patients with alcohol, who are led to abstinence therapy, but for which appropriate therapeutic options are not available in a timely manner, for a maximum period of three months, in duly substantiated exceptional cases for a further three months.

The condition for eligibility for aid is that the necessity of the drinking alcohol has been particularly well founded in the medical prescription.

2.

Anti-dysmenorrhea are only eligible as

a)

Prostaglandin synthtaase inhibitor in normal pain,

b)

systemic hormonal treatment of control anomalies.

3.

Clopidogrel as monotherapy for prevention of atherothrombotic events in persons with a heart attack, ischaemic stroke or with a proven peripheral arterial disease is only eligible for persons with

a)

Amputation or vascular intervention due to peripheral arterial occlusive disease (pAVK), or

b)

diagnostically clearly secured typical Claudicatio intermittens with pain back formation in < 10 minutes at rest or

c)

Acetylsalicylic acid intolerance to the extent that more economic alternatives cannot be used.

4.

Clopidogrel in combination with acetylsalicylic acid in acute coronary syndrome for the prevention of atherothrombotic events is only available for persons with

a)

acute coronary syndrome without ST-route elevation during a treatment period of up to 12 months,

b)

Myocardial infarction with ST-line elevation, for which thrombolysis is eligible, during a treatment period of up to 28 days.

Treatment with clopidogrel plus ASS in acute coronary syndrome with ST-line lifting infarction, which has been implanted in a percutaneous coronary intervention, is not the subject of this regulation.

5.

Insulin analogues, fast acting for the treatment of type 2 diabetes mellitus, including:

a)

Insulin Aspart,

b)

Insulin Glulisin,

c)

Insulin Lispro.

These active substances are only eligible for aid as long as they are not associated with additional costs in comparison to fast-acting human insulin. This shall not apply to persons,

a)

that are allergic to the active substance human insulin,

b)

in which a stable adequate metabolic situation with human insulin is not achievable despite intensification of therapy, but this can be proven with fast-acting insulin analogues, or

c)

in which, due to disproportionately high doses of human insulin, therapy with fast-acting insulin analogues is more economical in individual cases.

6.

Insulin analogues, long-acting for the treatment of type 2 diabetes mellitus, including:

a)

Insulin glargin,

b)

Insulin detemir.

These active substances are only eligible for aid as long as they are not associated with additional costs in comparison with human insulin acting as intermediates; the dose unit necessary to achieve the therapeutic target should be taken into account. Sentence 2 shall not apply to:

a)

treatment with insulin glargine for persons in whom, in the context of intensified insulin therapy, even after individual examination of the therapeutic objective and individual adjustment of the extent of the reduction in blood sugar in individual cases, a high the risk of severe hypoglycaemic episodes, or

b)

Persons who are allergic to intermediate-acting human insulins.

7.

Climacteria therapeutics are only eligible for systemic and topical hormonal substitution; both for the beginning and for the continuation of a treatment of postmenopausal symptoms, the lowest dose unit for the shortest possible dose is the lowest possible dose. Duration of therapy.

8.

Prostate amitcases are only eligible for aid

a)

once for a duration of 24 weeks as a therapy trial, and

b)

in the longer term, provided that the therapeutic test referred to in point (a) has been successful.

9.

Juice preparations are only eligible for adults in justified exceptional cases; the reasons must be in the person.

Unofficial table of contents

Annex 9 (to section 23 (1))
Maximum amounts eligible for aid for medicinal products

(Fundstelle: BGBl. I 2012, 1993-1999;
with regard to of the individual amendments. Footnote)

Section 1
Performance Directory




Nr.Performance aid- Capable Highest- amount

	Inhalation area 1)
1	Inhalation therapy, also by means of ultrasound atomisation
	a)	as single inhalation	€ 6.70
	b)	as a space station in a group, per participant or participant	3,60 €
	c)	as a predators in a group in the application of local natural healing waters, per participant or participant	5,70 €
2	Radon inhalation
	a)	in the stollen	11,30 €
	b)	by means of hoods	13,80 €
	Area Physiotherapy, exercise exercises
3	Physiotherapy (also on neurophysiological basis, respiratory therapy) as individual treatment		19,50 €
4	Physiotherapy on neurophysiological basis for central movement disorders which are acquired after completion of the brain maturity, as individual treatment, minimum treatment duration 30 minutes.		23,10 €
5	Physiotherapy on a neurophysiological basis in the case of central movement disorders, which are acquired or are acquired up to the age of 14 years, as individual treatment, minimum treatment duration 45 minutes		34.30 €
6	Physiotherapy (also orthopaedic gymnastics) in one group (2-8 persons), per participant or participant		€ 6.20
7	Physiotherapy in cerebral dysfunction in a group (2-4 persons), minimum treatment duration 45 minutes, per participant or participant		10,80 €
8	Disease gymnastics (respiratory therapy)
	a)	in the case of cystic fibrosis and severe bronchial diseases as a single treatment, minimum treatment duration 45 minutes	34.30 €
	b)	in case of cystic fibrosis and severe bronchial diseases in a group (2-5 persons), minimum treatment duration 45 minutes, per participant or participant	10,80 €
9	Motion Exercises		7,70 €
10	Physiotherapy or exercise exercises in the motion bath
	a)	as a single treatment-including the necessary aftercare	23,60 €
	b)	in a group (up to 5 persons), per participant or participant-including the necessary afterrest	11,80 €
11	Manual therapy for the treatment of joint blockages, minimum treatment time 30 minutes		22,50 €
12	Chirogymnastics-including the necessary aftercare		14,40 €
13	Extended outpatient physiotherapy 3) Minimum treatment duration of 120 minutes, per day of treatment		81,90 €
14	Device-based physiotherapy (KG) including medical training sessions (MAT) and medical training therapy (MTT), treatment guideline 60 minutes, limited to a maximum of 18 treatments per calendar half-year		35,00 €
15	Extension-treatment (for example, Glissonschlinge)		5,20 €
16	Extension-treatment with larger apparatus (e.g. inclined board, extension-table, Perl-type device, loop table)		€ 6.70
	Area Massages
17	Massages of single or multiple body parts, also special massages (connective tissue, reflex zone, segment, periost, brush and colone massage)		13,80 €
18	Manual lymphatic drainage according to Dr. Vodder
	a)	Partial treatment, 30 minutes	19,50 €
	b)	Large-scale treatment, 45 minutes	29,20 €
	c)	Full treatment, 60 minutes	39,00 €
	d)	Compression bandaging of an extremity 2)	8,70 €
19	Underwater pressure jet massage with a tank contents of at least 600 litres and an aggregate power of at least 200 l/min as well as with pressure and temperature measuring equipment-including the necessary afterrest		23,10 €
	Area Packs, Hydrotherapy, Baths
20	Hot role-including the necessary post-rest		€ 10.30
21	Warmping of one or more parts of the body-including the necessary aftercare
	a)	for re-usable packaging materials (for example paraffin, fango paraffin, moor paraffin, pelose, turbatherm)	11,80 €
	b)	use of natural peloids (healers, moors, natural fango, peloses, mud, mud) once used without the use of film or non-woven fabric between skin and peloid
		(aa) partial pack	€ 20.50
		(bb) Large pack	28.20 €
22	Sweat pack (for example, Spanish coat, salt shirt, three-quarters-pack by Kneipp)-including the necessary aftercare		14,90 €
23	Cold pack (partial package)
	a)	Application of clay, quark or similar	7,70 €
	b)	Use of once used peloids (healers, moors, natural fango, peloses, mud, slick) without the use of film or fleece between skin and peloid	15,40 €
24	Hay bag, Peloidkompresse		9,20 €
25	Wickets, supports, compresses and others, including with the addition		4,60 €
26	Dry pack		3,10 €
27	a)	Partial casting, partial blitzguss, partial cast iron	3,10 €
	b)	Full cast, full-cast casting, interchangeable castings	4,60 €
	c)	Cover, depreciation, washing	€ 4.10
28	a)	at-or descending part-bath (for example, after Hauffe)-including the necessary afterrest	12,30 €
	b)	at-or descending full bath (overheating bath)-including the necessary aftercare	20.00 €
29	Interchangeable wheels-including the necessary afterlife
	a)	Partial bath	9,20 €
	b)	Full bath	13,30 €
30	Brush-massage bath-including the necessary afterrest		19,00 €
31	Natural moor baths-including the necessary afterlife
	a)	Half bath	32.80 €
	b)	Full bath	39,90 €
32	Sand baths-including the necessary post-rest
	a)	Partial bath	28,70 €
	b)	Full bath	32.80 €
33	Brine-Photo-Therapy		32.80 €
	Treatment of large-area skin diseases with balneo-phototherapy (single bath in brine combined with irradiation by long-wave ultraviolet light [UV-A] or short-wave ultraviolet light [UV-B], including after-fat) and light-oil bath -including the necessary post-rest
34	Medical baths with additives
	a)	Partial bath (hand or foot bath) with additive, for example vegetabilie extracts, essential oils, special emulsions, mineralic humic acid-containing and salicylic acid-containing additives	€ 6.70
	b)	Sitting room with added function-including the necessary afterrest	13,30 €
	c)	Full bath, half bath with addition-including the necessary afterrest	18,50 €
	d)	in the case of a number of additional additives,	3,10 €
35	Gas-containing baths
	a)	Gas-containing bath (for example, carbonic acid bath, oxygen bath)-including the necessary afterrest	19,50 €
	b)	Gas-containing bath with addition-including the necessary afterrest	22,50 €
	c)	Carbon dioxide gas bath (carbonic acid bath)-including the necessary afterrest	21,00 €
	d)	Radon-Bad-including the necessary afterlife	18,50 €
	e)	Radon supplement, 500 000 millistat each	3,10 €
	Expenses other than those referred to in this section shall not be eligible for aid. In the case of partial, seat and full baths with local natural medicinal waters, the maximum amounts eligible under point 34 (a) to (c) and (35) (b) shall be up to EUR 3.10. Further additions to this shall be eligible for aid in accordance with point 34 (d).
	Refrigeration and heat treatment
36	a)	Ice cream application, cold treatment (for example, compress, ice bag, direct contact)	9,80 €
	b)	Ice application, cold treatment (for example cold gas, cold air) large joints	€ 6.70
37	Ice bath		9,80 €
38	Hot air treatment of one or more body parts or heat application (incandelated light, spotlights also infrared) in one or more body parts		5,70 €
	Electrotherapy area
39	Ultrasonic treatment, also phonophoresis		€ 6.20
40	Treatment of one or more body sections with high-frequency currents (short-, decimetric or microwaves)		€ 6.20
41	Treatment of one or more body sections with low-frequency currents (for example, stimulus current, diadynamic current, interference current, galvanization)		€ 6.20
42	Targeted low-frequency treatment, electrogymnastics; in the case of spastic or abrupt paralysis		11,80 €
43	Iontophoresis		€ 6.20
44	Two or four-cell bath		11,30 €
45	Hydroelectric full bath (for example, Stangerbad), also with the addition-including the necessary afterrest		22,00 €
	Light therapy area
46	Ultra-violet light treatment
	a)	as a single treatment	3,10 €
	b)	in a group, per participant or participant	€ 2.60
47	a)	Irritant treatment of a circumscribed skin area with ultraviolet light	3,10 €
	b)	Irritation treatment of several circumscribed areas with ultraviolet light	5,20 €
48	Quartz lamp pressure irradiation of a field		€ 6.20
49	Quartz lamp pressure irradiation of several fields		8,70 €
	Logopedie area
50	Treatment planning and report
	a)	Initial consultation with treatment planning and meeting, once per treatment case	31,70 €
	b)	Standardized procedures for treatment planning, including evaluation, only on special medical prescription if there is a suspicion of central speech disorder, once per treatment case	49.60 €
	c)	detailed report	11,80 €
51	Single treatment for speech, speech and voice disorders
	a)	Minimum treatment time 30 minutes	31,70 €
	b)	Minimum treatment duration 45 minutes	41,50 €
	c)	Minimum treatment time 60 minutes	52,20 €
52	Group treatment in case of speaking, speech and voice disorders with counseling of the patient or of the patient or, where appropriate, of the parents, per participant or participant
	a)	Children's group, minimum treatment time 30 minutes	14,90 €
	b)	Adult group, minimum treatment duration 45 minutes	17,40 €
	Occupational therapy (Ergotherapy)
53	Functional analysis and initial consultation including consultation and treatment planning, once per treatment case		31,70 €
54	Single treatment
	a)	in the case of motor disturbances, minimum treatment time 30 minutes	31,70 €
	b)	for sensomotoric or perceptive disorders, minimum treatment duration 45 minutes	41,50 €
	c)	in the case of mental disorders, minimum treatment time 60 minutes	54,80 €
55	Brain power training as a single treatment, minimum treatment time 30 minutes		31,70 €
56	Group handling
	a)	Minimum duration of treatment 45 minutes, per participant or participant	14,40 €
	b)	in the case of mental disorders, minimum treatment time 90 minutes, per participant or participant	28,70 €
	Area Podological Therapy 4)
57	Corneal removal at both feet		14,50 €
58	Cornea removal at one foot		8,70 €
59	Nagel processing on both feet		13,05 €
60	Nagel processing at one foot		7,25 €
61	Podological complex treatment at both feet (corneal removal and nail processing)		26,10 €
62	Podological complex treatment at one foot (corneal removal and nail processing)		14,50 €
	Other business
63	A doctor who is a member of the house		9,20 €
64	Travel expenses for journeys by the person treating the person (only on a home visit to the home) when using a motor vehicle of EUR 0.30 per kilometre, or the lowest cost of a regular transport vehicle
	In the case of visits to a number of patients on the same route, points 63 and 64 are only partially eligible for each patient or patient.

Section 2
Extended outpatient physiotherapy

1.

Expenses of the extended outpatient physiotherapy (EAP)-number 13 of the list of services-are recognized as eligible for aid only in the following indications:

a)

Spinal syndromes with significant symptom

aa)

(also post-operative) fresh herniated disc (including post-operative),

bb)

Symptoms of radicular, muscular and static symptoms,

cc)

Spondylolysis and spondylolistheses detected with radicular, muscular and static symptoms,

dd)

unstable spinal injuries with muscular deficit and misstatics, if services are provided in a conservative or post-operative way,

ee)

looser correctable thoracic scheuermann kyphosis > 50 ° to Cobb,

b)

Skeletal system operation

aa)

post-traumatic osteosyntheses,

bb)

Osteotomies of the large tube bones,

c)

Prosthetic joint replacement for movement restrictions or muscular deficit

aa)

Shoulder prostheses,

bb)

Knee endoprostheses,

cc)

Hip endoprostheses,

d)

Surgical or conservatively treated joint diseases, including instabilities

aa)

Knee ligament ruptures (except for insulated inner band),

bb)

Shoulder joint lesions, in particular after

aaa)

Surgically supplied banker lesion,

bbb)

Rotator cuff rupture,

ccc)

heavy shoulder stiffness (frozen shoulder),

ddd)

Impingement-syndrome,

eee)

Shoulder joint luxation,

fff)

tendinosis calcarea,

ggg)

periathritis humero-scapularis,

cc)

Achilles tendon ruptures and Achilles tendon demolitions,

e)

Amputations.

In addition, a regulation is required for recognition as eligible expenditure.

a)

a hospital doctor or a hospital doctor,

b)

a specialist in orthopaedics, neurology or surgery,

c)

a doctor for physical and rehabilitative medicine, or

d)

a general practitioner or a general practitioner with the additional name "Physikalische und Rehabilitative Medizin".

2.

An extension of the extended ambulatory physiotherapy requires a new medical prescription. A certificate issued by the therapy institution or by the doctors or doctors employed is not sufficient. After the completion of the extended outpatient physiotherapy, the site of the arrest is to be presented with the therapy documentation together with the invoice.

3.

The extended outpatient physiotherapy includes at least the following benefits per day of treatment:

a)

Physiotherapy, physiotherapy,

b)

Physical therapy as required,

c)

Medical build-up.

If necessary, the following additional services can be provided:

d)

Lymphatic drainage or massage or connective tissue massage,

e)

Isokinetic,

f)

Underwater massage.

These additional benefits shall be subject to the maximum amount referred to in Section 1 (13).

4.

The patient or patient must confirm the performed services on the daily documentation, stating the date.

Section 3
Medical setup training

1.

Expenses for a medically prescribed medical training session (MAT) with sequence training equipment for the treatment of functional and performance restrictions in the supporting and locomotor system are eligible if:

a)

the training is prescribed by

aa)

a hospital doctor or a hospital doctor,

bb)

a specialist in orthopaedics, neurology or surgery,

cc)

a doctor for physical and rehabilitative medicine, or

dd)

a general practitioner or a general practitioner with the additional name "Physikalische und Rehabilitative Medizin",

b)

therapy planning and control of results are carried out by a doctor or a doctor of the therapy facility; and

c)

each therapeutic session is carried out under medical supervision; the carrying out of therapeutic and diagnostic services may be partially delegated to specially trained medical personnel.

2.

The eligibility of aid is limited to a maximum of 18 treatments per calendar half-year.

3.

According to the decision of the Bundesärztekammer (Federal Medical Association), the adequacy and thus the eligibility of expenses for expenses are determined by a doctor or by a doctor. Thereafter, the following services shall be eligible for medical aid up to the rate of 2.3 times the fee rates of the system for the payment order for doctors:

a)

Entrance examination for the medical training therapy including biomechanical functional analysis of the spine, special pain-anamnesis and possibly other function-related measurement methods as well as documentation analogous to point 842 of the Annex to the Rules of Fees for Doctors. The calculation of a control examination analogous to point 842 of the system of fees regulations for doctors is not possible before the end of the treatment series.

b)

Medical training therapy with sequence training including progressive-dynamic muscle training with special therapy machines analogous to point 846 of the system of fees for physicians, plus additional device-sequence trainings analogue Point 558 of the Rules of Fees for Doctors Fees (per-session) and accompanying physiotherapy exercises referred to in point 506 of the Annex to the Fees Regulations for Doctors. The numbers analogous to 846, analogous to 558, and the number 506 of the system for doctors ' fees can only be billed once per session.

4.

Where the benefits are provided by eligible service providers for medicinal products, the appropriateness of the expenditure referred to in paragraph 14 of Section 1 shall be determined.

5.

Fitness and strengthening methods, which do not meet the requirements of the medical postgraduate training, are not eligible for assistance. This is also the case if they are carried out on identical training devices with health-promoting objectives.

Section 4
Medical foot care expenses

Expenses for medical foot care by podologers, podologists, medical foot care workers and medical foot care workers are only eligible for aid in the diagnosis of "diabetic foot syndrome".

1)

The substances required for inhalation (medicinal products) are also separately eligible for aid.

2)

The necessary binding material (for example, mullbinding, short tie binding, flow pad binding) is also eligible for auxiliary aid.

3)

May only be recognised as eligible for assistance in the implementation of such therapy facilities, which are approved by the statutory health insurance companies or professional cooperatives for outpatient rehabilitation/extended outpatient physiotherapy.

4)

Expenses for medical foot care by a podologist, a podologist, a medical foot nurse or a medical foot nurse are only eligible for aid in the diagnosis of "diabetic foot syndrome".

Unofficial table of contents

Appendix 10 (to § 23 (1) and § 24 (1))
Approved service providers for medicinal products

(Fundstelle: BGBl. I 2012, 2000)

The cure must be provided by one of the following persons and correspond to the professional image of the service provider or the service provider:

1.

Employment and occupational therapist or employment and occupational therapist,

2.

Ergotherapist or Ergotherapist,

3.

Physiotherapist or physiotherapist,

4.

Physiotherapist or physiotherapy,

5.

Logopädin or logopäde,

6.

academic language therapist or academic speech therapist who has the admission of the statutory health insurance funds in accordance with § 124 of the Fifth Book of Social Code,

7.

clinical linguist or clinical linguist,

8.

masseuse or masseur,

9.

medical caretaker, or medical bath master,

10.

Podologist or Podologist,

11.

Medical foot nurse or medical foot nurse according to § 1 of the Podologengesetz (Podologengesetz).

Unofficial table of contents

Appendix 11 (to § 25 (1) and (4))
Eligible expenditure for aids, self-treatment and self-control equipment, body replacement parts

(Fundstelle: BGBl. I 2012, 2001-2009;
with regard to of the individual amendments. Footnote)

Section 1

Aids, devices for self-treatment and self-control, body replacement parts

The expenditure on the purchase of the following aids, equipment and parts of the body shall, where appropriate within the limits of the maximum amounts, be eligible if they are prescribed by a doctor or by a doctor:

1.1

Abduction storage keil

1.2

Suction device (for example in the case of kehlkopferkdisease)

1.3

Adaptations for various consumer goods (for example, universal holders for severely disabled persons for the purpose of facilitating personal care and for food intake)

1.4

Alarm device for epileptics or epileptics

1.5

Anatomical spectacle frame

1.6

Anus-Praeter-Utilities

1.7

Dress-up or pull-out aids

1.8

Aquamate

1.9

Armcuff

1.10

Wrist strap or towel

1.11

Arthrodesene seat cushion or seat case

1.12

Respiratory therapy equipment

1.13

Atomiseur (for drug spraying)

1.14

Ramp for an ambulance

1.15

Erecting loop

1.16

Dressing chair (up to 150 Euro eligible for erection function)

1.17

Stand-up

1.18

Buoyantion aid (in the case of severe disability)

1.19

Bath tub, shower, rinsing glass, bottle, brush, pipette or rod

1.20

Eye check valve, also as a foil

2.1

Bath stocking

2.2

Bathing Wannensitz (in the case of severe disability, total endoprosthesis, hip joint-luxation danger or polyarthritis)

2.3

Bath tub shortening

2.4

Ball syringe

2.5

Disabled-Tricycle

2.6

Irradiation mask for outpatient radiotherapy

2.7

Bednässer-Weckgerät

2.8

Beugebandage

2.9

Billroth-Batist-Lätzchen

2.10

Bubble Fistelbandage

2.11

Blind guide dog (including crockery, linen, collar, muzzle)

2.12

Blind guide (ultrasonic eyewear, ultrasonic control device)

2.13

Blindenstock, long stick or tactile stick

2.14

Blood coagulation measuring device (in the case of continuous anti-coagulant or artificial heart valve replacement)

2.15

Blood lancet

2.16

Blood glucose meter

2.17

Bracelet

2.18

Rupture tape

3.1

Clavicula-Bandage

3.2

Communicator (in the case of dysarthric speech disorders)

3.3

Computer-specific equipment for the disabled; special hardware and special software up to 3 500 Euro, possibly plus up to 5 400 Euro for a Braille line with 40 modules

4.1

Decubitus protection means (for example, on-or documents for the bed, special mattresses, wedges, pillows, on-or documents for the wheelchair, shelters for elbows, lower legs and feet)

4.2

Delta-Wheel

4.3

Turntable, Translator

4.4

Shower seat or chair

5.1

Insoles, orthopaedics, including the ganganalysis required for adaptation

5.2

Once-protective trousers in cross-section paraplegics

5.3

Ekzemmanschette

5.4

Electric scooters up to 2 500 Euro, except for registration and insurance

5.5

Electrostimulator

5.6

Epicondylitis bandage or pliers with pelottes

5.7

Epitrainbandage

5.8

Dietary probe

6.1

Fepo device (functional electronic peronaeus prosthesis)

6.2

Heel protection (pillows, pillows, peel, schooner)

6.3

Fingerling

6.4

Finger rail

6.5

Fixed-aid

6.6

Foot-part relief shoe (single shoe supply)

7.1

Gehgipsgalosche

7.2

Walking aids and equipment

7.3

Hearing protection

7.4

Genutrain-Active-Kniebandage

7.5

Device for treatment with electromagnetic alternating fields in the case of atrophic pseudarthrosis, endoprosthesis loosening, idiopathic hip necrosis or delayed bone fracture healing (in combination with an appropriate surgical therapy)

7.6

Face-to-face replacement parts (ectoprothesis, epithesis)

7.7

Gilchrist-Bandage

7.8

Plaster bed, reclining

7.9

Glass rods

7.10

Rubber shorts in bladder or intestinal incontinence

7.11

Rubber stockings

8.1

Necktie, neck, head, chin support

8.2

Wrist strap

8.3

Hebekissen

8.4

Home dialyser

8.5

Helping hand, scissor pliers

8.6

Heart-Atmungs-Monitor or monitor

8.7

High-frequency therapy device

8.8

Hearing aids (behind-the-ear devices [HdO devices], pocket devices, hearing glasses, sound signals transferring devices [C.R.O.S.-devices, Contralateral Routing of Signals], wireless hearing aids, otoplastics, in-the-ear devices [IdO devices], sound-absorbing devices at Partially implanted bone conduction hearing system), every five years, including additional costs, unless, for medical or technical reasons, an early regulation is mandatory; expenses are for persons aged 15 years and over 1 EUR 500 per ear shall be limited, possibly plus the Expenses for a medically indexed necessary remote control; the maximum amount may be exceeded, as far as is necessary, in order to provide sufficient care for deafness of borderline deafness or in case of comparable Serious facts to be guaranteed

9.1

Impulse vibrator

9.2

Infusion cutlery or equipment and accessories

9.3

Inhalation device, including oxygen and accessories, but no humidifiers, filters, scrubbers

9.4

Inner shoe, orthopedic

9.5

Insulin application aids and accessories (insulin dosing device, pump, injection)

9.6

Iris bowl with blackened pupil in case of changes in the cornea of a blind eye

10.1

(free)

11.1

Cannulas and accessories

11.2

Catapultsitz

11.3

Catheters, also balloon catheters, and accessories

11.4

Pine spreading device

11.5

Klosett-mattress for the home area in the case of permanent bed and existing incontinence

11.6

Cum Foot

11.7

Klumphandschiene

11.8

Klyso

11.9

Kneading material for exercise purposes in cerebral-paretic children

11.10

Knee cap/bandage, universal joint bandage

11.11

Knee pad/slide on lower leg amputation

11.12

Ankle and joint supports

11.13

Body replacement parts including accessories, less of 15 Euro for breast prosthesis holders and 40 Euro for swimsuits, Bodys or corselets for breast prosthesis holders

11.14

Compression stockings/pantyhose

11.15

Coordinator after SchielHandling

11.16

Head ring with stick, headwriting

11.17

Head protectors

11.18

Remediation Shoe

11.19

Krabbler for spastics and spastics

11.20

Convulsant

11.21

Ambulance and accessories

11.22

Nursing bed

11.23

Hospital

11.24

Cross-support bandage

11.25

Crutch

12.1

Latex funnel in cross-sectional paralysis

12.2

Bodybinding, but no kidney, flannel binding and heat-binding binding

12.3

Reading aids (reading belts, leaf turning bar, leaf turning device, sheet reading device, supporting frame)

12.4

Light signalling system for the deaf and high-grade hearing impaired

12.5

Lifter (nursery, multilift, bath helpers, jacks or bath lifter)

12.6

Lispelprobe

12.7

Lumbar bandage

13.1

Malleotrain-Bandage

13.2

Mangoldsche Schnürbandage

13.3

Manutraine Bandage

13.4

Measuring shoes, orthopedic, which cannot be produced as standard, minus an inherent part of 64 Euro:

13.4.1

street shoes (first equipment two pairs, replacement regularly after two years at the earliest),

13.4.2

House shoes (first equipment two pairs, replacement regularly at the earliest after two years),

13.4.3

sports shoes (initial equipment a couple, replacement regularly at the earliest after two years),

13.4.4

bathing shoes (first equipment a couple, replacement regularly at the earliest after four years),

13.4.5

Interim footwear (due to a temporary supply of 64 Euro per share)

13.5

Milk pump

13.6

Oral Lock

13.7

Mouthstab/grip rod

14.1

Conservationists

14.2

Neurodermatitis-Overall for persons who have not yet completed the twelfth year of life (two per year and up to 80 Euro per overall)

15.1

Orthesis, orthoprosthesis, correction rails, corsets and similar, also holding chains and similar

15.2

Orthosis shoes, less of a natural part of 64 Euro

15.3

Orthonyxie-Nagelcorrective pliers including the adaptations

15.4

Orthopaedic dressings on confectioners (maximum of six pairs of shoes per year)

16.1

Pavlik-Bandage

16.2

Peak-Flow-Meter

16.3

Penis Terminal

16.4

Peronaeusschiene, Heidelberger Winkel

16.5

Phonator

16.6

Polarimeter

16.7

Psoriasiskamm

17.1

Quench rail

18.1

Reflectometer

18.2

Rektophor

18.3

Rollator

18.4

Rolling Board

18.5

Skirting board

19.1

Schede-Wheel

19.2

Chamfer gebrett

19.3

Safety goggles for the blind

19.4

Protective helmet for the disabled

19.5

Threshold current device

19.6

Segofix bandage system

19.7

Seat cushion for femoral amputees

19.8

Seat shell, if seat corset is not sufficient

19.9

Scolioseumcurvature bandage

19.10

Spastikerhilfen (gymnastics/exercise equipment)

19.11

Special shoes for diabetics, less a part of 64 Euro

19.12

Sphincter stimulator

19.13

Speech amplifier after Kehlkopfresektion

19.14

Spread Footbandage

19.15

Spreader pant/shell/car top

19.16

Syringes

19.17

Stabilisation shoes in case of ankle joint damage, Achilles tendon damage or paralysis (a simultaneous supply with orthoses or orthoses is excluded)

19.18

Stand Exerciser

19.19

Stoma supplies, sphincter plastic

19.20

Knit ladder for setting up and oversetting paralyzed

19.21

Stubbies

19.22

Mute protective cover

19.23

Stump stocking

19.24

Suspensory

19.25

Symphysis belts

20.1

Talocrur (ankle cuff after Dr. Grisar)

20.2

Therapeutic movement equipment (only with spasm circuit)

20.3

tinnitus device

20.4

Toiletries in the case of severely disabled

20.5

Tracheostoma supply, also water protection device (Larchel)

20.6

Seat belt seat

21.1

Transmission systems if, according to the differentiated specialist paediatric diagnosis, if there is an auditory processing and perception disorder, there is also a limitation of the language comprehension in the jamming sound

21.2

Exercise rail

21.3

Urinals

21.4

Urostomy Bags

22.1

Sanding shoes (single shoe supply)

22.2

Vibration trainer for numbness

23.1

Water-resistant walking aid

23.2

Changing pressure equipment

24.1

(free)

25.1

(free)

26.1

Zyklomat-Hormon pump.

Section 2

Wigs

Expenses for medical perches are eligible for assistance up to the amount of 512 euros if a pathological loss of hair (for example, Alopecia areata), a significant impediation (for example, as a result of injury to the skull) or an inpatient loss of hair. total or extensive hair loss is present. The expenses for a second wig are only eligible if a wig is expected to be worn for longer than one year. The expenses for the re-purchase of a wig shall only be eligible if at least four years have elapsed since the previous procurement, or if the head shape has changed in children before the end of this period.

Section 3

Blindness and mobility training

1.

Expenditure on two long-flocks and, where appropriate, electronic guide devices according to the medical regulations are eligible for aid.

2.

Expenses for the necessary training in the use of these aids (mobility training) are eligible for the following extent:

a)

Expenses for training in the use of the Langstock as well as for training in orientation and mobility up to the following maximum amounts:

aa)

Lessons of 60 minutes, including 15 minutes of preparation and follow-up as well as the preparation of teaching material, up to 100 lessons

63.50 Euro,

bb)

Travel time of the coach or coach per hour, with each hour is calculated proportionally in 5-minute intervals

50,48 Euro,

cc)

Travel expenses of the coach or coach per kilometre travelled 0,30 Euro or
the lowest cost of a regular transport vehicle,

dd)

necessary accommodation and catering of the coach or trainer, as far as a daily return to the place of residence of the coach or of the coach is not reasonable, per day

26 Euro.

In principle, mobility training is carried out as individual training outpatient or in a stationary part of a special facility. If a number of blind people are informed in one day, the expenses of the trainer or coach can only be taken into account proportionally,

b)

Expenses for a required night training (for example, if there is a loss of sight, change of place of residence) shall be recognised in accordance with point (a),

c)

Expenses for a supplementary training on guide devices can generally be recognised up to 30 hours, including the costs of accommodation and meals, as well as the travel expenses of the trainer or trainer in the to the appropriate extent. The recognition of further hours is possible if the trainer or the trainer or a doctor certifies the necessity.

3.

The expenses incurred for the mobility training are to be proved by the invoice of a blind organization. A direct settlement can also be accepted by the mobility trainer or the mobility trainer if she or she is entitled to the invoicing in relation to the statutory health insurance companies. In the case of VAT (a proof of the financial office is to be submitted), the eligible expenses are increased by the respective applicable sales tax.

Section 4

Vision aids

Subsection 1
General provisions on aid eligibility for visual aids

1.

Visual aids to improve the visual acuity are eligible for aid

a)

for people who are the 18. have not yet completed their life year,

b)

for people who are the 18. if both eyes have a severe visual impairment due to visual weakness or blindness, at least stage 1 of the classification of the degree recommended by the World Health Organization of the degree of vision Visual impairment. A severe visual impairment occurs, inter alia, if:

aa)

the visual acuity of the visual acuity of the best possible correction with a pair of glasses or with possible contact lenses on the better eye ≤ 0.3 or

bb)

The two-eyed field of view at a central fixation is ≤ 10 degrees.

The Visus is to be determined with the best correction with spectacle lenses or contact lenses.

2.

The eligibility of the aid for the initial procurement of a visual aid is conditional upon the fact that it has been prescribed by a ophthalmologist or an ophthalmologist. In the case of replacement, the determination of the refraction is sufficient for an optician or an optician; the expenses for this purpose are eligible for assistance of up to 13 euros.

3.

Expenses for the re-purchase of a visual aid shall be eligible if, if the visa remains the same, three years have elapsed since the purchase of the previous visual aid, two years have elapsed in the case of soft contact lenses, or if the renewed visual aid has been renewed. Procurement of visual aid is necessary because

a)

the refraction has changed,

b)

the previous visual aid has been lost or become unusable,

c)

the shape of the head has changed.

4.

As visual aids to improve the visual acuity, the following are eligible:

a)

Eyeglass lenses,

b)

contact lenses,

c)

enlarging vision aids.

5.

In the case of persons who are subject to full-time compulsory education, expenses for glasses are eligible for assistance if they are required to participate in school sports. The amount of eligible expenses shall be determined in accordance with subsection 2 (1) and (2); for eyewear, expenses of up to EUR 52 shall be eligible for aid.

Subsection 2
Eyeglass lenses to improve the Visus

1.

Expenses for eyeglass lenses are eligible for maximum amounts up to the following maximum amounts:

a)

for tempered glasses with glass thicknesses up to +/-6 Dioptria (dpt):

aa)

Single-strength lenses:

aaa)

for a spherical glass

31,00 Euro,

bbb)

for a cylindrical glass

41.00 Euro,

bb)

Multi-strength glasses:

aaa)

for a spherical glass

72.00 Euro,

bbb)

for a cylindrical glass

EUR 92.50,

b)

for tempered glasses with glass thicknesses above +/-6 dpt plus glass

21,00 Euro,

c)

for three-step or multifocal lenses plus glass

21,00 Euro,

d)

for glasses with prismatic effect plus glass

21,00 Euro.

2.

In addition to the expenditure referred to in point 1, additional costs for plastic, light and light protection glasses for the respective indications up to the following maximum amounts shall be eligible for aid:

a)

for plastic glasses and high-breaking mineral glasses (light glass) plus glass per glass

21,00 Euro, aa) for glass thicknesses from + 6/8 dpt, bb) for anisometropia from 2 dpt, cc) regardless of the glass thickness aaa) for people who are the 14. have not yet completed their life year, bbb) for persons with chronic pressure eczema, with malformations or malformations of the face, especially in the area of the nose and ears, if, despite optimum adaptation using silicate glasses, a satisfactory seat of the eyeglasses is not is guaranteed ccc) for eyewear required for full-time education for participation in school sports,

b)

for light protection glasses or phototropic glasses plus glass

11,00 Euro, aa) in the case of circumscribed loss of transparency (turbidity) in the area of refractive media, which lead to light scattering (for example, corneal scars, lens bevings, glass-body exercises), bb) in the case of pathological continuing pupil extensions, cc) In case of continuation of the pupil constriction (for example, absolute or reflective pupil stiffness, Adie-Kehrer syndrome), dd) in the case of chronic recurrent irritable states of the anterior and medial eye sections, which are not medically recoverable (for example, keratoconjunctivitis, iritis, cyclitis), ee) in the event of changes in the area of the Lider and its surroundings (for example, Lidkolobom, Lagophthalmus, Narbenzug) and obstructing the flow of tear, ff) in the case of Ciliarneuralgia, gg) glare due to inflammatory or degenerative diseases of the retina, the cornea or the optic nerves, hh) in the case of total color blindness, ii) in the case of unbearable glare in the case of practical blindness, jj) in the case of intracranial diseases in which, according to medical experience, there is a pathological sensitivity to light (for example, brain injury, brain tumours), kk) in the case of glass thicknesses from +10 dpt due to enlargement of the entrance pupil.

3.

Non-eligible expenses are:

a)

High-refractive Lentikulargläser,

b)

anti-reflective glasses,

c)

polarizing glasses,

d)

Glass with a curing surface coating,

e)

Glasses and dressings in the spectacles to prevent damage to the workplace or to the leisure area,

f)

screen glasses,

g)

eyewear insurance,

h)

Glasses for a so-called second eyewear, the correction strengths of which already correspond to the existing glasses (multiple regulation),

i)

Glasses for a so-called reserve groove, which are required, for example, for reasons of road safety,

j)

Glasses for sports spectacles, except in the case of subsection 1, point 5,

k)

Brillenetuis,

l)

Eyeglass frames, except in the case of subsection 1, point 5.

Subsection 3
Contact lenses to improve the Visus

1.

Expenses for contact lenses to improve the visa are eligible for assistance:

a)

Myopia from 8 dpt,

b)

Hyperopia from 8 dpt,

c)

irregular astigmatism, if it achieves a visual strength of at least 20 percent compared to eyeglass lenses,

d)

Astigmatism rectus and inversus from 3 dpt,

e)

Astigmatism obliquus (axial position 45 ° +/-30 ° or 135 ° +/-30 °) from 2 dpt,

f)

Keratoconus,

g)

Aphakie,

h)

Aniseikony of more than 7 per cent (the aniseikonium measurement must be carried out and documented in accordance with a generally accepted reproducible method of determination),

i)

Anisometropy from 2 dpt.

2.

Expenditure on short-term lenses is only eligible for aid per calendar year

a)

for spherical contact lenses up to 154 Euro,

b)

for toric contact lenses up to 230 Euro.

3.

If contact lenses cannot be worn uninterrupted for medical reasons, in addition to the contact lenses, expenses for spectacles under subsection 2 shall be eligible for aid in addition to the contact lenses in the presence of an indication as specified in point 1. In the absence of an indication as referred to in paragraph 1, only the comparable costs for glasses shall be eligible for aid.

4.

The following are not eligible:

a)

Contact lenses as post-operative care (also as a bandage lens or bandage) after non-auxiliary interventions,

b)

Contact lenses in coloured versions to change or reinforce the body's own colour of the iris,

c)

One-day lenses,

d)

multifocal multi-focal contact lenses,

e)

contact lenses with light protection and other edge filters,

f)

Cleaning and care products for people who are the 18. Have completed their life year.

Subsection 4
Enlarging vision aids to improve visual acuity

1.

Expenses for the following medical-prescribed enlarging vision aids are eligible for aid:

a)

Visually enlarging visual aids for the proximity of at least 1.5 times the magnification requirement primarily as a light field magnifying glass, hand and fixed magnifier, optionally with illumination, or spectacle lenses with magnifying glass (magnifying glass); in well-founded individual cases as a telescope system (for example, according to Galilei, Kepler), including the system carriers,

b)

electronically increasing visual aids for the proximity as mobile or non-mobile systems with a magnification of at least 6 times the magnification requirement,

c)

Visually enlarging visual aids for remote areas as focusing hand-rims or monocular.

The condition for eligibility is that the visual aid has been prescribed by a specialist in ophthalmology, who or who is responsible for the need and the type of visual aids required, or in cooperation with an ophthalmologist. according to a suitably equipped optician, or a suitably equipped optician.

2.

Non-eligible expenses are:

a)

Telescope magnifier systems (for example, according to Galilei or Kepler) for the intermediate distance (room correction) or the distance,

b)

separate light sources (for example, to increase the contrast or to illuminate the reading),

c)

Fresnel lenses.

Subsection 5
Therapeutic vision aids

1.

Expenses for the following therapeutic visual aids for the treatment of an eye injury or eye disease are eligible for aid if the visual aid has been prescribed by a specialist in ophthalmology or ophthalmology:

a)

Glass with light protection with a transmission up to 75 percent at

aa)

substance loss of iris, which reduce glare protection (e.g. iris colobom, anirial, traumatic mydriasis, iridodialysis),

bb)

Albinism.

If, in addition, a refraction compensation is required in the case of a light protection glass, the expenditure for the corresponding glasses according to subsection 2 shall be eligible. In addition, the expenses for a ready-made side protection are eligible if the side protection has been successfully tested.

b)

Glass with ultraviolet (UV) edge filter (400 nanometer wavelength) at

aa)

Aphakie,

bb)

Photochemotherapy for the absorption of long-wave UV light,

cc)

UV protection according to pseudophakia, if no intraocular lens has been implanted with UV protection,

dd)

Iriskolobom,

ee)

Albinism.

If, in addition, a refraction compensation is necessary in the case of the edge filter glass and, in addition, a reduction in transmission is necessary in the case of albinism, the expenditure for the corresponding glasses according to subsection 2 shall be eligible. In addition, the expenses for a ready-made side protection are eligible if the side protection has been successfully tested.

c)

Glass with edge filter as band-pass filter with a transmission maximum at a wavelength of 450 nanometres in blue-pin monochromasie. If, in addition, a refraction compensation and, if necessary, a reduction in transmission are necessary in the case of the edge filter glass, the expenditure for the corresponding glasses according to subsection 2 is eligible. Subject to a successful austestation, the expenses for a ready-made side protection are also eligible for assistance.

d)

Glass with edge filter (wavelength greater than 500 nanometres) as a long pass filter to avoid rod bleaching and to counterbalance

aa)

Congenital lack of or congenital lack of spigot in the retina (Achromatopsia, incomplete atchromatopsia),

bb)

dystrophic retinal disorders (for example, Zapfendystrophies, cones-rod dystrophies, rods-pegs-dystrophies, retinopathia pigmentosa, chorioidemia),

cc)

Albinism.

The extent of the transmission reduction and the location of the edges of the filters are to be individually tested, the subjective acceptance is to be checked. If, in addition, a refraction compensation is necessary in the case of the edge filter glass, the expenditure for the corresponding glasses according to subsection 2 shall be eligible. In addition, the expenses for a ready-made side protection are eligible if the side protection has been successfully tested.

e)

Horizontal prisms in glasses ≥ 3 prismatic diopters and films with prismatic effect ≥ 3 prism diopters (total correction on both eyes) as well as vertical prisms and foils ≥ 1 Prismendioptrie, at

aa)

Pathological disorders in sensory and motor cooperation of the eyes with the aim of enabling binocular vision and improving sensory cooperation of the eyes,

bb)

Eye muscle paresis in order to eliminate or reduce muscle contractions.

The condition for eligibility is that the Regulation should be issued on the basis of a comprehensive ophthalmology orthopaedic pleoptical diagnosis. Regulations issued on the basis of isolated results of a subjective heterophie test method are not recognized. In case of alternating prismatic strength or temporary use, for example pre-or post-operative, only the expenses for Prismatic films without support glass eligible. Balancing cracks in oversized eyeglass diameters as well as height equalization cracks in multi-strength lenses are not eligible. If a refraction compensation is required in the case of spectacle lenses with therapeutic prisms, the expenses are of the corresponding spectacle lenses in accordance with subsection 2.

f)

Occlusion shells or lenses in the case of double perception which is permanently therapeutically impossible to influence;

g)

Plastic bifocal lenses with a particularly large close-up part to remedy the accommodative play in people who are the 18. Have not yet completed their life year;

h)

Occlusion flasters and films as amblyopia therapeutics, subordinated occlusion capsules;

i)

Watch glass associations or ready-made side protection in the event of incomplete closure (for example, due to facial paralysis) or in the case of state after keratoplasty, in order to avoid drying out of the cornea;

j)

Iris lenses with transparent, optically effective centre in the case of loss of substance of the iris, which reduce glare protection (e.g. iris colobom, anirids, traumatic mydriasis, iridodialyse or albinism);

k)

Verbandlinsen or bowls at or after

aa)

Corneal erosion or epithelial defects,

bb)

Abrasio after surgery,

cc)

Corrosive or incineration,

dd)

Corneal injuries (perforating or lamellious),

ee)

keratoplasty,

ff)

Corneal inflammation and ulceration (for example, bullosa keratitis, neuroparalytica keratitis, lagophtalmo keratitis, filiformis keratitis);

l)

Contact lenses as drug carriers for continuous drug delivery;

m)

Contact lenses

aa)

In the case of pronounced, advanced keratoconus with keratoconusally induced pathological corneal changes and corneal traditions under 7 millimetres central or in the apex,

bb)

after corneal transplantation or keratoplasty;

n)

Plastic glass as protective glass at

aa)

seriously vulnerable persons suffering from epilepsy or spastics,

bb)

functionally one-eyed (best-corrected visual acuity of at least one eye less than 0.2).

In addition, if a refraction compensation is necessary, the expenses for the corresponding spectacle lenses according to subsection 2 shall be eligible. Contact lenses are not eligible for this indication.

2.

Non-eligible expenditure shall be

a)

Edge filter on

aa)

age-related macular degeneration,

bb)

diabetic retinopathy,

cc)

Opticusatrophy (except in connection with a dystrophic retinal disease),

dd)

Fundus myopicus,

b)

Composite lenses or shells after non-eligible interventions;

c)

Occlusion lenses and shells as amblyopia therapeutics.

Unofficial table of contents

Appendix 12 (to § 25 (1), (2) and (4))
Non-aid tools, self-treatment and self-control equipment

(Fundstelle: BGBl. I 2012, 2010-2012)

Non-eligible aid shall not include items which are neither necessary nor economically appropriate (Article 6 (1)), which have a low or disputed therapeutic benefit or a low cost of delivery (Article 25 (2)); or that belong to the general standard of living. In particular, the following items shall not be eligible for aid:

1.1

Adju-Set/-Sano

1.2

Angorawash

1.3

Anti-allergenic-Matrazen, Matrazenbezüge und Bettbezüge

1.4

Aqua Therapy-Hose

1.5

Worktop to the hospital chair

1.6

Eye heating pads

1.7

Car driver's back support

1.8

Car seat

1.9

Car boot lifter

1.10

Autolifter

2.1

Bath wanning guard/headrest/mat

2.2

Bandages (as far as not listed in Appendix 11)

2.3

Basal thermometer

2.4

Abdominal strap

2.5

Irradiation equipment/lamps for self-treatment, unless listed in Annex 11

2.6

Bed (as far as not listed in Annex 11)

2.7

Bed Board/stuff/storage cushion/board/rust/rust/rust/support

2.8

Bed-Table

2.9

Bidet

2.10

Screen glasses

2.11

Bill-tub

2.12

Blind watch

2.13

Blood pressure gauge

2.14

Bridge table

3.1

(free)

4.1

Shower

5.1

Purchasing network

5.2

One-time gloves, unless they are required for regular catheterization, endotrachial suction, sterile suction catheter or cross-section paralysis to be used in the intestine.

5.3

Ice bags and compresses

5.4

Electrical typewriter

5.5

Electric Toothbrush

5.6

Electric vehicles, unless listed in Annex 11

5.7

Electrical Air Filter

5.8

Electronic-Muscle-Control (EMC 1000)

5.9

Erection aids

5.10

Ergometer

5.11

Ess and drinking aids

5.12

Exoskeletons

5.13

expander

6.1

Color recognition device

6.2

Fever thermometers

6.3

Foot gymnastics roll, footrocker (for example, venous trainer)

7.1

Garage for ambulances

8.1

Gloves, unless they are required in accordance with point 11.21 of Appendix 11

8.2

Hand coach

8.3

Hangings

8.4

Dumbbell (Federhantel)

8.5

House notrufsystem

8.6

Skin protection

8.7

Home coach

8.8

Heating blanket/cushion

8.9

Auxiliary equipment for housework

8.10

Höhensonne

8.11

Hearing cushions

8.12

Hörkragen Akusta-Coletta

9.1

Intrashal device (sound wave device)

9.2

Inuma device (alpha, beta, gamma)

9.3

Ionization equipment (for example, Ionisator, Pollimed 100)

9.4

Ionopront, Permox oxygen producer

10.1

(free)

11.1

Cat fur

11.2

Ring lights not covered by point 12.4 of Appendix 11

11.3

Knickfoot strumpf

11.4

Knoche Nature-Break-Slip

11.5

Colorimeter

11.6

communication system

11.7

Motor vehicle including retrofit for disabled persons

11.8

Medical records, unless:

a)

they are directly related to the treatment of a disease (bladder or intestinal incontinence in the context of a decubitus treatment or dermatitis),

b)

in addition to bladder or intestinal incontinence, there are such serious malfunctions (for example, half-lateral paralysis with speech loss), which otherwise threatens the entry of decubitus or dermatitis,

c)

Participation in social life is thus rendered possible

11.9

Circulatory equipment

12.1

Storage cushion/support, except point 1.1 of Appendix 11

12.2

Language Master

12.3

Air purification equipment

13.1

Magnetic foil

13.2

Monophonator

13.3

Oral shower

14.1

Neck heating pads

14.2

Nail Pliers

15.1

Oil Dispersion Apparatus

16.1

Pulse frequency meter

17.1

(free)

18.1

Red light bulb

18.2

Back trainer

19.1

Saline brush

19.2

Sleep Therapy Device

19.3

Footwear not listed in Appendix 11

19.4

Special seats

19.5

Spirometer

19.6

Spranzrupture tape

19.7

Sprout wall

19.8

Sterilizer

19.9

Voting system for Kehlkopflose

19.10

Scooter

19.11

Stockstand

19.12

Stage bed

19.13

SUNTRONIC-System (AS 43)

20.1

TaktellDevice

20.2

Tampon applicator

20.3

Tandem for the disabled

20.4

Telephone amplifier

20.5

Phone Holders

20.6

Therapeutic heat/calciferments

20.7

Stair lift, monolift, platform lift

21.1

Exercise mat

21.2

Ultrasonic therapy equipment

21.3

Environmental Control Unit

21.4

Urine test device

22.1

Venenkissen

23.1

Scales

23.2

Wall stand

23.3

Toilet seat

24.1

(free)

25.1

(free)

26.1

Dental care products

26.2

Two-wheeler for the disabled.

Unofficial table of contents

Appendix 13 (to section 41, paragraph 1, sentence 3)
In accordance with § 41 (1) sentence 3, early detection examinations, preventive measures and protective vaccinations

(Fundstelle: BGBl. I 2015, 885)

1	Early detection and preventive measures
1.1	Telemedical care (telemonitoring) in chronic heart failure
1.2	Early detection investigations
1.2.1	U 10 for persons who have completed the seventh, but not yet the ninth year of life
1.2.2	U 11 for persons who have completed the ninth, but not yet the eleventh year of life
1.2.3	J 2 for people who are the 16th, but not yet the 18. Have completed life year
2	Protective vaccinations
2.1	Early summer meningoencephalitis (FSME-) protective vaccinations without restrictions
2.2	Flu vaccinations without restrictions
2.3	Vaccination against Humane Papillomaviruses (HPV) for girls, which is the ninth, but not yet the 18. Have completed life year

Unofficial table of contents

Annex 14 (to section 41 (3))
Early detection programme for hereditary persons with increased familial breast or ovarian cancer risk

(Fundstelle: BGBl. I 2014, 1202-1203)

Expenses for the genetic test in hereditary subjects with an increased family breast or ovarian cancer risk are based on the expenses for

1.

the risk assessment and the interdisciplinary advice,

2.

the genetic analysis and

3.

participation in a structured early detection programme

together and shall be eligible for the following packages if these studies have been carried out in the centres set out in point 4.

1.

Risk estates and interdisciplinary counselling Pro Family are eligible for a one-time risk assessment with interdisciplinary initial consultation, family registration and notification of the gene funeral in a lump sum of 900 Euros. The package also includes the advice of other family members.

2.

Genetic analysis expenses for a genetic analysis in the case of a person suffering from breast or ovarian cancer (index case) are eligible for a flat-rate sum of EUR 5 900. If a healthy person seeking advice is examined only with regard to the mutated gene sequence, the costs of 360 euro are eligible for aid. The genetic analysis is carried out in the case of the index cases. This is usually a diagnostic genetic test, the costs of which are attributed to the diseased person. On the other hand, the costs of a genetic analysis of the index person of the healthy person looking for a genetic test are attributed to the person who is a predictive genetic test. A predictive genetic test is available if no treatment options for the index person can be derived from the test, so the gene analysis does not have a diagnostic character. Such a situation must be dealt with separately by means of a written medical opinion.

3.

Structured early recognition programme expenses for participation in a structured early-recognition programme are eligible for assistance once a year in the amount of € 580 per year.

4.

Centers for familial breast or ovarian cancer-BerlinCharité-Universitätsmedizin Berlin, breast center Dresden University of Dresden, University Hospital Carl Gustav Carus, Clinic and Poliklinik für Frauenheilkunde and ObstshilfeDüsseldorfUniversitätsklinikum Düsseldorf, Frauenklinik, breast centres Göttingen University Medical Göttingen, Breast Centre, Gynecological Cancer Center HannoverMedical University Hannover, Institute of Cell and Cell Molecular-pathologieHeidelbergUniversity Heidelberg, Institute of HumangenetikKielUniversitätsfrauenklinik KielKöln/BonnUniversität zu Köln, Klinik und Poliklinik für Frauenheilkunde und Obstshilfe, Zentrum für Familiären breast-und EierstockkrebsLeipzigUniversität Leipzig, Institut für Humangenetik, Zentrum für Frauenheilkunde und Obstshilfe Familial breast and ovarian krebsMünchenTechnische Universität München, Klinikum rechts der Isar, Klinik für FrauenheilkundeLudwig-Maximilians-Universität München, Klinik für FrauenheilkundeMünsterUniversität Münster, Institut für HumangenetikRegensburgUniversität Regensburg, Institut für HumangenetikTübingenUniversity Tübingen, Institute of Human Genetics Ulm, Department of Gynecology and Obstetrics at the University of Würzburg, Department of Medical Genetics at the Institute of Human Genetics, Center for Medical Genetics Family breast and ovarian cancer